Show UniProt / TrEMBL protein name		View in Fasta format (DNA)		View as list

# Yersinia pestis biovar Medievalis str. 91001, 91001

>YP3859 putative membrane protein
MSLLPVMVIFGLSFPPIFLELLISLALFFVVRRILQPTGIYEFVWHPALF
NTALYCCLFYLTSRLFS
>YP2293 Predicted glycosylase
MMRYSGNPLITPQDITPSHPGFKVECAFNAGITKLGDETIMLIRIAESVI
PESEGITVVPLLMEISGHWQVTTRVFKHDDPAYDFSDPRLISDIADPSTV
YLTSLSHLRVARSHDGVTFVVDDQPFIFPANGDEAFGCEDARITQIDGAY
YINYSAVSAKGICTALAVTQDFTDVKRLGLIFCPDNRDACLFPEKINGKY
MTLHRPAPKHFGKPEIWLASSLDLLHWGDHRHLLGTSQDPWDALKLGGGA
QMLKTEKGWLQIYHGVDATQRYSLGALLLDLEQPTKILAKSPVPLLQPQA
PYELHGFFGNVVFTCGALIENDSLRVYYGAADECMCLAEMPLAQLWQHLS
V
>YP1956 Uncharacterized enzymes related to aldose 1-epimerase
MNEKVFTLPVVEQISPYISQRQLDELPVVVVSHPKVRAAISLQGAHLLAY
QPSGEQPIIWLSNNTPFKEGIAIRGGVPICWPWFGPTAQPAHGFARILPW
TLSAHDENENGVILTFTLEDNDMTRQYWPHAFTLIARFKLGDECEVELES
HGDYQAAAALHTYFQIGDISQIKVSGLGEKYLDKVLKVADVTQQGDLVFN
GQTDRVYTQPEAYSLIKDAALKRTIEVHHHHQSDVVAWNPGAELSCSMVD
MPNDGYKTMVCVETARVNKPLVAAPDAPARLAMTIRSRKNT
>YP3930 hypothetical protein
MINVGIFTGYYPYTLSGTIDKIKQAGMGCVQLDLEFTDIDLRRGRITKEK
AHQVRNAFRRANIPIVAISAYTNLVHPDPVKRAENIAAVKEILAHARHFG
TPYVISETGTYNTDSDWLYDPKNSTEEAYQEFKAIAKELATFAYEHNAVF
LVENYVNNIIGSVGQVARLMQEVEHPGLGLALDPTNYFDDKNIDAIDETL
HNIFNVLESRIKIAHAKDCKKTDAIAEKFGGGAAEHNSFRGAGSVELPAA
GLGALNYPLYVELLAQKHPNIPLIIEHVDEEDIPRAKRFVDEVLMATGS
>YP1050 Predicted kinase
MVEQQIAHDLNLTDAITGSLADIGQKADLAVVVGGDGNMLGAARVLARYD
IKVIGVNRGNLGFLTDLDPDNALQQLSDVLEGEYLSEQRFLLETHVRRTN
QQSRISTAINEVVLHPGKVAHMIEFEVYIDDRFAFSQRSDGLIIATPTGS
TAYSLSAGGPILTPTLDAIVLVPMFPHTLTARPLVISSSSTIRLKFSHIT
SDLEISCDSQIALPIQEGEEVLIRRSDFHLNLIHPKDYSYFNTLSTKLGW
SKKLF
>YP2928 hypothetical protein
MITKSITNVVHSAQGGVLQFNFMQGNMLKNMLAGDIMLNLFDTPRLDMAI
ANIFLRQLDDSGIVRVTPLLFHNDQLVTYKNAQDEIIWQTTAPDFTAFVT
LSFSHEQEETYYYSVRVENHSAQALRYDLIYGQDLSLSDAGATKTNESYC
SQYLDHKVFSLDKYGYTVSSRQNLPQSTGNPLLQLGSFSPAVGFSTDGYQ
FFAKQYKFSHLPTIVTEPSLENRNYQYEMAYVALQLQPVTLSAGDSADSV
FYGFYLSHQPEANIAQAFDVARIRANYRQPQREPATEQASPTQQGYDQRP
LSGDKLTAEEIEQLFDGEKQFVEQLDGELLSFFYQEANYVTLAEKERHLE
RPTGHIISSGNNIDFTNPIMNSTHYIYGVFNSHLTLGNTSFNKLLGVNRN
MLNQFKSSGQRILVQIGGEYRILAMPSAYEVGANFSRWIYKLAEGMIQVR
AFASQSEPVIQLDIAVSGHSQPLNVIVSHQLIMGNLEEEATVQVERHGDL
LQISRTGDDHGPRFSIATRGGFTGVERYVDSDSQGVQYLLLQGQIAQQAS
IAFGGVLNGVDSRGKWLDFEHERQAYHAQYRALLNDFSVSFSAAPQQAQK
LNHAMHWFTHNALTHYSSPHGLEQPAGAAWGTRDVSQGPIEFFMAMGRYQ
QVEAILCQTYRHQYLETGTWPQWFMFDEYAQVQQQESHGDIVVWPLKALA
DYLLATDRVALLDTRLSYTSIKQNFAFTGEQETLLQHVQRQIDHIVAHLV
PGTYLSSYGDGDWDDTLQPANQSLRENMVSGWTIPLTLQTLKTLTKALQA
YPQFADFIARIVTLTSNMEADYHKYLIKDGVISGFIHFNQGEAEYLLHPT
DTTTQIKYRLLPAKRSIISESFDKEMAEQHMKIIMDNLMYPDGVRLMDRM
AEYKAGKQTYFKRAELSANLGREIGLQYCHAHIRFIEALCKMGMAQELYD
NLFKTIPVGIQESVPNAELRQANSYFSSSDAKFDDRYQAYNNFDQLKTGA
VAAKAGWRIYSSGPGIYINQIVSNVLGVRYQAGDLLLDPVISRQFGDVTL
NYQLYNLPVTLRIYPQQGEFTPKRVLLDGQSLAFTLQDNPYRSGAALIHR
QEIEGRLTAHSQLEIYL
>YP1465 putative C4-dicarboxylate transporter, large subunit
MDAFILVFTLAILLAIGVPVAYAVGLSAIAGAFWIDLPLEAVMIQITSGV
NKFSLLAIPFFILAGAIMAEGGIARRLVNFAYIFVGFIRGGLSLVNIVAS
TFFGAISGSSVADTASIGSVMIPEMDKKGYPRDFAAAVTASGSVQAILTP
PSHNSVIYSLATGGTVSISALFIAGIVPGLLLSLTLMLMCVGFAYKRGYP
KGERVPFRQALKIFVDTLWGLMTVVIIMGGILSGVFTATESAAIACLWSF
FVTMFVYRDYKWSELPKLMYRTVKTVTIVMILIGFAASFGAIMTYMQLPE
RITDFFTSISDNKYVILMCINIMLLLIGTLMDMAPLILILTPVLMPVTNS
LGIDPVHFGMIMLINLGIGLITPPVGSVLFVASAVSKQKIEQVVKAMLPF
YGALFFVLMLVTYIPEISLWLPRMFGIYNG
>YP1496 ABC-type sugar transport systems, ATPase components
MREYSSGGRAGNRGSGEHVKVGIRPEHLRLCDQAEAHLIGQIQHIEHLGE
AAYFYVSVNNFDPMLVRHSEDQKLALGDDVGLMIPAHHAHLFDNKGVAFR
RTASAVQKPFSTA
>YP3554 putative transport ATP-binding protein
MSSIRLRNVTKRFGKTETLHNINLDIEDGEFAVFVGPSGCGKSTLLRMIA
GLEEISDGEVLIDDEVINDVAPSHRGVAMVFQSYALYPHMTVAENMGYGL
KVNKVPKEQIRHQIEMVAKTLQLSHLLDRKPKQLSGGQRQRVAIGRAIVR
NPKVFMFDEPLSNLDAELRVEMRLHIAKLHQEMKTTMVYVTHDQVEAMTL
ADKIVVMNYGKIEQMGSPMSLYYNPVNKFVAGFIGSPKMNFLPATVESWQ
PDSVTVTVAEGHSLTLALHTSPLQAGDPVTIGIRPEHLSVADSTVQTLDF
HCEVVERLGNNTYLFGQCHGHDGFKMLLAGDVHFRPYQKLNLSFDAGYCM
VFNADGLRINAEIPVPHE
>YP2024 Predicted N-acetylglucosaminyl transferase
MLEMLFLLLPVAAAYGWYMGRRSAQQDKQQDANRLSREYVAGVNFLLSNQ
QDKAVDLFLEMLKEDSSTVEAHLTLGNLFRSRGEVDRAIRIHQALMESAS
LTFEQRLLAVQQLGRDYMAAGLYDRAEDMFNQLVEEQDFRLGALQQLLII
HQATSDWHNAIEVAEKLVKMGKDNQRLEIAHFYCELALQAMGSDDLDKAM
GLLKKAATADKQCARVSIMRGRVHLAKGEYAKGVEALERVLEQDKEVVSE
ALPMLSECYQHLQQPQAWANFLKRCVEDNTGAAAELMLAEVLEQQEGHDV
AQTYINRQLQRHPTMRGFYRLMDYHLADAEEGSAKESLLLLRDMVGEQIR
TKPRYRCHKCGFTAHSLYWHCPSCRAWASVKPIRGLDGQ
>YP0440 Predicted nucleoside-diphosphate-sugar epimerases
MRPWLIFGAGRGVGAHLLALANQHADSASNPRPVTLLIRNQQQAEELRNK
GLTVVCGDACDPASVREACQLAGEDAAIISTLGNNNANYQGNRLIIDTAE
QLGLKRMLLVTSIGCGDSWPTLSPAARAAFGQAVREKSLAESWLQTSNLI
YTLIRPGGLLDQPATGNAIRLQTEAHGMVTRADVAHHISQMIEDPATYYQ
AYALIEPGLARKVKMN
>YP3550 putative galactosidase
MKFFKPALLTVCLSLSLMVGANAAEPFTIAPLKNVPADFIKGADISTLAE
VERQGGKFFNEQNVQQDAMAILKANGVNYVRLRLWVDPKDSDGQSYGGGS
NDLATTLALAKRAKAQGLKVLLDFHYSDFWTDPGKQFKPKAWQKMNYDQL
KVAIHDYTRDTIATFKKEGVLPDMVQIGNESNGGLLWPEGKSWGEGGGEF
DRLAGLLNAAIGGLRENLSSPSDVKIMLHLAEGTKNDTFHWWFDEITKRN
VPFDIIGLSMYTYWDGPISALQTNMDDISQRYQKDVIVVEAAYGYTLENC
DNAENSFTAKEEKDGGYPGTVQGQANFIHDLMQSVINVPDGRGKGIFYWE
PTWISVPGNTWATPAGMKYINDNWKEGNARENQALFDCQGKVLPSMKVFN
>YP1011 3-carboxymuconate cyclase
MKQAVYVASPDSQQIHVWQLDSAGELTLLQTVDVPGQVQPMAISPNQRHL
YVGVRPDFGIVSYHIADDGTLTAAGMAPLPGSPTHIDTDRQGRFLFSASY
SFNCVSISPIDTHGVVQAPIQQLDDLPAPHSANIDPTNQILLVPCLKEDK
VRLFDLSAEGQLTPHAQADITVAAGAGPRHMAFHPNHQVAYCVNELNSSV
DVYQISNNGQEYHLVQSLDAMPADFTGTRWAADIHITPNGRYLYISDRTA
NLLGIFTVSEDGRVISLVGHHLTEAQPRGFNIDHSGNFLIASGQKSDHIE
VYRIDQNTGELTTLKRYPVGKGPMWVSIRGAQNS
>YP2733 putative membrane protein
MKNRLFKTLGGLVFLLSFLFLMKYLIINSIIPLIKIEDRIIFSSSIAICL
ISFPLMSYVMTASVYFFIFNKVPKFNKLIVKYLTMLTIASFIVSFPIPFY
IDYKLKNNGYVVCDRISWMSPNTYVRDLSLCK
>YP1128 conserved hypothetical protein
MSRLLSRRQAPDERGLTQRITPAQAGWGYVGFEVYELNEGQPLTLTAVPD
ERCLVLIAGRASISTPSAQFPNIGDRMSPFERHKPWAVYVTPGEAVQVQA
ITPLELAVCSAPGKGTYPTRLISPEDIGAEARGKGHNQRYVHNILPEDHP
ADSLLVVEVYTNEGASSSYPSHKHDTDNPPHETYLEETYYHRLNPEQGFC
MQRVYTDDRSLDECMAVYNREVVMVPRGYHPVATMAGYDSYYLNVMAGPV
RKWIFSWENDHVWINHNYPIT
>YP3757 putative pectinesterase
MPINALSKTLLLGLISFAALGEVSAAQYNAVVSAMAQGDEFSSINAALQS
APPDSSPFVIFLKKGVYTERLEVNRDNVTLKGEERDTTVIGANTAAGMLN
PQGTKWGTSGSSTVLVNAANFTAENLTIRNDFDFPANQAKAEGDPTKLKD
TQAVALLLAEKSDKARFRQVKLEGYQDTLYSKTGSRSYFTDCDISGHVDF
IFGSGVTVFDRCNIIARDRRDISPPYGYITAPSTQNTAPYGLIVLNSRLT
KEPGVPAKSFALGRPWHPTTAFDDGRYADPAAIGQAVFINTVMDDHIYGW
DKMSGKDKQGEKVWFYPQDSRFFEANNQGPGAEINEGRRQLSAEQLKAFT
LPMIFPDWTVQ
>YP2731 putative membrane protein
MKNRPFNILFGMIIFSVVLFMMYLVFLCLISLIRMEDKITFSSSIVICLI
SSPLLFYATAGSVYIFVFNKEPKFNKMIVKYLTMLAIASFIMSFPISFYV
DYKLKSNGYVVCDKISWMSPNFYVRDLSLCR
>YP1775 Predicted nucleoside-diphosphate-sugar epimerases
MIAVTGATGQLGRLVINVLLKKVPAHDIIAAVRSPDKAKDLMALGVQVRQ
ADYNQPTTLDSAFKGVDKLLLISSSEVGQRVAQHTAVINAAKRAGVKLLA
YTSLLHADKSPLGLGEEHRATEGLLRDSGLPVVLLRNGWYTENYAASIAP
ALAHGAFIGAAGNGRIASASREDYAEAAATVLVQENQAGKIYVLAGDDAY
TLSEFSAEITRQSGKAVAYQDLSEADFKHALISAGLPDGLAGMLADSDAG
AAQGGLFDDSHTLSKLIGRPTTPYAKVITATLATR
>YP3531 putative PTS permease protein
MLFEATLVGIWAFLCGIDKYDVALNIHRPLITGPVVGLIMGNMEVGLIAG
ATLELAWLGLVPNAGAQPPDVTMGTIAAVAFAVMTGQSPEVAMGVGMPIA
VLMQMIIIGFFAMTAFTMGRADKYAEQADTAGISRLLIGTLLTRSMLYFV
IAFVTVYFGEHAATWIDENTPTALLEGLGIGAKMVPAIGFAMLLKIMWSK
EVAGVFFIGFVMTTYLKLPIMAIAILGAAVAVLYYFFSGNNNGSNNNGNN
TNKQPEDFEDGI
>YP0324 putative membrane protein
MPTGVSMQNVTQIMNDEQQEEEEPSYSFSGGVTGFVFYWLAFAIPFFVYG
PNTVFFLLYTWPFFLALMPVSVLIGIALGMLSRGHLLFTIGGTGIAVVCL
FWMLFSLLTGW
>YP2926 putative membrane protein
MINKRKIVLAAILLTVNGGLFAQSVVIDQLKVSEHLYPKGFESEFQNNLD
FYRDGVGVDEKAKVPYDTIRIEGTEIVKGYYTNTTEVGLYLNILTESVKA
GNLQALQRIKETLTTLEQAPKWNGLFYWPYDIRDGKLVTNPDEIVPAVDN
GNLSFALAGVAGAFLDSSDADKQEIVQRIEAILDGQKPGWAALYDENKGL
LSSGWSTKNNASLGYFVDRKGNESRAAVAWAVLATKDMGAKALPVSAFSK
MELYTQRYEINGKQYNPLLTWDGAYFQMMMPQIWLNERELMPNYGIVEDH
TFIQKVYASKHGIPMVSSSATTDNAYHAFGVPQLSESKVRFKNKIDDGYT
GTPHAIALSYIVDPAGAISALKKLKQAYPNIESPYGWYDAVDSSGKISKN
ILSLDVGMFVGAFLAKEINADVEKYLQSKGDMELLKEMYQSYVPNNYKPL
DGLSSSSLH
>YP3532 putative PTS permease protein
MASDITVDKDHTAKAKTDSLVDKIDSYQDLEVRKVVTRKDLWKCAIRGLF
MEGNFNFERMQAGGFAYSMIPALKKIHGNNRADLAKSLKNHLQFFNASPK
LFTFLLGTAVAMEENKEKPSMINVMKVAGMGPTGGIGDAIDHMTLMPLTL
ALGASIAIEGSIAGPFVFFILYQTVHFLVYFGLMFMGYRAGTAAMVNMGD
ATEKLAKAANIMGIFVIGALCATFIRLQTTAAIDLGGKTVELQTALFDKI
MPNLLPLALVFFMFKMVKGTGFWAKPPVLIFSTLAAGVVGHLLGIV
>YP1466 putative C4-dicarboxylate transporter, small subunit
MARYYLSAMDVLYRLSIWVAGIALIIMVAAIPIGIFARYIQNDGLSWPEP
VAILCMVTFTFIGAAASYRSGSHIAVSMVTDRIPEAGKKICALLVNLLMV
MISLFILSYSYILCSELWSQPVAEFPLLTAGQTYLPLPVGSAITLMFIIE
RLFFGPQTQRPVVMIGNS
>YP1240 putative membrane protein
MTPQRILVLGASGYIGQHLVPLLSQQGHQVTAAGRRIEWLKEQAWPNVNC
CFVDLYQPATLNAALQDIDVLYYLVHGMGDGQDLIEQERLAASNMKNALQ
PLGTAQTSSVKQIIYLGVLQPGDNSSSHLIARKLTGDILRQSGIPVTELR
ASIIVGPGSAAFEVMRDMVYNLPILTPPRWVRSKSSPVALDNLLVYLTEL
LNHPTEENRIWDVAGPEYISYQTMFERFIAISGKRRWLIPIPLPTRFISV
YFINMITSVPTSIASALIEGLNHDLPADGRALQALIPQKLIRFEDAVKET
LRREDEVVDSADWGYDPEARARWRPGYGFYPKQAGCQRSTTASSEALWHV
VQQIGGKEGYFYGNPLWKIRARMDDMIGGGVVYGRPERETLELGDLIDGW
KVITVKPLRQLALMFGMKAPGLGRLTFTIKDLGGCRSLDVRAWWHPAGFS
GLLYWFVMMPAHLFIFRGMARRITALAEHDDRERDARAKNSAGSKQ
>YP2231 conserved hypothetical protein
MWQAVNRLLSECLGPAEIRERTELPGGDIHEAWRLSYGEKEVFVKCNTRE
MLPIFTAESDQLSLLARSKTVQVPEVYGVGSDRDYSFLLLEYIPLKPLDA
HNAYCLGQQLAHLHQWSEQLQFGLDFDNDLATTPQPNSWQRRWAQFFAEK
RIGWQLQLAAEKGMSFGDIDDITNAVQERLQSHQPQPSLLHGDLWPANCA
ASSNGPVIFDPACYWGDRECDLSMLPLYPTLPAQIYDGYQSVWPLPIGFI
ERQSIYQLYYLLNRSNLFGGKHLINAQKAVDNLLHPEQFSL
>YP0375 conserved hypothetical protein
MSAIPRKLIFAVIIGNRGFFPSYLVSDARRDAQALFDRLGINIIMLNEEQ
TPLGGVENWHDAKVCAELFRQHSEEIHGVVVILPNFGDEKSVSDAIRLSG
LKVPVLVQAEEDALDKMGLATRRDSFCGKISLCNNLRQYGIPFTLTKQHV
CSLNSEIFSRDVEQFVQLCRVVHAMKRVRVGAIGARPTNFNTVRYSEKLL
ENLGITVETLDLSEVFFRVANLSDNDIRVGEKLALLKANGDTSTIPQDKL
HKMAKLFVVISEWIIANDIDTTAMQCWTSLQQNLGINVCSIMSVMSGQLM
PSACEVDVMGALSMYALASCSLAPASIADWNNNFGAERDKCVLFHCGNFA
SESLESSTMGTADIIGTTVGCENTCGAVHGRMKSGPLTYFRLSSDDFTGQ
VRAYVGEGRSVSDELNTVGCRAVVEVPQLESLLTHICNNGFEHHVAMNHS
ATAQVLQEAFSKYLGVDCYWHGKP
>YP3545 putative glucosidase
MMKTLKNWLLINEYPDHLELRVDDRHIFCLYVLEPNLCRVLIKREGELAL
SRTWSIAPQGDVPWSGRDRLSLEGFSLPGYQLEKHEQQLVVTTECLRVTI
HQPLHLTWEYKNPHGEWLPLAADRPTSAYLLSPQGEAIAHYQRRYPNEQY
YGLGEKAGDLNRAGRRFEMRNLDAMGYNAASTDPLYKHIPFTITRRDDVS
FGLFYDNLSSCWLDLGNEIDNYHLAYRRYQAEAGDLDYYLFLGPKVLDVT
KAFVRLTGKTQFGPKWSLGYSGSTMHYTDAPDAQVQLQKFIALCQQHDIP
CDSFQLSSGYTSIKNKRYVFNWNYDKVPQPKVMSQTFLQAGIKLAANIKP
CLLQDHPQYQQAAERGLFIRDSETDLPERSTFWDDEGSHLDFTNPDTVNW
WQENVTKQLLEMGIGSTWNDNNEYEVWDGEARCNGFGKSIAIKHIRPVMP
LLMMRASMEAQKAFAPEMRPYLISRSGCAGMQRYAQTWSGDNRTCWQTLR
YNIRMGLGMSLSGLYNLGHDVGGFSGDKPEPELFVRWVQNGVMHPRFTIH
SWNDDNTVNEPWMYPAATPMIRDAMALRYRLLPYFYTLQWQASHDDEPML
RPTFLDHEHDSLTFKENDDFMLGRDLLVASVVDAGQRQRQIYLPDNQVGW
YCFHSGQWYSGGQTITLDAPLERLPLLVRAGAALPLSRRIAFVNPEADCQ
RELALYPTQGGGQSSGMLFEDDGESHRWQQGHALWLNWQVTTDNHRIDIT
FSRTGNYQPAWRELTINLPTNESRTLSINGVAGNTLDLTKLA
>YP2927 putative transporter ATP-binding protein
MMTGVMLHNVNKIYPNGMQVLHDINLDIKDGEFMVIVGPSGCAKSTMLRM
IAGLEEISSGELTIADRKCNDVQPKDRGIAMVFQNYALYPHMTVYENMAF
GLKVAKKTKAEIAQRVNEAAELLEITDLLQRKPKEMSGGQCQRVALGRAM
VRKPAVFLFDEPLSNLDAKLRVSMRLRISKLHQQLRESGRPATMIYVTHD
QVEAMTMGERVCILRKGKIMQVDRPMNVYRHPLNKFVAEFVGSPAMNMFS
GRIEEYQEQLVIRCGEYRFPLPADKVAKSRSYLGREIDFGIRPEDISISR
ADVANALTATVIRVDAMGSDEFIYFNLMGQQAICKRPNPEDEIQINETCH
FSFNLDKCHLFDKESEKNILYI
>YP0617 Predicted nucleoside-diphosphate-sugar epimerases
MAKVLLLGASGLVGGELLRLLRLDARVTSIIAPTRNPLPAMNKLINPHGE
NIGQLLKMLHEPVDLVFCALGTTRKQAGSQAAFRQVDYRLVLLSGETGRR
LGARHFLLVSALGANPDSWLFYNRTKGEAERDLQAQGWPQLTFARPSMLA
GQRATPRLLENLSAPLFALLPAKWRLINAKDVAQAMLDQAFAPPQEGVTV
LSSAQMQPTLRP
>YP3527 agaR, DeoR-family regulatory protein
MKAAIERRMEIFNIVTQQGKARVEDLAERFNVSSVTIRSDLSFLEKNGYI
VRSHGSAIPNTGVIAELTVHEKRRRNSGVKSLIGQAAAKLINSGDTVILD
SGTTTREIAANLRSVENVVVMTNGLDVAMELASAPGVEVLISGGVLRKSA
MSFSGSQAEASLKNFRFDKVFLGVDGFDLRVGITTYNEQEASLNRLMCDI
SEQIIAVADSTKFGKRSCHMIREFGDIDILVTDSDIPEEYVQRLRDMRIE
VIIAEKEK
>YP3540 agaY, putative aldolase
MFLVSSREMLRQAQIGGYAIPAFNIHNLETIQAVVETAAEMASPVILAGT
PSTFSYAGTEYLVQICQQAARHYRMPFALHLDHHESYDDITQKVAAGIKS
IMIDGSHFNFEQNIALTRQVVEYCHRWDGTVEAELGRLGGQEDDLTVDEK
DALYTDPGSAAHFIQATGIDSLAIAIGTAHGMYKEAPSLDFDRLALIRRN
TDIPLVLHGGSGIPDEDVRRCIELGISKVNVGTELKIAFSGALKAYFLEN
KGANDPRHYMVPAKAAMKKVIQDKINVCGSAGKR
>YP3528 agaZ, putative tagatose 6-phosphate kinase
MHPLEKLVQRHKAGEQIGIYSVCSAHPLVIEAALEQALENDSELLIEATS
NQVDQFGGYTGMTPVDFRDYVFAKADALHFPLEKLILGGDHLGPNRWQHL
LANEAMAHADDLIAAYVAAGFKKIHLDCSMSCADDPVPLSDEIVAERAAR
LAAIAEATEYQHFNTHTAVYVIGTEVPIPGGATEELDEIEVTSPEAARKT
IECHQKAFEKSGVAECWPRVIGLVVQPGVEFDHTGVIDFCPEKAHELSKV
MDEYDYQVFEAHSTDYQTDDAYRALVKGHFAILKVGPALTFALREALFSL
CHIEEELFPAEQCSRLRQVMEDVMLKSPEYWKRYYLGDTEQVRLARVYSF
SDRMRYYWPMEAVQAAQEKLFANLNSAPIPLPLLSQYMPRQFTAVREGTL
SFEATALVKQQIKNTLIGYVNACHLFNGNTSK
>YP0769 ampG, Beta-lactamase induction signal transducer AmpG
MLNRMLCPIPCGRAGRFIMPNRYSNLFTQRNSIILLLLGFASGLPLALTS
GTLQAWMTVENVNLKTIGIFSLVGQAYVFKFLWSPLMDRYTPSFLGRRRG
WLLVSQLLLIIAIIAMGFMEPAKHLWWLAAVAVLVAFCSASQDIVFDAYK
TDLLTTEERGTGAAVSVLGYRLAMLVSGGLALWIADRYLGWQSTYWLMAG
LMLIGVFATLLAPEPDIRIAPPKTLEQAIVAPLRDFFGRNNAWLILLLIV
FYKMGDAFAASLSTTFLIRGVGFDAGEVGLVNKTLGLIATIIGALYGGLL
MQRLSLFRALMIFGILQAVSNMGYWLLAITDKNIFSMGSAIFLENLCGGM
GTAAFVALLMTLCNKSFSATQFALLSALSAVGRVYVGPIAGWFVEAHGWP
LFYLFSIAAAIPGLLLLYVCRQTLDHTQKTDEFMPRIAFKTAYRWALRLL
IIGGLLLSVWLILLICNALDWTSAPQVADTLLLRGIQFSIVGMTLGGLLD
YLALRRQKLA
>YP3075 amyA, Glycosidases
MLSARSIPNPALYRIHPVSFRDGQGNGVGDYRGLNGVCDSLLPCWISMLR
RCSTCSPILRPRRRPGQPCHWLGGTARSERVIRALGVINGSCRGLLPLFF
FIQIHMKSCLRKQRSNAWLM
>YP2049 araA, L-arabinose isomerase
MDVFKQSEVWFVIGSQNLYGPKTLQQVMDNAHQVVNSLNNEAGLPVKLVL
KPLVTTPDEITALCREANYDTACIGIMTWLHTFSPAKMWIGGLSILNKPL
LQFHTQFNAQIPWKTMDMDFMNLNQTAHGGREFGFIGARMRQQHSVITGH
WQDKEAHQRIGQWMRVAAAKQESQQLKVARFGDNMREVAVTEGDKVAAQI
QFGYSVNAYGIGDLVAVVDAVSKGDIDTLVEEYEATYRFTDAVKLNGDKR
ENLLDAARIELGMTRFLEQGGFKAFTTNFENLYGLKQLPGLAVQRLMQQG
YGFGGEGDWKTAALLRILKVMGTGLKGGTSFMEDYTYNFQPGNDLVVGSH
MLEVCPSIAKEEKPLLDVQHLGIGGKADPARLIFSTPAGPALNASLIDMG
NRFRLLVNVVDTVEQPHPLPKLPVARAIWQAQPSLATAAEAWIIAGGAHH
TVFSQAVGVDELRLYAEMHGIEFLLIDNDTTLPAFKNEIRWNEVYYQLNR
>YP0360 araD1, L-ribulose-5-phosphate 4-epimerase
MTSFEYRMMFFIIACPSEYYFMRCTMLEQLKQQVFEANLALPKYKLVTFT
WGNVSGIDREHGLVVIKPSGVEYDVMSVNDMVVVDLATGKVVEGDKKPSS
DTDTHLVLYRAFAEIGGIVHTHSRHATIWAQAGKSLSALGTTHADYFYGP
IPCTRLMTEAEITGDYEHETGKVIVETFAEQGLRAADIPAVLVNGHGPFA
WGSNAANAVHNAVVLEEIAYMNLFTHQLTPGVGDMQQTLLDKHYLRKHGA
AAYYGQ
>YP0905 araD2, putative class II aldolase-family protein
MNSPPFSEPPPSLEPPPASKLSPPAKQVPFSEQQVRDDLVNYARSLFQRG
LSSGGAGNISVKLPDGSFLVTPTNSCLGELDSQTLSKLDAEGNHISGDKP
SKEVPMHLAMYRARSTCGAVVHLHSPYLTALSCLTNIDHTNCLPPITPYY
VMRIGRLPLLSYMKPGDPAIATALADTARDHNAVLLANHGPVVSGSTLKN
LKIRHGSIF
>YP2029 araD3, L-ribulose-5-phosphate 4-epimerase
MQDFQPICTQFLAIYPIPVISCGAENGTNSVIQDTTMLNELKQQVLAANL
ALPRHNLVTFTWGNVSAIDRQKGLLVIKPSGVEYASMTLDDMVVVELESG
NVVEGSKKPSSDTDTHRVLYLNFPQIGGIVHTHSRHATIWAQAGLDLPAW
GTTHADYFYGSIPCTRLMTHEEIAGRYEWETGNVIVDTFHERGITPDAVP
AVLVNSHGPFAWGSSAENAVHNAVVLEELAYMGIFSRQLNPQLGDMQPQL
LDKHYLRKHGKDAYYGQ
>YP2051 araF, L-arabinose-binding periplasmic protein precursor
MHKLTKALAVVGLAAVMSHSAIAESMKLGFLVKQPEEPWFQTEWKFADKA
GKDLGFEVIKIAVPDGEKTLNAIDSLAASGAQGFVICTPDPKLGPAIEAK
ARSYNLKVIAVDDQFVNAKGKPMESVPLVMMAATKIGERQGQELWKEMNK
RGWQPAETAVMAITSDELDTARRRTGGSMAALQASGFPEKQIYKVPTKSN
DIPGAFDAANSMLVQHPEVKNWLIVGMNDNTVLGGVRATEGQGFKAPNVI
GIGINGVDAVSELSKGQATGFYGSLLPSPDIHGYKSIQMLHDWVTKDVEP
AKFTEVTDVVLITRDNFKAELEKKGLL
>YP2052 araG, L-arabinose transport ATP-binding protein
MSAPHSALQAELDAAQSPYLAFRGIGKSFPGVLALDDISFTCQAGQIHAL
MGENGAGKSTLLKILSGNYTPTQGEIHIKGKAVNFTNTTDALDAGVAIIY
QELHLVPEMTVAENIYLGQLPTKMGMVDRKLLRYESRIQLSHLGLDIDPD
TPLKYLSIGQWQMVEIAKALARNAKIIAFDEPTSSLSAREIEQLFRVIRE
LRAEGRVILYVSHRMEEIFALSDAITVFKDGRYVRTFDDMTQVNNASLVQ
AMVGRNLGDIYGYQPREIGSERLTLQAVKAIGVASPISLTVHQGEIVGLF
GLVGAGRSELLKGLFGDTKLTSGKLLLDGQPLTIRSPIDAISAGIMLCPE
DRKADGIIPVHSVQDNINISARRKTLTAGCLINNRWEADNALLRIQSLNI
KTPGPQQLIMNLSGGNQQKAILGRWLSEDMKVILLDEPTRGIDVGAKHEI
YNVIYQLAKQGIAVLFASSDLPEVLGLADRIVVMREGAISGELDHEYATE
EQALSLAMLRTPNIATNTASAVA
>YP0355 araH1, putative sugar ABC transporter, permeaseprotein
MKKNRFLPIDGTISGLLGIFCLATLAFSLAMPGRFFTENTFLSIAFQLPE
LGLLTFAMFVPMLSGGLNLSIIGTANLTSLFMAWLLIQYVPADASTTTQL
MWLLLALMGAALIAVVIGTLTGLMIARIGAHPILVTLGSMTIISSIGVYL
TKGAALSGMPPIVRSMGSEVVMGVPIPMIIFIVASLLLALFLGKTRLGKT
IYMCGSNINATWFSGIRTDRVMMAIYTMSSLLCVLAGLIMMSRFNSARMG
YGDSYLLLTVLAIVLGGTNPFGGVGKVSHVFCALLVLQVIATGLSLLGVS
LHVNLAVWGITLIFALAFKFFKEKWKAKRAMRQNRLNYLKKCHAK
>YP3142 araH10, putative sugar transport system permease
MGNRSLSMTQRPRKVKWVLPKGATQFGALAVILLIDSLVAPHFFSIHIQD
GRLFGSIIDILNRGAPVALLALGMTLVIATGGIDLSVGAVMAIAGATAAT
LTSAGYPFMTVLALSLAVGALCGLWNGFLVAVLQIQPIVATLMLMVAGRG
IAQLITEGQIVTFDSGGLATLGSSTLMYLPMSVVIACSMLILVWLLTRKT
ALGLFIESVGINLRSARNAGVSTRLVLIAVYVICGVCAAVAGIIVTADIR
GADANNAGLWLELDAILAVVIGGASLMGGRFNLLLSVIGALIIQGMNTGI
LLSGYQPEFNLVLKAIVVLAVLVVQSPMISLSHLFQRRK
>YP3143 araH11, putative sugar transport system permease
MLKRNVPLLITIAVFILGYAFCLSQFPSFSSSRVWCDLLTDNAFLGIVAV
GMTFVILSGGIDLSVGSVIAFTGVLLAKLIGTYGIHPVYAFAIVLVMGAM
FGALMGWIIDSLKLPAFIITLAGMFFIRGMSFIVSEESLPINHPIYETLA
NYAWRVPGGGRFTLLAFIMLMVVAFGILLAHHTRFGHNVYAIGGNSVSAG
LMGVPVRRTTIKIYMLSSTLAALSGIVFSLYTSAGYALAASGVELDAIAA
VVIGGTLLAGGIGTVFGTLFGVLIQGLIQSYITFDGTLSSWWTKIVIGIL
LFSFIVIQKAMSAFYLNRRSRPQSSPLTPV
>YP3397 araH12, sugar transport system permease protein
MSQANQSEFNSPENGDKKPFFRLKSLNLQVFVMLAAIAIIMLFFTFTTEG
AYLSARNISNLLRQTAITGILAVGMVFVIISAEIDLSVGSMMGLLGGIAA
IFDVWLGWPLPLTIVVTLALGLVLGAWNGWWVAYRKVPSFIVTLAGMLAF
RGILIGITNGTTVSPTSNAMSQIGQSYLPSGIGFGIGAIGLMLFVAWQWR
RRNHRIRLGLPVAAPQGDVTRQTITAVIVLGAIYLLNDYRGVPTPVLILT
ALMLAGVFMATRTAFGRRIYAIGGNIDAARLSGINVERTKLAVFAINGLM
VAMAGLILSSRLGAGSPSAGNIAELDAIAACVIGGTSLAGGVGSVAGAVM
GAFIMASLDNGMSMLDVPTFWQYIVKGAILLLAVWMDSATKRRV
>YP3484 araH13, putative sugar transport system permeaseprotein
MTSRQYYIKDKVMGSIVKEVDDVRQVSLMKRTALFLLDNSTTVVFIVMLI
AAGFFSDRFYSGDNITNVLRQSVPLGLAALGMLFVILTGGIDLSIGSIMA
FVSVLVGLLIPEFGLWPALIAGVGIATLMGAFSGFLVTWFNIAPFIATLA
MMTIARGVALIISKGQPVFIDNDAFVNFGTGYFLGIPLPVYVFLGFAIIC
QLVYKNSVFGRLVVSIGSNETATRFAGIRVNNYKLAVYAISAFACGAAGI
ISATRTGVGSPVLSIGFELDVIAAVVVGGASLAGGHGNVVNTIIGVFILS
IISNLMNLMNISGYNQQVVKGVIIIIAVMVQSLKSRSKA
>YP3770 araH14, putative ABC transporter permease protein
MLKFIQNNREGTALLAILTLFALLGIIDRNYFSLQTFTMIFSSAQILILL
AIGATLVMLTRNIDVSVGSITGLCAVTVGMALNAGFGLAASCLFALLVGM
VAGFFNGILVTWLRIPAIVATLGTLGLYRGLMLLLTGGKWIEGLPADLKS
LSTPILFSISPIGWLTMLLILAMAWLLGKTAFGRSFYATGDNLQGARQLG
VRTDSLRIFAFSMNGVMAALAGIVFASQIGFIPNQTGNGLEMKAIAACVL
GGISLLGGTGTIIGAILGAFLLTQIDSVLVLLRLPAWWNDFIAGLVLLGV
LVFDGRLRCAVERNIRQQKYARFTAQAIISDKKPTVSDNNPAASNKKKAA
L
>YP3771 araH15, putative ABC transporter permease protein
MNLYRRYGWELTLAALLVLEILLFGLSNSRMLDINVLLFSTSDFICIGIV
ALPLTMVIVSGGIDISFGSTIGLCAIFLGIVFQAGVPMSVAIPLTVLVGA
LCGLINAGLILYTGVNPLVITLGTLYLFGGSALLLSGLSGATGYEGIGGF
PAAFTDFANQTLFGLPIPLVIFMLCVLLFWLLMHRTHSGRHVFLIGQSSR
VARYSALPIARTLCMLYAMTGVASAISAILLVSYFGSARSDLGASFLMPA
ITAVVLGGANIYGGSGSILGTALAVLLVGYLQQGLQMIGTPNQISSALSG
ALLILVVVGRSISLHRHLIYEWLQRRRSRKASA
>YP3911 araH16, putative ABC transporter, permease protein
MTWLNRTIPDDRIIRLQLLILIAVMLVFSLTLGQRFFSLGNFQSMSSQLP
ILGMLALGMGLTMLTGGINLSIIAGANACSLVMAAIIVSHPGQPAFLLLA
LVAGLLVAVAIGTLNGVLISVIGVSPILATLGTMTLITGLNILLSNGDVI
SGFPPVIQYIGSGDIVGIPVAMILFLLVAAGLWVLLEHTTLGRSIYLVGS
NEQATRFSGVNTHRVQIAVYILSALLGWGAAILMMAKFNSAKAGYGESYL
LVTILASVLGGINPDGGFGRIIGLILALVVLQLLESGLNLLGVSSYLTMA
LWGGVLILFIALQNRKA
>YP3912 araH17, putative branched-chain amino acid transport system, permease component
MDKLKLRQLTGHHEFYLGLLVLLLAIGLSVQSPEFLTLGNLTDVATSYAI
LGILACGLFVVLIAGGIDISFPAVTAIAQYVMASWVITQGGSFPLALVMA
MAVGLLLGLINGLLVYWLKVPAIIITIATLNLFYGLLVYFTNGTWLYGFP
DWFMTGINWFSFEGSDGYDYGLTLPLLCLAGTIIFTGVMMNYTRLGRQIF
AMGSNKDAASRLGINIFRLHLYVYGYMGILAGVAAVVQAQISQSVAPNSL
MGFELTVLAAVVLGGTSMSGGRGSLTGTVLGVMLLAFLQNGLTLLSVSSY
WHTVFSGVIILVSISTTAWNEKRKLLREH
>YP0356 araH2, putative sugar ABC transporter, permease protein
MANFGRLKPQSVEGWLAWVIVLMLALFSLLSREFLSIQNVLDLAESYAVT
GIFALGLFVVLVTGGIDISFAAVASVVQYVVASLLLNDVIASPVLCLVIA
VAIGVLLGFVNAVLIYYLNIVSIIITISMQSLLFGMLMWLTNGHSIYDLP
NWWVDQRSILPFTVNGESYQIGLPLVIMLAIALLTWILLNKTHIGRQLYA
VGGSPESARRIGIRVSLIYLFAYGYLGAAAAIGGMLQTYRMSEVVPSALV
GGELDVLAAAVLGGASLSSGRGSVIGTLMGVFLIGILKNGLNLIGVSSYF
VNIVIGMVIVAAICVTHYKKRKETDVGFV
>YP0371 araH3, putative sugar ABC transporter, permease protein
MMKATTGTALASHLPGGASWSRENMLLLLLKMRTFIALFLILGFFSIMVP
GFLATGSLIIMVKHIAINAFLALGITFVIITAGIDLSIGATLGLCGMIAG
WMITQGIVLPMFGIAIFPSVWVVVPVVLVIGALIGAVNGWIITRYNVAPF
ICTLGTMYVVRGASMLISGGETFPGLQGNPQLGNTGFDLLGSGTLLGLPI
AIWIMFILALVIAYVARRLPFGRHVYAIGDNERAAELSGVKVRQVKVWVY
TLSGFCAAIAGIIVSAQLVASHPANGSGFEMNAIAAVVLGGTSLAGGRGT
ILGTLIGAFVIGILADGLVMMGISEFWQMVIKGIVIIVAVIIDQMQNRMQ
HKAAIVSQKVTAIPSDVTSQAGIISQTVKSE
>YP1132 araH4, sugar transport system permease protein
MLQPLSKPQASVKSAMRFDPITFFERFGVLIFMFLLLIFFQLQNSNFLSE
RNIFNILTEVSIYGIMAVGMTFVILTAGIDLSVGSILAVSAMTAAYVIKG
DNFTTIDPNAWGGMSWLIGLSICLAMGTLIGFLQGLGVTRLRLPPFIVTL
GGMTIWRGLTLVINDGAPIAGFDAGYRWWGRGDLLGISIPIWIFAIVAIA
GYLALHKTRWGRFVYAIGGNPEAARLAGVNVKRVLVSVYVVIGCLAGLAG
FILSARLGSAEAVAGISFELRVIASVVIGGTSLMGGYGRIGGTIIGSIIM
GILINGLVLMNVSAYYQQIITGLIIVLAVAFDTYAKNRRGAL
>YP1296 araH5, putative ABC transport integral membrane subunit
MDKATETRREGAPTASKLNGQAMLGWVLHHIVWIWLIALVVIFGVFNEFF
LTISNLQNVMVQATVLGTLGLAVALPLLVAEIDLSIPANAGFSAAVGAMA
YAELGLPWPIAALIGLLVGTFIGFFNGVCITRLKMVSLIETLAMMIIIQG
ALLALTQGKTLTNLSEGYIWIGQATIGGWPLMPVVFLLVLAVMGAVLKYT
VLGRSIYAVGGNPVASNSAGIRVARVKIIAYTISGFLAALAGFLLASWQM
AITSNQGSSYLLYAIAAPIIGGVSVFGGHGNVKGVLGGVLLLTVIQVGLA
IVNVPSFYVGMIGGVIIFIAVAIDAFRIRYFG
>YP1442 araH6, ribose transport system, permease protein
MSKELPLPDVQPWRHQLFDFLYKWGMLLTVVALIALFGLASDNFLDPNNI
INILRSIAIVTVIAIGVSISLSIGGFDLSVGSTASLANAVVVSLFVWYGF
GTTGAIILTLLICTLVGLFNAFLIVVLKIPDMLATLASLFVIQGVAMTYS
RGGSITQSMLLPSGDMAEGVIPEIFSALGQVPVIVLIMLAVTVVVQLYLS
LTKHGRRMYAIGGNPQAARLAGIRTVRYRVLAYVLSAQLAALGGILLASR
IGSSQVNAGSGYLMDAVAAAYIGFSLAGSGKPNAFGTLIGAIILGVLQNG
LVMLSVPYYAMDIIKGLVLAMALALTYIQKR
>YP1578 araH7, putative permease of ABC transporter
MVIDLPAHSKPSRSFNAIIAWCLQRPSTFTFMLIVIVCVTVGAINPAFLQ
LSNLFDIARASVVVGLFALGVLIVLASGGLDVSFTAIAALCMYAVTKFVL
WYWPDAPVIAMFIASACGGAILGGINGVLVHSLKTSSLIVTIGTQYLYRG
GLLTFIGTALYMNIPEQLEQFGKSPLYTVSNINQGITILPLFFLILVFAS
LLTWWLLNRTLLGRAIFAIGGNSDIAQRLGFDVRGVQIFVFTYAGLLAGI
AGMVHVASNRIANPFDLNGLELTVIAAVILGGARITGGSGTVLGTLMGVV
LVVLVNNVLILVGIPSTWQKVIIGAFIIAAGSAFGWRKYR
>YP1581 araH8, putative sugar transport system permease protein
MGVQTVMKVQTRMGCKQLTRRMLNDKQLNFLVMVNMLVITVAATLTQGAF
VDLYNLQTMAGQVPELGLLAMGGMLAMIVGNGGIDLSGIALANLAAVVAG
TLTPGWVNAVDSPLLFTVVFVLCALLVGLTGGLINGVLIAYAKLTPILCT
LGTQLIFTGFAVVISHGSGVKIGFIEPLSFIGDGLIANIPFCFALFILLA
TLLGLWLRFSATGIRLYLLGTNLKAAQYIGIAQQRLLVVIYTLSGTLAAI
AGIIIAARSTSATADYGSSYVLIAILIAVMAGVRPEGGYGRMGCLLLSAT
ALQFLSSTFTFLDVSSFFRDCAWGALLLFFIIFSRINPLDFVKSLWRKNT
PSVQSPVR
>YP2053 araH9, L-arabinose transport system permease protein
MKELIMSSVTLSSDKKNPVSTESNGGIPQPQQPQNAPTKSGLGLSRIWDS
YGMLVVFAVVFIGCVIFVPNFGSFINMKGLGLAISMSGMVACGMLFCLAS
GDFDLSVASVIACAGVTTAVVINMTESLWIGVGAGLLLGAACGLINGFVI
ARLKINALITTLATMQIVRGLAYIISDGKAVGIEDERFFALGYTNWFGLP
APIWITVACLVLFGFLLNKTTFGRNTLAIGGNEDAARLAGVPVVRTKIII
FVLSGLVSAAAGIILASRMTSGQPMTSIGYELIVISACILGGVSLKGGIG
KISYVIAGILILGTVENAMNLLNISPFSQYVVRGLILLAAVIFDRYKQLA
KRTI
>YP2859 araJ, putative sugar transport protein
MPVALLALALCAFAIGTTEFVIMGLLPQVAGDLHISIPTAGWLISGYALG
VAIGAPIMAVLTAKLPRKKTLLLLMVIFIIGNLMCALAYSYDFLMFARVI
TALCHGAFFGIGAVVAANLVAPNRRASAVALMFTGLTLANVLGVPLGTAL
GQAFGWRSTFWVVSVIGLFSLAALYSKLPSSSEEAPTELRKEIAALRGGG
IWLSLLMTVFFAAAMFALFTYIAPILTEVTQVSEHGVSWTLLLMGVGLTL
GNIVGGRLADWRLSVSLTMTFLLIAVFSALFSWTSYSLLAAEVTLFLWSA
AAFSAVPALQINVVAYGKKAPNLVSTLNIAAFNVGNALGAWVGGVVIAKG
LGLTAVPLAAAALAVMGLLLCLFTFSRARTIGNKMA
>YP1321 bcr, probable drug resistance translocator protein
MQKNRTSHIGLIFILGLLSMLMPLAIDMYLPSMPIIAQEFGVESGRVQMT
LSAYVLGFAIGQMFYGPMADSIGRKPVIFWGTLIFALAGMACALVQSVEQ
LINMRFLHGLSAAAASVVINALMRDMFTKDEFSRMMSFVVLVMTIAPLLA
PIIGGALLVWFSWHAIFWTMAGAALVGAVLVALFIQETLPPERRQKFHLR
TTIGNFGSLFRHKRVLSYMLASGFSFAGMFSFLSAGPFVYIDLNGVSPQN
FGYYFALNIVFLFLMTFINSRNVRRFGALKMFRFGLIVQFVMGIWLVVVC
VAGLGFWALVLGVAAYVGCIAMITSNAMAVILDDFPHMAGTASSLAGTLR
FGIGAVVGTLLSMASSRSAWPMVSSMAFCIIVAMLLYLYASRPSHKTVS
>YP3549 bgaB, puative beta-galactosidase
MSKFPPLSAKVSALLHGADYNPEQWENYPDIIDKDIAMMKQAKCNVMSVG
IFSWVKLEPSEGEYNFSWLDELIEKLYAAGIHIFLATPSGARPAWMSQKY
PEVLRVGRDRVPALHGGRHNHCMTSPVYRQKVRQINQKLAERYAHHPAVI
GWHISNEYGGECHCHSCQQKFRLWLQDRYQTLDNLNEAWWSAFWSHTYSD
WSQIESPAPQGEVSIHGLNLDWRRFNTAQVTEFCSEEAKPLKAANPELPV
TTNFMEYFYDYDYWKLAQVIDFISWDSYPMWHREKDETQLACYTAMYHDL
MRTLKQGRPFVLMESTPSATNWQPTSKLKKPGMHILSSLQAVAHGADAVQ
YFQWRKSRGSVEKFHGAVVDHVGHIDTRVGREVSELGRILEAMSPVMGSK
VDADVAIIFDWESRWAMDDAEGPRNCGLEYEKTVAEHYRPFWERGIAVDI
INADCDLSGYKLVIAPMLYMVREGFAERATRFVEQGGQFVATYWSGIVNE
SDLCHLGGFPGPLRPLLGIWSEEIDCLADGESNQVQGLAGNKAGLQGPYQ
AIHLCDLIHLEGATAVARYRDDFYADRAAVTVNFVGEGKAWYVASRNDAA
FQRDFFMNIAEELNLARALDTQFPYGVTAHRRTDGESEFIVVENYSNDSK
SLVLPAVYRDMVDQQPVQGSLTLAPWGSRVLTRYLE
>YP0886 bglA, 6-phospho-beta-glucosidase
MPAVIREIVMSYQQLPKDFLWGGAVAAHQVEGGWDKGGKGVSIADVLSGG
SHGVDRVMTDGVLEGYRYPNHEAVDFYSHYKEDIALFAEMGFKCFRTSIA
WTRIFPHGDEQQPNEAGLQFYDDMFDELLKYGIEPVITLSHFEMPWHLVK
EYGGWKNRKVVDFFVKFSEVVMARYKSKVKYWMTFNEINNQRNWKYPLFG
YCCSGVVFTEQENPEETLYQVLHHQFVASAKVVKLGHAINPEFKIGCMVA
MVPLYPFSCHPDDMMYSVEAMRERYLFGDVHMRGYYPSYILQEWARRGFN
IHMEEGDLETLRDGCADYMGLSYYMSNAVSAINPGSGNSLSGFEGSVPNP
HVKASDWGWQIDPVGLRYSLSVLYERYQKPLFIVENGFGAIDKVAADGMV
HDDYRIAYLKAHIEQMKKAVFEDGVDLMGYTPWGCIDCVSFTTGEYSKRY
GFIYVDKNDDGTGTMARSRKLSFDWYKKVIASNGEVL
>YP1160 bglB, putative beta-glucosidase
MNLNKTGFFTAFTFLSAPVWATPQLKEAESIPSVIAAMTLEEKAAFVSGT
GMNNAEKVAGAAGSTLAIPRLGIPQIVFADGPVGVRLGAGPTGGEKRFAT
GFPVSVAMAATWDPAIIKRVGGAIGDEAKQYGVDLILGPAINIQRHPLNG
RNFEYFTEDPLLNAIMTASYIDGMQTEGVGAVLKHFAANNQETRRQIVNE
IISDRALHEIYFPGFEYAMEKAQPWAVMSSYPSINGTPSSQNPWLLKDVL
RQQWKFDGFVMSDWYGVADPVSALKGGNDLNMPGGRTPDDSLFLTPNTDP
KDVVLAALKSGELTQDQIDENIRNILNVVIKTHRFKNGDAAMMPEPVDHS
ALARQIAADSMVLLKNDAHTLPIKAAFRVAAFGQNIDNFFVTGGGSAEVN
IDPKRLVTLPQGLKNAGIALIRQIGDQALDEPVNQPALTKAAQQSDIALI
SIGRSSTEGADRYSMAMHPDEVAMIKKVASAFHQQNKKVVVLLNIGSPIE
MTSWEQYADAILLTWQPGEQAGNAVADILLGKVNPSGKLPLTFPKRLEDS
PSFGNYPGNAKTVIYGEGIYVGYRYFDTKRIAPMYPFGYGLSYSTVNYGK
ISPEKPVFNIDTENSIEVSIPVRNTSGIDTKEVVQLYVHDNASRLDRPEQ
ELKAFEKVSLSAGEEKRVAFKLDKRAFSYYDEDKNNWVLEPGLFTLRIGR
SSRDIHAETPLIVKSSTPAFSFDTPWIDIQTYEKAATIVARFIGDEQTNA
WIYGNPTLGDKLEDALKLKPEFAKDEAKRQKLKQEILQEINSL
>YP2239 bglX1, beta-hexosaminidase
MTVGPVMLDVASYELDAEEREILKHPLVGGLILFSRNFHDAEQLRELVRQ
IRAASHERLVVAVDQEGGRVQRFRDGFTRLPAAQYFAAINDAATAAQLAQ
EAGWLMAAEMMAMDIDISFAPVLDIGHVSAAIGERSFHSDPQQARIMAEC
FIRGMHSAGMKTTGKHFPGHGAVTADSHKETPHDNRPLAEIRTHDMVIFR
ELIQRKLLDAIMPAHVIYTEADARPASGSAYWLQEILRQELGFEGIIFSD
DLSMEGAAIMGSYAERGQASLDAGCDMILVCNNRQGAVSVLDNLSPIKAD
QLTRLYHSGQFDRQTLMASSRWQQANKALTALSERWDAHKQTLGQ
>YP2934 bglX2, putative glycosyl hydrolase
MSTVYRDATLPIEARIDDLLSQMTLAEKVGQLCQQPMLDYQQHRDDYLAG
VRAGRWGSRILADTAWAGNAPGENVDPCQLNEIQRAAVEHSRLGIPLLFA
RDVIYGQATVLPIPLAQAASWNPELVQQAYRVIAREAASLGIHWTFAPML
DIARDPRWGRTIETSGEDPWLTAQFAAAVVKGFQGDDLSAADSLMACAKH
FVGYAAVEGGRDYDTTELSDNTLHNVHLPPFQAAIEAGVGSVMTGFCDFG
GTPVTAHGELIRGWLKQQQNFDGLVISDWGSIADLTHFGIAQDALRAAEL
ALQAGVDMAMTHEAYEDKLDQLVLQGRIKEALLDDAVRRVLRAKFRCGLF
ERPYVDEEWHKRELRRPEHLALAQRLAEQSIVLLKNRQALLPISRTSVPL
TLAVIGPHAHSQRQHLGSWCLDGDADQVMSIYQSLCAIAGEVKVITEQSC
FSDEMIECAHRADIVILCTGESHRRTGEARNIAELQLPPGQEELIAAVGR
TGKPLVVIQCTGRPLPSPATEQYADALLYGWQCGSEAGKAIARIIFGEQV
PCGKLPMTVPRSTGQIPIYYGRKPLGKMRDYREYQPYKDLADTPLYPFGF
GLSYTRFTYSDLQLSHESLELGASLRVTMTVTNDGAVAGDEVVQCYIRQY
VASTTRPQRELKGFQRISLQPGELGEVSFTLGVRELAFYGQHRRYAQEPS
RISVFVGGDSTTPHQADFTLFENLYTV
>YP1461 cDA11, putative polysaccharide deacetylase
MPAMNRKLRRRTMAKEIFCAFGVDVDAVAGWLGSYGGEDSPDDISRGMFS
GEVGTPRLLKLFADHNLRATWFIPGHSIETFPEQMKAVAAAGHEVGIHGY
SHENPIAMTPAQEEAVLDHCIALLTQLTGKSPTGYVAPWWEFSNVTNELL
LKKGIKYDHSLMHHDFHPYYVRVGDHWTRIDYSKSPDHWMKPLQRGAETA
LVEIPANWYLDDLPPMMFIKKAPNSHGFVNPRHLEEMWRDQFDWVYREHD
YAVFTMTIHPDVSGRPQVLLMLERLLKHIQSHQGVRFVTFDEIADDYLRR
MPRKI
>YP2206 cDA12, Predicted xylanase/chitin deacetylase
MKQVGLRIDVDTYRGTQYGVPSLLTVLEKHDIRASFFFSVGPDNMGRHLW
RLFRPRFLWKMLRSNAASLYGWDILLAGTAWPGKKIAKDFGPLMKAAAMA
GHEVGLHAWDHQGWQANVASWSQQQLTEQVQRGVDTLQQSIGQPISCSAA
AGWRADERVLAVKQQFDFSYNSDCRGTHPFRPLLPNGSLGSVQIPVTLPT
YDEVVGGEVQAENFNDFIIDAILRDSGVSVYTIHAEVEGMSQAAMFEQLL
MRAKQQDIEFCPLSKLLPSDLQLLPVGKVIRAAFPGREGWLGCQSDIKDA
E
>YP2480 celA, PTS system, cellobiose-specific IIB component
MSFEHQKVLGMEKKKIYLFCSAGMSTSLLVSKMKVQAEKYDVPVIINAYP
EALASAQGAHADVILLGPQIAYMLPEIAKMFPNKPVEVIDTLLYGKVDGL
GVLKAAVAAIKKAKQ
>YP2481 celB, PTS system, cellobiose-specific IIC component
MSTFITSLEKVILPFAIRIGRQQHVNAIKNGFIRLMPLTLTGAMFVLINN
VFLSFGEGSFFFSMGVRLDGDTITMLNGWKAIGGNVYNGTLGIMSLMTPF
FISMALAEEKKVDPLSAALLAIAAFMTVTPFSVGEAYAVGANWLGGANII
SGIIIGLVVAEVFTFIVRRNWIIRLPDSVPTSVSRSFSALIPGFIILSIM
GLISYTLALYGTNFHQIIIDSISAPLSKMGSVVGWVYVMFSSLLWFFGVH
GAMALSALESGIMMPFALENVATYTQYGSVEAALAAGKEFHMWAKPFVDS
YIFLGGTGATLGLIIAIFIASRREDYRQVAKLAAPASIFQINEPILFGLP
VIMNPLMFIPFIMVQPILAIITSVAYYSGLIPPITNIAPWTMPAGLGAFF
NTNGSIAALLLSLFNLGVATLVYLPFVIIANKAQGEIDRTVESEDDIANS
LKF
>YP2482 celC, PTS system, cellobiose-specific IIA component
MFDLSSIVDNEQTSDALEDVVMGLIINAGQARSLAYNALKQAKAGDFAQA
DELMAQSRSALNDAHLVQTQLIEADQGEGKTKVTLVLVHAQDHLMNAMLA
RELITELIELHQKIQ
>YP0447 citE1, putative ATP/GTP-binding protein
MKSTPSAYALGATLYMPATRTDIADIIIHNKISGLRSLVICLEDAVSEDD
VPLAISQLSTLLGTLAVEKKRDGSAHWPLIFVRPRHEAMGLALITRFNLS
AINGFVLPKFTQASITTWWEIMKETHLCMMPTLETEDVFDVAKMSTLARE
LENHPSRQRIVALRIGGNDLMSVISMRRSRKLTLYDGPMGYVIKMLVSVF
CPKNFALTAPVCEQIDNPQLLETELALDIAHGLVGKTAIHPSQIEVIQRA
LMVDTHDHADALRILNSTQAVFKSQGAMCEPSTHKRWAAAILERAQYYGI
MPDFTAMAVRDAPRKHQSG
>YP1670 citE2, putative citrate lyase beta chain
MSNLDTYQTRSWLFTPATRSDRFAKAAENGADVAIIDLEDSVSQADKEQA
RQKAISYLSSRPATSLPLALRINGLDTRAGIEDIHALLECGSLPDYLVLP
KTESAAHLQILDRLMMFAGSDTRLIGIIESVRGLNAVESIAAATPKLAGL
IFGAADMAADIGAASTWEPLALARARLVSACAMNGIPAIDAPFFDVHDVS
GLQSETLRASDFGFSAKAAIHPAQISTINTLFTPTAAEIRHARAVLAENT
KGVGTVNGMMIDEAVARQARRVLTRAGISA
>YP2620 crr, PTS system, glucose-specific IIA component
MGLFDKLKSLVSDDKKDSSVIEIVAPLSGEIVNIEDVPDVVFAEKIVGDG
IAIKPSGNKMVAPVDGTIGKIFETNHAFSIESDSGIELFVHFGIDTVELK
GEGFTRIAEEGQRVKKGDVVIEFNLALLEEKAKSTLTPVVISNMDEIKEL
IKLSGSVTVGETPIIRIKK
>YP0337 dAK1_1, putative dihydroxyacetone kinase
MLSLRALNYRGIQLTHPLFLFIFHFNEIAMNRIINDPDQVVEEAIKGYLA
AYPHFFAKTAHEKVLKYPEIPLQGKVGVVTGGGSGHEPAFLGYIGKNMLD
AVAVGEIFSSPAAGAFLEAFKVADGGAGVACLYGNYAGDNMNVKMAAKKA
EAMGIRVRTVVANDDVASAPPSEREKRRGVAGEIFMWKVGAAAASQGYAL
DNVIEVAQKAIDHCRSIGVGLTSCTIPAVGKPNFSIEDGMMEVGIGHHGE
PGIRVESLQNAHQMAKTMVDLVVADRPFSQGDEVAVLISGLGATPTIELY
IYYAEVAKLLEAQGITIYRPYIGNYFTSLDMMGVTLTLMKLDDELKSLID
VPTHSLGLTQLE
>YP0338 dAK1_2, Dihydroxyacetone kinase
MKALLITDGSIKDKCITDGTPIIEEMANTILANREYLSEIDGAIGDGDHG
INMAKGFNLCAENIKGKNLTLAEALDALSDALMEGIGGSMGPLYGSIFMG
MAESIRGCDKMDAVAFGAMLKGGLADLQEVTDARVGDKCIMDTLIPASAA
FELAQQQQQSFVESLHRMKHAASMGRDSTLDLVAKIGRASRLGERSRGVL
DAGATSCCLILTQLADSVERRLVP
>YP2112 dalD, putative mannitol dehydrogenase
MNTDLKSPPAVWLHIGAGSFHRAHQAWYLHRLLASGDDRWTIALANIRDD
AIPLLDTLRAQHGEYVLETVTPSGERQYEKITSLRNIIPWDKALDHLVAQ
GSKPETRVISFTVTEGGYYLDNQFNLQQDNSDIQADLRGDCRTIYGAISR
ILQQRQQDKSGPVTLLNCDNLRHNGERFRHGLLEFLALRGQQSLLNWVTS
QTRSPNTMVDRITPRPSADIAQRVLEKTGIVDNAPVMGESFIQWVIEDDF
IAGRPALENVGAEMVTSVLPYEEAKIRILNASHSCIAWAGSLIGQCYIHE
STQTDAIRQMAYDYVTQDVIPSLTPSPLDLAHYRDVVLERFSNPYIRDTN
QRVAADGFSKIPGFITPTLIECYQRGGVPTATAMLPALFFVFMESWHQGT
LPYEYQDGILDPAAVHAMFQSSDPAGLFARDSALFGPLANDDQFEQLLRQ
SINRVSAWVSTNR
>YP1467 dctP, putative C4-dicarboxylate transporter, periplasmic protein
MRLPTSFPTLCLTASALLLSQVLFSQSATAQQIKAADVHPKDYPNVVAMK
DMGEKLKVATDGRLEMKTFPGGVLGDEKQMIEQAQMGAIDIIRVSMTPVA
SILPEINVFTLPYIFRDEDHLHKVLDGKIGQEIGGKITDNKNSKLVFLGW
MDGGTRHLITKQPVIKPEDLSGMKIRVQGSPIALATLKSMGANALSMGVS
EVFSGMQTGVIDGTENNQPTFVAHNYLPVVKNYTLSGHFIIPEVFLYSKA
KWDKLSAEDQQTILKLAKEAQAEQRVLWTAYEQQAHEKMKAGGVQYHEID
RDYYYKATQPVRDEFGKGHEDLIKQIGDVQ
>YP3743 deoB, phosphopentomutase
MWGGGANEYSPPPERESTQERAMKRTFIMVLDSFGIGASADAKKFGDEGA
DTLGHIAEACARGEANVGRSGPLTLPNLSRLGLGKAAEESTGTFPVGLDK
NADIIGAYGYASELSSGKDTPSGHWEIAGVPVLFDWGYFSDVENSFPQEL
LDKLVKRANLPGYLGNCHSSGTVILDQLGEEHMKTGKPIFYTSADSVFQI
ACHEETFGLDRLYELCEIAREELTDGGYNIGRVIARPFIGDKPGHFQRTG
NRHDLAVEPPAPTMLKKLVDEKGGEVVSIGKIADIYAQVGITQKVKATGL
DALFDATIEEMKKAGDNTIVFTNFVDFDSSYGHRRDVAGYAAALELFDRR
LPELMALIKEDDILILTADHGCDPTWPGTDHTREHIPVLVYGPKVKPGSL
GHRETFADIGQTVAAYFGLSPMDYGKNML
>YP1270 deoR3, deoxyribose operon repressor
MTIRRDLSAEPTSVILLGGYVVMDPKSNNANNYFVSDQQAKQVEEKRRIG
QLAAQLIIENDTVFFDCGTTIPWIIDEIDEELAFTAICYSLNTFLALQDK
PNCKVILCGGEFKPNNCIFTPLSQQSELDNICPNKAFISAAGVSIEYGAT
CFNFDEILLKHRAMAKSQYKILVADHSKFGKIKPASIGTLAQFDALVTDR
PPVAEFYLFFSQHSVKIYC
>YP0637 ebgC1, conserved hypothetical protein
MIIGNIHHLALLPYLPAQLRDAIEYVKSHINADTPLGKHDIDGNNVFVLV
SNDSTDLLENRRAEYHAKYLDIQIILAGQEGMAFSNLPAGKPDTDWLADK
DIAFLPAGTDEKHVVLQTGDFVVFFPGEVHKPLCAVGEPANVRKAVVKIA
VK
>YP2352 ebgC2, conserved hypothetical protein
MILDELKKAVNNPIYPEVIRRTLAAISQMDLAALPAGELEIEGREIYLNH
MIATTKPLYEQRPELHRYYIDIHILLEGSEVIGASPSTQGQRPTMDFDSE
KDYGLFEGMSTETLLTLAPGDIALLFPGELHRPMGTLTDPAPIRKLVVKV
ANHLL
>YP2643 ebgC3, conserved hypothetical protein
MISGSLAQPAFFSGLPERLQWVLAYLADMPLAQLSCGRHEIDGELMFMNV
MAFDTQPAESKKAELHRTYADVQLLISGIEGIEYSTLTPTEHLEPYHPDD
DYQLIADIPDKSQLRMLPGMFAVFLPGEPHKPGCQIAGSGAIKKVVVKVH
YSLLNS
>YP1910 eda, KHG/KDPG aldolase
MKSWKTSAEQIMTAGPVVPVIVINKLEQAVPLAKALVAGGVRVLEVTLRT
PCAVEAIRAIAKEVPEAIIGAGTVLNPQQLAEVVEAGAQFAISPGLTDEL
LKAACEGSIPLIPGISTVSELMLGMSYGLREFKFFPAEANGGVKALQAIG
GPFSQVRFCPTGGITPNNYRDYLALKSVLCIGGSWLVPADALESGDYARI
TELAKQAVEGAAA
>YP2344 edd, phosphogluconate dehydratase
MNPIITRVTQRIIARSAATRTAYLQRISAAKEHTVHRSQLACGNLAHGFA
ACQPEDKAALKNRVRSDIAIITSYNDMLSAHQPYEHYPQQLKDALHEVGA
IGQVAGGVPAMCDGVTQGQDGMELSLMSRDVIAMSAAIGLSHNMFDGALY
LGVCDKIVPGLLMAALSFGHLPAIFVPAGPMASGLPNKEKVRIRQLYAEG
KVDRQALLEAEAASYHSAGTCTFYGTANSNQMVMEVMGLHLPGASFIQPN
TPLRDALTAAAARQITRLTETGINCIDGNHIDVNHINSSHINSSYLPVGQ
LVDEKVVVNGIVALLATGGSTNHTLHLVAMARAAGIIINWDDFSELSEAV
PQLCRIYPNGPADINYFQASGGVALLVNMLLQGGLLHEEVHTVAGFGLQR
YTQEPYLAAGKLQWRPGPQQSLDATVIASLEQPFSAQGGTKVLNGNLGRA
VMKTSAVPREHQVIEGPARVFESQHDVEAAFESGDLDRDCVVVVRYQGPQ
AIGMPELHKLMPPLGVLLDRGFKVALVTDGRLSGASGKVPSAIHVTPEAY
CGGLLANVRNGDRIRVDGVSGELSLLVDEAELATRDSPLPAISAFHVGCG
RELFGALREQLSGAEQGACCIRF
>YP0663 emrB, multidrug resistance protein B
MAQKPLEGAPLAWMTVALSLATFMQVLDSTIANVAIPTIAGDLGSSNSQG
TWVITSFGVANAISIPVTGWLAKRVGEVRLFLWSTGLFVLASWLCGMSNS
LGMLIFFRVIQGLVAGPLIPLSQSLLLNNYPPAKRSMALALWSMTIVVAP
IFGPILGGYISDNYHWGWIFFINIPIGLVVVLLAGSTLKGRETKTEIRPI
DTIGLVLLVVGIGALQIMLDQGKELDWFNSTEIIVLTVVAVVAITFLIVW
ELTDDHPVIDLSLFKSRNFTIGCLCLSLAYMLYFGAIVLLPQLLQEVYGY
TATWAGLASAPVGILPVLLSPLIGRFAHRIDMRQLVTFSFIMYAVCFYWR
AYTFEPGMDFGASAWPQFFQGFAIACFFMPLTTITLSGLPPERMAAASSL
SNFMRTLAGSIGTSITTTLWTQRESLHHAQLTEFVNPYNPNATQAYQELE
KLGMSQQQASAYLAREITNQGLIISANEIFWLSAGVFLMLLALIWFARPP
FTSGGGGGGAH
>YP0310 eno, enolase
MSKIVKVIGREIIDSRGNPTVEAEVHLEGGFVGLAAAPSGASTGSREALE
LRDGDKSRFLGKGVLKAVAAVNGPIAQAVIGKDAKDQANIDKIMIDLDGT
ENKSQFGANAILAVSLAAAKAAAASKGMPLYEHIAELNGTPGKFSMPLPM
MNIINGGEHADNNVDIQEFMIQPVGAKTLKEAVRIGSEVFHHLAKVLKAK
GLNTAVGDEGGYAPNLGSNAEALAVIAEAVKAAGYELGKDITLAMDCAAS
EFYKDGKYVLAGEGNKAFTSEEFTHFLEDLTKQYPIVSIEDGLDESDWAG
FKYQTEVLGDKIQLVGDDLFVTNTKILKEGIEKGVANSILIKFNQIGSLT
ETLAAIKMAKDAGYTAVISHRSGETEDATIADLAVGTAAGQIKTGSMSRS
DRVAKYNQLIRIEEALGDRAPFNGLKEVKGQ
>YP3518 epd, D-erythrose 4-phosphate dehydrogenase
MAIRIAINGFGRIGRSVLRALYESGRRAEISVVAINELASAEGMAHLLKY
DSSHGRFAWDVRQECDSLYVGDDIIRLIHQSEIEQLPWSELGIDVVLDCS
GVYGSREDGEAHVASGAKKVLFAHPGGHDLDATVVYGVNHQDLRAEHRIV
SNASCTTNCIIPIIQLLDIAYGIESGTVTTIHSSMNDQPVIDAYHQDLRR
TRAASQSIIPVDTKLAAGITRIFPKFCDRFEAISVRVPTINVTAIDLSVS
VTHPVGVAEVNQLLQKAARGAFRGIVDYTELPLVSMDFNHDPHSAIVDGT
QTRVSGQHLIKTLVWCDNEWGFANRMLDTTLAMAKSGF
>YP2897 exuT1, ExuT transport protein
MMRKIKGLRWYMIALVTVGTILGYLTRNAIAVAAPTLQEQLHITTQQYSY
IIAAYSAAYTLMQPVAGYVLDVMGTKVGYAMFAVMWAIFCMSTALASSWG
GLAIARGAVGMAEAAMIPAGLKASSEWFPAKERSIAVGYFNVGSSIGGMI
APPLVVWAIVMHSWQMAFIITGVLSLIWAIAWLILYKHPKDQKRLSDEER
EYILSGQEAQHSTANAKKMSAMQIIRNRQFWGIAIPRFLAEPAWGTFNAW
IPLFMFKAYGFNLKEIAMFAWMPMLFADVGCILGGYLPPLFQKYFKVNLI
VSRKLVVTMGGVLMIGPGTIGLFTSPYAAIALLCIGGFAHQALSGALITL
SSDVFGRNEVATANGLTGMAAWTASTLFALVVGALADTMGFSPLFAALAV
FDLLAVVVIWTVLQDRTADEPTNDPVQRPPVGQN
>YP3544 exuT2, putative sugar transporter
MSIDINQSAKIVGRRKIKSLRWWMLALFLLGVTVNYITRNSLGILAPELK
TSLNMTTEQYSWIVASFQLAYTVFQPLCGWLIDVIGLKMGFLVCASVWAV
VCMMHAGAGTWFQLAVLRFFMGSAEAAATPANAKAISDWFPKKERPIAAG
WAGVGFSIGAMLAPPIIVLAHVALGWQGAFLFSGALAMIWVLLWWRFYHS
PDTHPNLSQEEFELIHQDNEPVLPRLPFLKSLAILSKNKKFYGIAIPAFL
AEPAWAVFSFWVPLYLATERGMDLKQIAMFAWLPFLAADIGSVASGYLTK
LYQKWFGCSRVNSVVASSVTGAFMMVSLAFVAVTKDPYLAIALISIGGFG
HQVISCMLSALVVDSFDKNQVATVNGLRGSSAWIASFLFTLLIGAVSDTI
GFNPLFIAMGFFDLIGAVFLIALFAERRNKPQPTV
>YP3323 fba, putative class-II fructose-bisphosphate aldolase
MKTNRLNLCCVMSTAVSSEFANTRRTTMALISLANGLAHARKNGYALGAF
NVLDSHFLRALFAAAKQERSPFIINIAEVHFKYLSLESLVEAVKFEAAHH
DIPVVLNLDHGLHFEAVVRALRLGFSSVMFDGSTLEYEENVRQTREVVKM
CHAVGVSVEAELGAVGGDEGGALYGEADSNKFTDPAIARDFVDRTGIDAL
AVAIGNAHGKYKGEPKLDFARLAAIHQQTGLPLVLHGGSGISDTDFRRAI
SLGIHKINFYTGMSQAALAAVEQKMTHRHAIYDEFAELFLGIEEAITDVV
AQQMRIFGSSEQI
>YP3520 fbaA, fructose-bisphosphate aldolase class II
MSKIFDFVKPGVITGDDVQKVFAVAKENNFALPAVNCVGTDSINAVLETA
AKVRAPVIVQFSNGGAAFIAGKGVKTDAPQGAAILGAISGAHHVHQMAEH
YGVPVILHTDHCAKKLLPWLDGLLDAGEKHFAATGKPLFSSHMIDLSEES
LEENIEICSKYLTRMSKIGMTLEIELGCTGGEEDGVDNSHMDASSLYTQP
QDVDYAYEKLNAISPRFTIAASFGNVHGVYKPGNVKLTPTILRDSQDYVS
KKHNLPHNSLNFVFHGGSGSTAEEIKEAVSYGVVKMNIDTDTQWATWEGI
LNYYKKNEGYLQGQLGNPEGADKPNKKYYDPRVWLRAAQVTMITRLELAF
KELNAIDVL
>YP3773 fbaB, putative aldolase
MADLDDIKDGKDFGIGIPQQNPAFTLKGSGSLDWGMQSRLARIFNPKTNR
TVMLAFDHGYFQGPTTGLERIDINIAPLFEYADVLMCTRGILRSVVPAAA
NRPVVLRASGANSILTYLSNEAVAVAMEDAVRLNACAVAAQVYIGTEHEH
QSIKNIIQLIDQGMRYGMPTMAVTGVGKDMVRDQRYFSLASRIAAEMGAQ
VIKTYYVDSGFERIAAGCPVPIVIAGGKKLPERDALEMCYQAIDQGASGV
DMGRNIFQSDAPIAMLKAVHAIVHKNENAAAAYQLFLHEQN
>YP0563 fbp, fructose-bisphosphatase
MELPMNQSYLWATLLTLAVLCINKSIFNRRFRDCVMKTLGEFIVEKQLDF
SHATGELTALLSAIKLGAKIIHRDINKAGLVDILGASGVSNIQGEDQMKL
DLFANEKLKAALKARGEVAGIASEEEDDIVIFDGGRAENAKYVVLMDPLD
GSSNIDVNVSVGTIFSIYRRITPFGTPITEEDFLQPGTKQVTAGYVVYGS
STMLVYTTGYGVHAFTYDPSLGVFCLSHEKVRYPATGCMYSINEGNYIKF
PLGVKKYIKYCQEQDEATKRPYTSRYIGSLVADFHRNLLKGGIYIYPSTA
SHPQGKLRLLYECNPMAFLAEQAGGKATDGVNRILDIVPEKLHQRAPFFV
GTKSMVEDAEGFIAKFPDEEAK
>YP1292 fruA, PTS system, fructose-specific IIBC component
MKTLLIIDSSLGQARGHLATLMLGAAAKKAGLSWVEKAADAELVIVAGSS
APADSTLNGKKVYVGDVEKAVRDPDGFLAQAIAQAAPYQAAATPEPTSVA
GAKRSVAGPKRIVAITACPTGVAHTFMAAEAIESEAKKRGWWVKVETRGS
VGAGNEITPEEVAAADLVIVAADIEVDLNKFAGKPMYRTTTGLALKKTVQ
ELDKALVEADVYQPKTSSSVASKKTETGGPYRHLLTGVSYMLPMVVAGGL
CIALSFVFGIEAFKEKGTLAAALMQIGGDSAFALMVPVLAGFIAFSIADR
PGLTPGLIGGMLAVSTGAGFLGGIIAGFLAGYVAKAISTKLHLPQSMEAL
KPILIIPLVASLIVGLTMIYIVGTPVAKIMTGLTHWLESMGTANAVLLGA
ILGAMMCTDMGGPVNKAAYAFGVALLSSSVYAPMAAIMAAGMVPPLAMGL
ATLLARNKFDKGEQEGGKAALVLGLCFISEGAIPFAARDPMRVLPCCIAG
GALTGALSMAFGAQLMAPHGGLFVLLIPGAIHPVLLYLVAIAAGTLLAGG
LYAMLKRPDAMVAKVA
>YP1294 fruB, PTS system, fructose-specific IIA/fpr component
MFQLSTQDIHLAAQADNKNAAITQVAAALTQAGCVTAAYVDGMLAREQQT
STYLGNGIAIPHGTTDTRDQVLNTGVQVFQFPQGIEWGADQTAYIVIGIA
ARSDEHLALLRQLTHVLSDDAVAARLAKTTSAEELRSLLMGEQKTAEFHF
DTSLIALDVAADNLITLQALNAGRLQQIGAVDARFVSDVITREPLNLGQG
IWLSDSTEGNLVSAVTISRPATAFEHKGEKVALLLTLSVADDQPLTVLNY
LSELLLAQKADALLNADAAALLALLTSEYVEQSKVLSAEFVIRNEHGLHA
RPGTILVNTIKQFTSEITVTNLDGTGKPANGRSLMKVVALGVKKGNRLRF
TASGEDAQTALDTIGEVIAAGLGEGAA
>YP1293 fruK, 1-phosphofructokinase
MSRRVATITLNPAYDLVGFCPEIERGEVNLVKTAGLHAAGKGINVAKVLK
DLGIDVTVGGFLGKDNQDGFQLLFSELGIANRFQVVPGRTRINVKLTEKD
GEVTDFNFSGFEVTKPDWDRFVTDSLSWLGQFDMVAVSGSLPAGVNPDDF
TDWMKRLRSQCPCIIFDSSREALVAGLKASPWLVKPNRRELEIWAGRPLP
ALGDVVEAAHALRDQGIAHVVISLGAEGALWVNASGAWLAKPPACDVVST
VGAGDSMVGGLIYGLLMRESSEHTLRLATAVAALAVSQSNVGITDRPQLA
AMMAKVDLKPFN
>YP3778 frwB, PTS system, IIB component
MTNIIAITACPSGVAHTYMAAEALERAARAKGWECKVETQGSIGVENKLT
AEDVAAADMVILTKDIGILFEERFAGKVIVRIAVSDAVKRADAIMDKIAA
YLEKNT
>YP3777 frwC, PTS system, IIC component
MMKELINILKNTRQHLMTGVSYMIPFVVAGGILLALSVMLYGKGAVPEVA
SDPNLKKLFDIGVVGLTLMVPFLAAYIGYAIADRAALAPAAIGAWVGASF
GAGFFGAIIAGLLGGIIVFYLKKISVPKTLRSVMPIFVIPIVGTLLTAGI
MMWGLGEPIGILTANLTQWLQGMQQGSVILLAIIMGLMLAFDMGGPVNKV
AYAFMLICVAQGVYTLVAVAAVAIATPPLGMGLATLIGRKYYSVEEREAG
KAAMLMGCVGITEGAIPFAAADPLRVIPANMIGSACAAVTAVLFGVQCYA
AWGGLIVLPVVDGKLGFVVALLVGMVVTALIANLLKRFTAQKQPGRSSAE
GDVNMDFDIKN
>YP3779 frwD, PTS system, IIB component
MRPQKNQACLETKQVIKSGGGMTIKLVAVTACVSGVAHTYMVAERLDKLC
LQLKWQLKVETQGALGVEYSLTEDDILQADAVILINDVAIKEQERFQNCR
CVQADIQTFLCHPEKILAATKKVISSPKTVSIVIK
>YP1469 galA, alpha-galactosidase
MSPPCHHLEQIFVFTGAIMNTTFVRLSSRSSDMIVRCSPYAEIVYWGKPL
LDYSPAMMEALNRPVANSRLDSDIPLTLCPENGRGLFSVPGMEGNRDGED
WSPIFTSQSHTLENNLLTIISEDTSAGLRLVSELQMCPDSGVIKTRNTLT
NIKAGCYRIDRLAVTLPFPERANEIMAFNGRWIKEFQRHSLKLDHGGYIQ
ENRRGRTSHEYFPGMVVGKAGFSEQQGEVWGLHLALSGNHRLRADCKSDG
RRQVQAEALYFSGEIVLEHLQSVSTPWVYATYSATGLNGMSHSFHHYVRQ
NIVPSLAEKPRPVHLNTWEGIYFKHDPDYIIQMVKNAAKIGVERFIIDDG
WFKGRNNDLSSLGDWYIDAEKYPQGLNPIIEAVNEYGMEFGIWVEPEMIN
QDSDLYRNHPDWVLKLDGYPLLKGRDQLLLDLSNPAVFDYLLERLSWLLG
EHKVDYVKWDFNREMVQPGHRGHPSLVQQTEQLYRLFDQLNLHFPHIEFE
SCASGGGRIDYEILQRCHRFWPSDSNDALDRQQIQRGMSYFFPPEVMGAH
IGGTPCHTTARMHSINFRGLTALFGHMGVELDPVSESPAEQQAFARYIAL
HKQLRPLLHSGNTIRLDHPDKTTLINAVIAHDQQQAVVLISQLALPEYAL
CGNVLIPGLNPSTHYQIEVLDMPDSMHKPRNNTMKRYPAWLKSPLIVSGD
WLEKAGIALPILNPESAILIQLSAVN
>YP1022 galK, galactokinase
MSLKQHTQTIFRQQFDRESDITIKAPGRVNLIGEHTDYNDGFVLPCAINY
ETVISCGKRDDRQIRVIAADYENQQDIFSLDAPIVPHPEYRWADYVRGVV
KHLQMRNADFGGADLVICGNVPQGAGLSSSASLEVAVGQALQSLYQLPLS
GVELALNGQEAENQFVGCNCGIMDQLISALGKKDHALLIDCRTLETRAVP
MPENMAVVIINSNIQRGLVDSEYNTRRQQCEAAARFFGVKALRDVEPSLF
FSIQDELDPVVAKRARHVISENARTLAAADALAAGNLKLMGQLMQESHIS
MRDDFEITVPPIDRLVEIVKSVIGDQGGVRMTGGGFGGCIIALMPLELVE
QVRTTVAQEYPAHSGGKKETFYVCQASQGAGLC
>YP1957 gapA, glyceraldehyde 3-phosphate dehydrogenase A
MEYMTIKVGINGFGRIGRIVFRAAQERSDIEIVAINDLLDADYMAYMLKY
DSTHGRFDGTVEVKDGHLVVNGKTIRVTAERDPANLKWNEVNVDVVAEAT
GLFLTDETARKHIAAGAKKVVLTGPSKDDTPMFVMGVNHKAYAGQEIVSN
ASCTTNCLAPLAKVINDKFGIVEALMTTVHATTATQKTVDGPSHKDWRGG
RGASQNIIPSSTGAAKAVGKVIPELNGKLTGMAFRVPTPNVSVVDLTARL
EKPASYKEICAAIKAASEGELKGVLGYTEDDVVSTDFNGEKLTSVFDAKA
GIALNDNFVKLVSWYDNETGYSNKVLDLISHISK
>YP3301 glgA, glycogen synthase
MMMRVLHVCSELFPLLKTGGLADVIGALPAAQLAEGADVRIILPAFPDLR
RGIPETVLVREIDTFAGRVALRYGHYRGIGIYLIDAPALYDRAGSPYHDA
SLYAYSDNYLRFALLGWMACELACGLDGYWRPEVVHAHDWHAGLTCAYLA
ARGRPARSVFTVHNLAYQGLFSADHLSELHLPAEFFQIYGLEFYGQISYL
KAGLFFADHVTTVSPTYAKEITQPAFGYGMEGLLQALARQGRLTGILNGV
DSDIWDPQSDTLLPTRYDAENLQAKAINKTHLQTAMGLQLAENKPIFAVV
SRLTVQKGLDLVLEALPELLALGGQLVVLGSGDATLQEAFLAAAAEHSGQ
VGVQIGYHEAFSHRIIAGSDVILVPSRFEPCGLTQLYGLKYGTLPLVRHT
GGLADTVVDCALENLADGSASGFVFNECEAQALVKAIRRAFVLWSRPKHW
RHVQRHAMRLDFGWQLAAVDYLSLYRRL
>YP3304 glgB, 1,4-alpha-glucan branching enzyme
MSVLPDRQVINQLISGHYGDPFSILGMHETSQGLQICALLPDAREVWLVE
TENGRRIAQLTLEDPRGFFIAQLTRRKKSFRYQFAVTWQENPQIIEDPYR
FGPLLQDIDSWLLAEGTHLRPYERLGAHLMSLDGVSGVSFAVWAPNAQRV
SVVGDFNFWDGRRHPMRLRRENGIWELFLPGIEAGQLYKFEIIDCHGQVR
LKADPYAFEAQMRPETASLISPLPDVVKSSAARQKANDLCSPVSIYEVHL
GSWRRHTDNNFWLSYRELADQLVEYVKYMGFTHVELLPINEHPFDGSWGY
QPLGLYAPTRRYGTPEDFKAFVAKFHQAGINVILDWVPGHFPSDEHGLST
FDGTALYEYADPREGYHQDWNTLIYNYGRNEVRNYLAGNAFYWMERFGID
ALRIDAVASMIYRDYSRAEGQWVPNYYGGRENLEAIAFLRYTNKTIGVER
PGSVTMAEESTDFPGVTLPPDIGGLGFNYKWNMGWMHDTLNYMQCDPVHR
KYHHNLMTFGMLYAYTENFILPLSHDEVVHGKRSILDRMPGDAWQKFANL
RAYYAFMWAHPGKKLLFMGCEFAQGREWNFETSLDWHLLDDENGWHSGVQ
RLVRDLNHCYRQYAPLYEWDYQPAGFEWLVVDDHENSVFAFLRRDAEGHE
LIAISNFTPVPRYHYRVGIPQGGHYREVLNSDSAFYCGSNLGNQGGIDSH
HVRSHNHEHSLLLTLPPLATIYLLREN
>YP3302 glgC, glucose-1-phosphate adenylyltransferase
MVRFESTDSLMLARQLPNKTVALILAGGRGSRLKDLTATRAKPAVHFGGK
FRIIDFALSNCLNSGVRRIGVITQYQSHTLVQHIQRGWSFLNEEMNEFVD
LLPAQQRLSTEQWYKGTADAVCQNLDIIRRYDAEYIVILAGDHIYKMDYS
RMLLDHVEKGAECTVACIPVPISEGSEFGIMEVTADYQITAFYEKPANPP
PIPGDPSNALASMGIYIFNADYLFKLLEEDNNTPGSSHDFGKDIIPQLTA
RKVVWAHPFDLSCVTSNAELPPYWRDVGTLDAYWRANLDLASVTPELDMY
DRAWPIRTHMEPLPPAKFVQDRSGSHGMTMNSLVSGGCIVSGSVVVHSVL
FPRVRVNSFCTIDSSLLLPDVHVGRSCRLRRCIIDRACHIPEGMVIGENA
DEDSARFYRSEGGGGVSDSGYAGKVRGKIEPLGFLFVRLDLLIRLSLLIR
LNLFIRMNLLIILTLFFKLASIQASH
>YP3300 glgP, glycogen phosphorylase
MLALVIVGARHCRLVVAIKLGKNVMTSPFSYTSPVVSVDALKHSIAYKLM
FIIGKDPTIATQHDWLNATLFAVRDRMVERWLRSNRAQLSQDVRQVYYLS
MEFLLGRTLSNALLSMGIYDEIEQALDEMGLSLSELLKEENDPGLGNGGL
GRLAACFLDSLATLALPGRGYGIRYEYGMFSQKIVNGQQMESPDNWLEYG
NAWEFPRHNTRYKVRFGGRIQQEGSKIRWLETEEILACAYDQIIPGFDTD
ATNTLRLWSAQASNEINLGKFNQGDYFAAVEDKNHSENVSRVLYPDDSTY
SGRELRLRQEYFLVSATVQDILNRHWAMHHTFNNLADKIAIHLNDTHPVL
SIPEMMRLLIDEHKFTWMDAWDVVQQVFSYTNHTLMSEALETWPVDMIGK
ILPRHLQIIFDINDHFLKLVEEQYPDDKELLSRVSVIDENNGRRIRMAWL
AVIASHKVNGVSALHSELMVQSLFADFARIFPNRFCNKTNGVTPRRWLGL
ANRPLAAVLDDSIGQTWRTDLSQLSELEKNLDYPSFLLALQKAKLENKKR
LAVYIAEKLNIVVNPAALFDVQIKRIHEYKRQLLNVLHVITRYNRIIDAP
DNNWVPRVVIFAGKAASAYYNAKQIIHLINDVAKVINNDPRINNLLKVVF
IPNYSVSLAQLIIPAADLSEQISLAGTEASGTSNMKFALNGALTIGTLDG
ANVEIREHVGEENIFIFGNTTEQVEALRKSGYNPRKYYDEDPELHQVLTQ
IATGTFSPEEPHRYTNLFDSLVNLGDHYQLLADYRSYVDTQEQVDALYRN
RDEWSRKTLLNIANMGYFSSDRTIKEYADEIWHIKPIRL
>YP3303 glgX, putative alpha-amylase
MAVLTHGSPTPSGAHFDGKGINFTLFSAHAEQVTLCLFDEQGQERQIAMP
ARTGDIWHGYLPGGKPGQRYGYRVSGPFEPSRGHRFNPHKLLIDPRTRAL
EGKVGDDPRFTGGVSQPDVRDSAAALPKCLVIHEEYDWQGDKPPAIPWGN
TVIYEAHVRGLTQLHPDIPPELRGTYAALAHPALIEHLKTLGITTLELLP
VQFHIDEPRLQKMGLSNYWGYNVLAPFAVDPDYASGREGISPLRELRDAV
KALHNAGIEVILDVVFNHSAELDVFGPTLCQRGIDNASYYWLTPDGEYDN
ITGCGNALRLSHPYVTQWVIDCLNYWRDSCHVDGFRFDLGTVLGRTPAFD
QHAPLFAALAADERLSACKLIAEPWDIGLGGYQLGNFPTGFSEWNDQYRD
AMRGFWLRGEVPRGTFAQHFAASSRLFEQRGRLPSASINQITAHDGFTLL
DLLCFNQKHNQMNGEENRDGSDNNHSNNFGCEGLVADAAIWQRRKACQRA
LLTTLLLSQGTPMLLAGDEQGHSQQGNNNAYCQNNILTWLDWGSADRALM
TFTADLIRLRQQIPALTQDQWWQSGDSNVQWLDSQGQALSDAAWEQGCQQ
QLQILLSQRWLVLINATDHECEMHLPEGEWEGIPPFGVSDHAERLTTWRG
SAHTICVLIKRD
>YP2602 glk, glucokinase
MTTYALVGDVGGTNARLALCAVATGEILQAKTYSGLEYESLEDVIKQYLS
EHQAKVTDACIAIACPITGDWVAMTNHTWAFSIAAMQQNLGLDHLEVIND
FTAVSMAIPVLPAQDVLQFGGTQPQPGKPVAVYGAGTGLGVAHLVNVDRR
WISLAGEGGHVDFAPNSEEEDQILAVLRQELGHVSAERVLSGPGLVNLYR
AIVISDARLPEKLAPKDITARALADSCTDCRRALSLFCVIMGRFGGNLAL
NLSTFGGVYIAGGIVPRFMEFFKASGFRAAFEDKGRFKDFLQDIPVYMIT
HPQPGLLGAGAYLRQKLGYELSS
>YP0095 glpF, glycerol uptake facilitator protein
MSQTASSTLKGQCIAEFLGTGLLIFFGAGCVAALKLAGASFGQWEISIIW
GLGVAMAIYLTAAISGAHLNPAVTIALWLFACFERRKVLPYIVAQVAGAF
CAAALVYGLYYSLFVDFEQTHQMVRGSTESLQLAGIFSTYPNPHISVVQA
FLVETVITAILMCLILALTDDGNGIPRGPLAPLLIGILIAVIGASMGPLT
GFALNPARDLGPKAFSYLAGWGDIAFTGGRDIPYFLVPIFGPIVGALLGA
FGYRALIGRHLPCDVCTLEDEESTTITTERKA
>YP0122 glpR1, glycerol-3-phosphate repressor protein
MKQTQRHDAIIELVRLQGYVSTEELVEHFAVSPQTIRRDLNELADQNKIH
RHHGGAALPSSSVNAAYNDRKVMWSEEKARIAQRVASQIPDGATLFIDIG
TTPEAVAHALMNHKGLRVVTNNLNVATLLTAKEDFRLILAGGEVRTRDGG
IIGEATLDFISQFRLDYGILGISGIDMDGSLLEFDYHEVRTKRAIIENSR
CVMLVTDHSKFGRNAMVNLGNMNLIDYLFTDQQPPASVMKIIEQHEVQLE
LC
>YP0359 glpR2, putative deoR-family regulatory protein
MLQAERHKIICTHVQQQGSALVTELSVLCQVSQETIRRDLTVLQKKQKLI
RSFGGAVALDSPEIPVIDIKEIHDGLNVIDRAESFRKRTEEHPDTKMKIA
KAALQFIRPGDCILLDNSSSCWFLARQIPDIEITVVTNSVKIIQALACRD
KVRIIGIGGEYSARHDDFHGPVAENAIRNFQINTFFFSCQGINQDSGVRD
GNDINAKLKQVMLQVSGQKILLADSSKFDQYAFCKICTLDEVDILITNRL
SSQNYRSDNPKLNIIESDK
>YP0904 glpR3, putative transcriptional regulatory protein
MMMIPEQRRDFIYRYVHEQNVASFMDLAELMNVSHMTVRRDIQILEAEGK
VVAINGGVKLNNLLKLELAYSEKASLNHELKQNIGVLAAMLIEPGQTLYL
DAGTTLFEVAKAVAASNCFNLTVVTNDFTISGYLMDMPHISLYHTGGLVD
RRNRSCLGNSAANFLNTINIDVAFLSSSSWDIARGMSTPSEGKAMVKAAV
MRASRRNILVSDSSKFGKYGMFPICNLQALTDIISDGNLPLVAQKQIKES
GVKLHLVNKEVRAPCSNSQPI
>YP1680 glpR4, probable deoR-family transcriptional regulatory protein
MIPIERHQKILALVAERGVVSIAELTERLGVSHMTIRRDVQKLEEQGAVL
SVSGGVRSTQRLAIEPSHQDKTMMFSRQKQAIGTSAALHIPRNSCIYLDA
GTTTLALARQLEDRDDLLVVTNDFVIANFLIESSQCRMIHSGGTLCRKNR
SCIGEAAAHSLRNLSIDIAFISASCWGLRGISTPDEDKVPVKRAISEASS
KRVLLADASKYGKVATYLALPLTAFDVVITDNSLSSTVYEELAEKALELI
IASPPR
>YP0093 glpX, hypothetical protein
MRVKRVQLTPLRLQVRKVIEFLPIFSFSIPQSTGLTMKRELAIEFSRVTE
AAALAGYKWLGRGDKNAADGAAVQAMRIMLNQVNIDGRIVIGEGEIDEAP
MLFIGEHVGTGQGDAVDIAVDPIEGTRMTAMGQANALAVLAVGDQGTFLH
APDMYMEKLVVGPAAKGAIDLNLPLEQNLCNIATALNKPLADLTVITLAK
PRHDGIIAAMQQLGVKVFAIPDGDVAASILTCMPESEVDVMYCIGGAPEG
VISAAVIRALDGDMQGRLLPRHQVKGDSEDNRRIGEQELLRCKSMGIEAG
NVLQLGDMARNDNVIFSATGITKGDLLEGIYRKGNMATTETLLIRGKSRT
IRRIRSTHFLDRKDPALHEFLL
>YP3343 glxK, putative glycerate kinase
MKIIIAPDSFKESLTAMQVAEAIEQGFSEIFPQAEYIKLPMADGGEGTVE
SMVAATSGELVNVEVTGPLGAPVKAFYGWMGDGETAVIEMAAASGLHLVA
PEQRNPLITTSYGTGELILAALNHGARKIILGIGGSATNDGGAGMMQALG
VQLRDQQGKALTVGGAALAQLVDIDLSQLDDRLAQTDILVACDVDNPLCG
AKGASAVFGPQKGATPERVQQLDAALQHYGEKIEQVTGKSVINVAGAGAA
GGMGAALFGLLNARLQPGIEIVTEALKLAATVQNADLVITGEGRIDSQTI
YGKTPVGVARVAKRFDIPVIAIAGSMAPDYEVVHQHGLDAVFSVLNHIQT
LPEALEEASDNIRITARNVAAVWKMGRS
>YP3804 gmhA, probable phosphosugar isomerase
MLERIKGCFTESIQTQIAAAEALPDAISCAAMALVQSLLNGNKILCCGNG
TSAANAQHFAASMINRFETERPSLPAIALNADNVVLTAITNDRLHDEVYA
KQVRALGQAGDVLLAISTRGNSRDIVKAVEAAVTRDMTIVALTGYDGGEL
AGLLGQLDVEIRIPSHRGARVQELHMLTVNCLCDLIDNTLFPHQND
>YP1430 gnd, 6-phosphogluconate dehydrogenase, decarboxylating
MALRLVTGVILQTGVFLMSKQQIGVVGMAVMGRNLALDIESRGYSVSIFN
RSSDKTDEVVAENPGKNLVPSYTVEEFVDSLEKPRRILLMVKAGEATDKT
IASLTPHLDKGDILIDGGNTYYKDTIRRNRELSAQGFNFIGTGVSGGEEG
ALKGPSIMPGGQKEAYELVAPILEKIAARADDGDACVAYIGADGAGHYVK
MVHNGIEYGDMQLIAEAYSLLKQSLGLSNEELASTFAEWNKGELNSYLID
ITKDIFTKKDEDGNYLVDVILDEAANKGTGKWTSQSSLDLGEPLTLITES
VFARYLSSLKDQRVAASKVLTGPKVQPFTGDKAEFIEKIRRALYLGKIVS
YAQGFSQLKAASNENNWDLNYGEIAKIFRAGCIIRAQFLQKITDAYAENA
DIANLLLAPYFKQIADEYQQALRDVVSYAVQNGIPTPTFSAAINYYDSYR
SAVLPANLIQAQRDYFGAHTYKRTDKEGVFHTEWMA
>YP3434 gntP, putative gluconate transporter
MEWINILWVMLGIGLMLVLNIRYQINSMVALLLAALLVGTLAGMDLLKLL
HTIKAGFGGTLGELAIIVVFGAVIGKLMVDSGAAHQIAQTLLRRFGLKYV
EAAVIIIGLIFGLAMFYEVAFIILAPLVIAIAVEAKIPFLKLAIPAVAAA
TTAHSLFPPQPGPVALVAAYGADMGMVYIYGVLVAIPSVICAGLILPKFL
GNLERPIPTFLKSDNPIDENNLPSFSTSILVPLIPAFIMIFTTIANIWLV
KGTTSYTILNFIGSSPIAMFIAMLVAFVLFGTGRGHKMEWVMHSFEGAVK
GVAMVILIIGAGGALKQVIIDTGIGDTIGMLMSAGGVSPYIMAWLITVLI
RLTTGQGVVSAMTAAGIIGAAVMDPVTGTITSVDPALLVLATAAGSNTFT
HINDASFWLFKGYFELSIKDTLKTWGLLELTNSVVGLAVVLLISMFV
>YP3316 gntT1, putative gluconate permease
MLLLLMIRYKLNGFISLILVALAVGIMQGMPIDKVVGSIKAGVGGTLGSL
ALIMGFGAMLGKLLADCGGAQRIATTLIEKFGQKHIQWAVVLTGFTVGFA
LFYEVGFVLLLPLVFSIAASARIPLLYVGVPMAAALSVTHGFLPPHPGPT
AIATIFNADMGKTLLYGTLLAIPTVILAGPVYARFLKGIDKPVPEGLYNP
KIFTDKEMPSFGVSVSTALVPVILMALRAVAEMILPKGHSLLPYAEFFGD
PVIATLIAVLIAIFTFGLNRGRSVESVMETLSDSIKIIAMMLLVIGGGGA
FKQVLVDSGIEQYIAGMMGNSGASPILMAWSIAALLRIALGSATVAAITA
GGIVAPLIATTGASPELMVIAVGSGSVIFSHVNDPGFWLFKEYFNLTIME
TIKSWSVLETIISVCGLIGCLLLSLVI
>YP3342 gntT2, GntP family permease
MTTVSALGALVALIVSIVLILRKVPPAYGMIAGALAGGLVGGADLIQTIN
LMITGAQGITNAVLRILAAGILAGVLIESGAANTIAETIVRKVGEKRALL
ALAVATMLLTAVGVFIDVAVITVSPIALAIAHRADISKMAILLAMVGGGK
AGNVMSPNPNTIAAADSFHVPLTSLMIAGIVPGLFGLALAYFMAKHLKHR
GSKVEAHELVVSKNDTALPAFGAAMAAPLVAIFLLALRPIAGIAIDPLVA
LPVGGLIGVVVMGQWRHTNQYMVSGLSRMAPVAIMLLGTGTLAGIIANSG
LKDVLISGLSASGMPSYLLAPISGALMSMATASTTAGTAVASAVFSSTLI
GMGISALAGAAMVHAGATVLDHMPHGSFFHATGGSVNMQVHERLKLLPYE
TAVGLMIAFVSTLMFGVFNLAG
>YP3315 gntV, putative gluconokinase
MAGQSIIVMGVSGSGKTTVGEAVARQIHAKFIDGDDLHPRANIQKMGSGQ
PLNDADRMPWLERLSDAAYSLSHKNETGIIVCSALKRCYRDRLREGNQGM
VFLYLKGNFDVIMARLQARSGHFMPSDLLRSQFDALEEPGPDEPDVICVD
IDTDIDEVVRRCVGALA
>YP1025 gpmA, phosphoglycerate mutase 1
MIRLIERSQRTCSLKYDGHIPNLIGVNVMAVTKLVLVRHGESQWNNENRF
TGWYDVDLSEKGRSEAKAAGKLLKDEGFTFDFAYTSVLKRAIHTLWNILD
ELDQAWLPTEKTWKLNERHYGALQGLNKSETAEKYGDEQVKQWRRGFAIT
PPALEKSDERFPGHDPRYAKLTDAELPTTESLALTIERVIPYWNDVIKPR
IASGERVIIAAHGNSLRALVKYLDDLGEDEILELNIPTGVPLVYEFDENF
KPIKHYYLGNADEIAAKAAAVANQGKAK
>YP3728 gpmB, putative phosphoglycerate mutase
MLQVYLVRHGETLWNAARRIQGQSDSPLTEIGIRQAHLVAQRVRNQGITH
IISSDLGRTQQTAKIIADACGLTMVTDPRLRELNMGVLENRPIDSLTPEE
EQWRKQMVNGTEGARIPEGESMTELGRRMHAALDSCLELPAGSKPLLVSH
GMALGCLLSTLLGLPAHAERRLRLRNCSLSRVDYQESPWLASGWVIESAG
DTAHLDMPALDELQR
>YP0064 gpmI, 2,3-bisphosphoglycerate-independent phosphoglycerate mutase
MSSTKKPLVLTILDGYGHREEQQDNAILNAKTPVMDVLWQQQPHTLIAAS
GLDVGLPDGQMGNSEVGHVNLGAGRIVYQDLTRLDKEIKEGDFFTNPTLT
AAVDNAVKTGKAVHIMGLLSAGGVHSHEDHIMAMVELAAKRGATAIYLHA
FLDGRDTPPRSAESSLKRFTAKFAELGNGRIASIIGRYYAMDRDNRWDRV
QLAYDLLTQAKGEFTADNAVAGLQAAYARGENDEFVKPTVIQATGEADAA
MNEGDTLIFMNFRADRARQITRTFVNAEFDGFKRDKVVNFGDFIMLTEYA
ADIKVACAYPPASLTNTFGEWLMKHDKTQLRISETEKYAHVTFFYNGGVE
EPFKGEDRILINSPKVATYDLQPEMSSAELTEKLVSAIGSGKYDVIICNY
PNGDMVGHTGDYDAAVKAVETLDNCIEQVVAAVKAADGQLLITADHGNAE
QMRDPATGQAHTAHTSLPVPLIYVGNKAVKAVEGGKLSDIAPTMLSLMEM
EIPQEMTGKPLFIVE
>YP0831 gsk, inosine-guanosine kinase
MKFPGKRKSKHYFPVNARDPLLQSVQAENEVSTSYIVGIDQTLVDIEAKV
DEDFITRYGLSQGHSLVIEDDVAERLYQELTHNDLITHEFAGGTIGNTLH
NYSVLADDRSVLLGTMCSNIKIGSYAYRYLCNTSSRTDLNYLQAVDGAIG
RCFTLITENGERTFAISPGQMNQLRPESIPEEVIAGASALVLTAYLVRCK
PGEPMPDATMQAIHYAKKHDVPVVMTLGTKYVIADNPQWWREFLNEHVSI
LAMNEDEAYELTGLNDPLMASDMALEWVDLVLCTAGPSGLYMAGYTEEAY
KRQTQHPLLPGAIAEFNLYEFSRAMRKAHCVDPFRIYSHIAPYMGGPEKI
MNTNGAGDGALSAVLHDITANGYHRNNVPNSSKHVRSYLSYSSLAQVCKY
ANRVSYQVLNQHSPRLTRGLPEREDSLEESYWER
>YP2551 hcaT, putative transport permease protein
MVLQSTRWLSLSYFTYFFSYGIFLPFWGLWLEGEGIPPETIGILLGAGLL
SRFLGSLIIAPRVKDPSHLVTAIRILALLTLAFAVGFWFGNGWAWLMVVI
AGFNLFFGPLVPLTDALAATWQKQITMDYGKVRLWGSLAFVIGSALTGKL
VSVWGHPAILYSLLFGVTAMLLGALLRPGVMPRGEVKHRNVAATPWKVLL
SEPQVWRFLLCVTLLQGAHAAYYSFSSIYWKDAGYSPATIGYLWSLGVVA
EILVFAFSHILFRRWTARSLLLLSAVSGIIRWSLMASTTELPWLIFIQIL
HCGSFTVCHLAAMRFISARSGADVIRLQSVYSALAMGGGIAVMTVISGFL
FENYQSGVFWVMALIVIPALFIRPRVAANPNELAS
>YP0903 hfi1, Hydroxypyruvate isomerase
MLKFAANLTWLFTEVPFLQRFALAAKAGFPAVECLFPYQEQIADVQQAQK
ASGIPVVLINAPAGEWENGQRGLASLPDAGEPFRHSVRLAREYAVALGCK
QIHIMAGNREESITFDEQYALLIERLRYAADYLMADNIRVLIEPLNNDNM
PGYFISSFPLAEKIIHQCERKNIFLQFDVYHCQKIHGNLWANLQHYWPLI
SHIQIASVPERHEPNKGEVNYPWLFQQLVIKNYPGWIGCEYQPENETFSG
LGWLGKNKNIKAFS
>YP1681 hfi2, Hydroxypyruvate isomerase
MHSWCGFIGTIQITSAPDHYKLDEEEGNHPYLLILFGCITCAGWADCEYQ
PLVAATQVLALGEPPTSL
>YP2243 hit, Diadenosine tetraphosphate (Ap4A) hydrolase and other HIT family hydrolases
MAEETIFSKIIRREIPADVVYQDELVTAFRDIAPQAPTHILIIPNVLIPT
VNDVTAEHEAALGRMVTVAAKLAEQEGIAEDGYRLIINCNHHAGQVVYHI
HMHLVGGRELGPLLPHK
>YP1696 hmsF, haemin storage system, HmsF protein
MAKLLIFIKSLIVGMMIVSTMGCAEKPTFVPPAQRALPQSERPWQKNTFV
VIAYHDVEDDSADQRYLSVRSSALNEQFVWLRDNGYHVVSVDQILAARNG
GPTLPDKAVLLTFDDGYSSFYRRVYPLLKAYKWSAVLAPVGTWIDTATDK
KVDFGGLSTDRDRFATWKQITEMSKSGLVEIGAHTYASHYGVIANPQGNT
EPAAANLQYDPKTKQYETVEAFKQRMEKDVALITQRIVQATGKQPRVWVW
PYGAPNGTVLNILRQHGYQLAMTLDPGVANINDLMNIPRILISNNPSLKD
FALTVTSVQEKNIMRVAHVDLDYLYDPDPAQEKENLDKLVQRISDLRVTH
VFLQAFSDPKGDGNIRQVYFPNRWIPMRQDLFNRVVWQLASRPDVEVYAW
MPVLAFDMDPSLPRITRIDPKTGKTSIDPDQYRRLSPFNPEVRQRIIDIY
RDMAYSAPIDGIIYHDDAVMSDFEDASPDAIRAYEKAGFPGSITTIRQDP
EMMQRWTRYKSKYLIDFTNELTREVRDIRGPQVKSARNIFAMPILEPESE
AWFAQNLDDFLANYDWVAPMAMPLMEKVPLSESNEWLAELVNKVAQRPGA
LEKTVFELQSKDWTQPEGNNAISGPILAGWMRQLQLSGAQSFGYYPDNFI
TGEPPLKDVRPVLSSAWYPLYDR
>YP1626 hpaI, 2,4-dihydroxyhept-2-ene-1,7-dioic acid aldolase
MFRGLVMFPLTNKFKQALKAKKPQIGLWLGLCSNYSAEILAGAGFDWLLI
DDEHAPNDVQRILGQLQTIASYPSQPVVRPAWNDPVMIKKLLDIGAQTLL
LPMIQNAAQARAAISATRYPPQGIRGVGSALARASRWNRIADYVQQADEQ
ICVLLQIETREALRNLPEILAVDGVDGVFIGPADLASDMGFAGNPHHPEV
RQAIDSAVMKIKTADKAAGILMTTPEVAEYYLKLGALFVAVGVDTTLLAR
TAEALAARFGVGNHHPPLAPSGGY
>YP1625 hpaX, putative 4-hydroxyphenylacetate permease
MSDSLSTAPGVTPPVNKNTPLSAQQQSVINKLFRRLIPFLFLLFVFAFLD
RINIGFAGLTMGKDLGLSATTFGLATTLFYVTYILFAIPSNIMLGIVGAR
RWIATIMVLWGIASTATLFAVGPNSLYLLRMIVGITEAGFLPGILVYLTY
WFPAHFRARANALFMVAMPVTMALGSLVSGYILALDGFLNMRGWQWLFLL
EGFPSVLLGGVVWFYLDDTPQKARWLTKEDKQCLQEMLESDRLQLAKQAD
YGALPQSAMWREIFTPVVLMYTLAYFCLTNTLSAVNIWTPQILQSFNQSS
SNITIGLLAAIPQVCTIAGMIWWSRRSDRVQERKMHTVLPYLFAAAGWVL
ASATQNSVIQLLGIIMASTGSFTAMAIFWTTPDQSISLRARAVGIAVINA
TGNIGSAVSPVLIGWLKDQTGNFNSGLYFVAGLLVIGAVIFLMIPMKKAP
PKAIF
>YP2351 idnK, putative thermosensitive gluconokinase
MSGKCIIVMGVSGTGKSCVGQALALALGAKFIDGDDLHPRANIQKMAAGQ
PLNDQDRAPWLERLSDVAYSLQQKNEVGFLVCSALKKQYRDRLREGNEGI
RFLWLTGDYDLVLHRMQQRAGHFMPESLLKSQFATLEAPGSDEPDVIPID
ISSSIADVVEHCIAALSLENHVSAILSE
>YP3150 ilvD, dihydroxy-acid dehydratase
MRQTLICKIKTRSEETMPKYRSHTTTHGRNMAGARALWRATGMTDDDFGK
PIIAVVNSFTQFVPGHVHLRDLGKLVAEQIVASGGVAKEFNTIAVDDGIA
MGHGGMLYSLPSRELIADSVEYMVNAHCADAMVCISNCDKITPGMLMASL
RLNIPVIFVSGGPMEAGKTKLSDKIIKLDLIDAMIQGANPNVSDEESAQI
ERSACPTCGSCSGMFTANSMNCLNEALGLALPGNGSLLATHADRKQLFLD
AGKHIVALTKRYYEQDDVSALPRNIANKAAFENAMILDIAMGGSTNTVLH
LLAAAQEGEIDFSMTDIDHLSRKVPHLCKVAPSTQKYHMEDVHRAGGVIG
ILGELDRAGLLNRDVSNVLGLNLTQTLEAYDVMLTQDEGVKQMYAAGPAG
IRTTKAFSQDCRYPSLDTDREEGCIRTREHAYSQDGGLAVLYGNIAADGC
IVKTAGVDKDSLTFRGPAKVFESQDEAVEAILGGKVVAGDVVVIRYEGPK
GGPGMQEMLYPTTYLKSMGLGKSCALLTDGRFSGGTSGLSIGHVSPEAAS
GGLIGLVQDGDFINIDIPNRGIVLDVSEAELAARRETEEAHGDAAWSPKG
RERQVSYALRAYAMLATSADKGAVRDKSKLGG
>YP1129 iolE, putative myo-inositol catabolism protein iolB
MTMVDQRTAVEPKTAVDQTTEVVRKAEVNQKIGIVRKIDIVRKTETVRKT
EADRHTTAVQLGINPLTWTNDDLPSLGAETSLETCLSEGKEAGFAGFELG
NKFSREAGVLGPILEHHQLKLVSGWYSGRLLERSVEEEIVAVRSHLALLR
ELGAKVMVFAEVSGCIHGEQQTPVHLRPRFPPARWAEYGAKLTAFARYTQ
ALGVQIAYHHHMGTVIESAQDIDNLMIHTGEEVGLLLDTGHLTFAGADPL
AVAQRWIARINHVHCKDVRTSVLADVKNRKTSFLDAVLSGVFTVPGDGGV
DYPPIMALLKQHGYQGWLVVEAEQDPNVAHPMTYARMGYHNLSRLAHNAG
LI
>YP3353 kdgK, 2-dehydro-3-deoxygluconokinase
MTSKNIAVIGECMIELSQKGTDLSRGFGGDTLNTAVYIARQVSAPDLNVH
YVTALGTDSFSEEMLTAWQQENIQTDLIQRMDNKLPGLYFIETDESGERT
FYYWRNDAAARFWLTSPAADDICQRLETFDYLYLSGISLAILDSASRQRL
LKLLRACRAKGGKVIFDNNYRPRLWQSKEETQEAYRDMLACTDIAFLTLD
DEDMLWGEKPLEQVIDRTQALGVSEIIIKRGADSCIVWVKEGSEAQQYDV
PAVKLPKEDVVDTTAAGDSFSAGYLAVRLTGGNAHDAAVRGHLTASTVIQ
YRGAIIPLAAMPTA
>YP1750 kduI, 4-deoxy-L-threo-5-hexosulose-uronateketol-isomer ase
MQVRQSIHSDHAKQLDTAGLRREFLIEKIFAADDYTMTYSHIDRIIVGGI
LPVSKAVSIGNEVGKQLGVSYFLERRELGAINIGGPGLIVVDGQTYDIGN
EEALYVGKGAKEVKFSSIDRANPAKFYYNSAPAHTTYPNKKITLAEASPQ
TLGDDATSNRRTINKYIVPDVLPTCQLSMGLTKLAPGSLWNTMPCHTHER
RMEVYFYFDMDEETAVFHMMGQPQETRHLLVHNEQAVISPSWSIHSGVGT
KRYTFIWGMVGENQVFGDMDHIAVSELR
>YP1470 lacY, galactoside permease (M protein)
MSKANAVQSYLRNNNFWLFGLFFFFYFFIMASYYPFFPIWLHDINNLSKT
DTGIVFGSISLFALAFQPIMGPLSDKLGLRKTLMWIIVGLLVLFAPFFIY
VFSPLLKYNIFIGAIVGGCYLGFVFTGGSHAIEAYIEKVSRHSNFEYGRV
RMFGCIGWALCATVVGILYTVNNQLIFWMASGCALILAVLLFFARPDRQS
TAFVVDTLGANKAVFNLKNALALLRKRELWFFVMYIVGVACIYDVFDQQF
ANFFTSFFATKQQGTEIFGFVTTGGEILNATVMFFAPVIIARIGSKNALL
LAGTIMSVRILGSAFATTATQVVFLKMLHMFEVPFLLVGSFKYITQVFEV
RFSATVYLIGFCFSKQLSMMFMSVFAGRMYDSMGYQDTYMVLGVIVLSFT
LISAFTLSGRSAVANLASRLKEDPSVTPPVSQPQS
>YP1785 lacZ, beta-galactosidase
MTSQEKVPLQVQLSLPQILSRRDWENPQITQYHRLEAHPPFHSWRDVESA
QKDRPSPQQQTLNGLWSFSYFTQPEAVPEHWVRCDLAEAKPLPVPANWQL
HGYDAPIYTNIQYPIPVNPPRVPDLNPTGCYSRDFTLEPSWLASGKTRII
FDGVSSAFYLWCNGQWVGYSQDSRLPAEFDLTPYLQAGSNRIAVLVLRWS
DGSYLEDQDMWRMSGIFRDVKLLHKPEIHLRDIHIMTHLSPEFTSANLEV
MAAVNIPSLQLNDPQVTGSYQLRVQLWLADKLVASLQQPLGTQAIDERGP
YTDRTQLVLRIDQPLLWSAEQPTLYRAVVSLLNHQQELIEAEAYDVGFRQ
VAIHQGLLKINGKAVLIRGVNRHEHHPQTGQAIDEESLLQDILLMKQHNF
NAVRCSHYPNHPLWYRLCDRYGLYVVDEANIETHGMQPMSRLSDDPSWFS
AFSERVTRMVQRDRNHPCIIIWSLGNESGHGATHDALYRWIKTNDPTRPV
QYEGGGANTLATDILCPMYARVDEDQPFPAVPKWSIKKWIGLPNESRPLI
LCEYAHAMGNSFGGFARYWQAFRQYPRLQGGFIWDWVDQSLTHHNDHGQP
YWAYGGDFGDTPNDRQFCMNGLVFPDRSPHPSLYEAQCAQQFFQFSLLST
TPLVINITSEYLFRESDNEQLYWRIMLEGESVLEGSQPLNLSPESSQCYR
LAEKLPTLNKPGQLWLNVEIRQPKETPWSPAQHRSAWHQWRLPQPLFSPS
SDLTNATAHYAPQLQHNLQLQHDLQLQQDEQHIKVTYQQQCWQFSRQTGR
LAQWWVADKPMLLRPLQDQFVRAPLDNDIGISEATHIDPNAWVERWKKAG
MYQLQQRCLSLHVDHLSHSVQISAEYGYEFEQEPLLHSHWVYRFDRHGRM
TIDVNVRIATSLPAPARIGMCCQLADISPTVEWLGLGPHENYPDRQLAAQ
YGHWSLPLEQMHTAYIFPSENGLRCNTHTLNYGRWTLTGDFHFGISRYST
QQLMVTSHQHLLEPEEGTWLNIDGFHMGVGGDDSWSPSVHIDDILTRETY
QYQICWQYKV
>YP3073 lamB1, maltoporin
MPTGKYNRRLLMITLRKLPIALAVAAGVLSTQAMAVDFHGYARSGIGWTA
SGGEQQCFQTTGAQSKYRLGNECETYAELKLGQELWKEGDKSFYLDTNVA
YSVSQRDDWESTDPAFREANVQGKNLIESLPGSTIWAGKRFYQRHDVHMI
DFYYWDISGPGAGLETIDLGFGKLSVAATRNSESGGSSAWIDNQRENAKY
TINNVYDVRLAGLETNPGGSLELGVDYGRADTQEGYSLAPNASKDGVMLT
AEHTQSLMGGFNKFVVQYATDSMTSYNTGHSQGTSVNNNGHLLRVIDHGA
INLAEKWDMMYVALYQDIDLDNNNGNTWYSVGVRPMYKWTPIMSTLLEAG
YDNVKSQHTGERNGQYKLTLAQQWQAGDSIWSRPAIRVFATYANWDEKWG
YSDTTGVAQDGTIGTNSRGKNNEVTFGAQFEAWW
>YP3547 lamB2, maltoporin
MILRLGILLNALCERNTKIINEDDMKTSLRTLSVALAAALVSPSVLAIEK
IDFHGYMRAGVGVSSDGGLAEWQKTMVGRLGNESDTYGEIGLGAEVYKKE
DVSFYLDSMVSMLSDGSNDSETTIGDDAQFGLRQLNLQIKGLIPGDKEAV
IWGGKRYYQRHDLHIIDTKYWNISGSGAGIENYTVGPGAVSVAWVRGDAN
DVDTRITGDSDVNINYIDVRYAGFKPWAGSWTEVGIDYAMPNPTKQQKEY
GGLYDADNAVMLTGEISQDMFGGYNKLVLQYANKGLAQNMISQGGGWYDM
WHKTDEAKGYRVINTGLIPITDKFSFNHVLTWGSANDITEYTDKTNLISL
VGRAQYQFTQYVCAIGEVGGFYQKDTYHNGSNYKQGGEKYTIALGLAEGP
DFLSRPELRVFASYLNDSENGKPFEDGTSNDTWNFGVQVEAWW
>YP0689 lpcA, phosphoheptose isomerase
MYHDLIRSELNEAADTLANFLKDDSNIDAIQRAAILLADSFKAGGKVLSC
GNGGSHCDAMHFAEELTGRYRENRPGYPAIAISDVSHLSCVSNDFGYDYV
FSRYVEAVGREGDVLLGISTSGNSGNIIKAIEAARAKGMKVITLTGKDGG
KMAGSADIEIRVPHFGYADRIQEIHIKVIHILIQLIEKEMVKA
>YP3076 malE1, maltose-binding periplasmic protein precursor
MTRSFTKSGIGKTARVLALSALTTLVLSSSAFAKIEEGKLVIWINGDKGY
NGLAEVGKKFEKDTGIKVTIEHPDKLEEKFPQVAATGDGPDIIFWAHDRF
GGYAQSGLLAELTPSKAFQEKLFPFTWDAVRFNGKLIGYPVAVEALSLIY
NKDLVKEAPKTWEEIPALDKTLRANGKSAIMWNLQEPYFTWPVIAADGGY
AFKFENGVYDAKNVGVNNAGAQAGLQFIVDLVKNKHINADTDYSIAEAAF
NKGETAMTINGPWAWSNIDKSKINYGVTLLPTFHGQPSKPFVGVLTAGIN
AASPNKELATEFLENYLITDQGLAEVNKDKPLGAVALKSFQEQLAKDPRI
AATMDNATNGEIMPNIPQMAAFWYATRSAVLNAITGRQTVEAALNDAATR
ITK
>YP3553 malE2, putative sugar-binding protein
MLYLHPRLIMKINKITALVLTALAVTQFAGFAAHAATQQLTVWEDIKKSA
GIKEAIADFEKQHQVKVNVLEMPYAQQIEKLRLDGPAGIGPDVLVIPNDQ
LGGAVVQGLLTPLSVDPTIVTTFTKPSIAAFTMDNALYGLPKAVETLVMI
YNKDMLPTPLATLDEYAAFSKKQRAENKYGLLAKFDQIYYSWGAIEPMGG
YIFGKDANGSLKANDIGLNTPGAVEAVTYLKTFYANGLFPIGTIGDNGLN
AIDSLFTEKKAAAVINGPWAFQPYEAAGINFGVSPLPALPNGKDMSSFLG
VKGYVVSTWSKDKALAQQFIEFINQPQYVKTRYQVTKEIPALTAMIDDPL
IKNDEKASAVAIQASRASAMPGIPEMGEVWGPANSALELSVTGKQEPKVA
LDNAVKQINMQIEAMQASNQ
>YP0612 malF2, sugar transport system, permease protein
MITLTPRLKRNLVPWLFLAPALVIFTWFKFIPMLQGLVMSFYKVNFNQPN
EWVGFANFSRAFGDEALHSAVFNTLLYVLVTMVVAAFIAFFLAMLLEGPA
RHLRFIRTAIFLPAVTSAAIVAEMWRILFNPTSNGVVNHVLSWFSIEAQG
FLADTDQALWTVMLLHIWKAVPYNMVIFIAGLVGISRDLYDASNVDGANW
WNRLRYVTLPGMIPALSVVLMLSFIRGFRVFAEVYATTGGGPSNATEMIM
THIYKLGFEQFDYGYASAVSFLLFAFTVVLTIGHLTLKKRIARY
>YP1499 malF3, putative binding-protein-dependent transport system, inner membrane component
MNAKLTQQAFTLPLLVVLLLVSFYTLGYAIYLSVHDIDLMSPPPFDFIGM
ANFIEVLQEPRMWSSLWNTLVYVAGSTVAELVLGSAIALFISRDFFGRKL
VRALLLLPMIVTPIVAGLIWRIFYDPNAGLFNWLAGLIGIPPIDWLGNPS
TAMASLILADIWQWTPFIILLVSAGLDALPSEPLEAAELDGARGWRLLAF
IKLPMMKPIILMALFLRMIDAFKSFDLIYVMTRGGPALATETTNMYAYLT
GFQDFRISAAVVIAIINTLLVIAVLSFASKKVMKDE
>YP2295 malF4, sugar ABC transporter, permease protein
MTFLKLKDKQVGSVLAASYLGYTSIFWFYPFIWLAVLSLTEWRFVGIPTF
NGLNNFILVMQDPLFWKSMLNVMRFLMYYLPIVFISSFLFAFGLQKLKHG
RTFVALSFLLANVSSGVAYSIVFSKIFSQNGPLNTFLYDWFGFTLPWLTS
PDFAMLSIALVVTWKFVGYYGLILFSGLNSIPKEIYSAAELDNTRTIKRL
FHITLPMINPQLIMVLVLAITVSFAIFTEPYLITGGGPLNSTTTPMIVMY
ETAFMKMQPSWAATMSIFIALISFGIILGVRKLLERKVEIV
>YP2931 malF5, putative permease protein
MKNKNVMMGYLFIAPWIIYFLVFILYPFFLSFQNSFLDINVLSPESTQFV
GLNNWISVSSDELFWRSLFNVIFNQVIFVLLSFVLAMGMALLLHEITHFG
GLFRTIMFIPVITSITVAMIIFNFLSSPAGPVQSLLLEWGVLDAPVFWKF
ERWLPMPLIAVFSTWKWFGIQMIIFLGGIAGISKSLYEAADIDGASWRRK
TWSITLPLLKPQIIFVMTMNIINGMQMFIEVLMNFDLHGGPYNAALTPVL
YLYKTGFSDMKMGTASTIGLLLAAVIYIFTMLQLKFTQEKEHS
>YP3077 malF6, inner membrane permease of maltose ABC transporter
MKGNIMQLSHTELQSRKKKIAWWQSDALKWLVISLLSLFTCYLIVLMYAQ
GEYLFAIVTLILVSLGLYVFANRRAYAWRYVYPGVAGMGLFVLFPLICTI
AIAFTNYSSTNQLTFERAQSVLLDRQFQTGKTFTFGLYPSDNQWRLQLTN
PDDGSLFISEPFSFEATGEQKVMVAPTNTAQTSEPASLRIITQSRQALSS
LVAILPDGAELRMSSLRQFSGTKPLYTLGADGKELINQQTGVKYWPNPST
GFYQAVNADGQWENEKLSPGFTVSIGWKNFLRVLHDEGIQKPFISIFIWT
ILFSVMSVTFTVAVGMVLACVVQWDSLKGKAIYRVMLILPYAVPSFISIL
IFKGLFNQSFGEINLMLSHLFGIKPAWFSDPITAKSMILIVNTWLGYPYM
MILCMGLLKAIPDDLYEASAMDGAGPFQNFFRITFPLLIKPLTPLMIASF
AFNFNNFVLIQLLTNGGPDMIGTSTPAGYTDLLVNYTYRVAFEGEGGQDF
GLAAAIATLIFILVGALAILNLKASKMNFD
>YP3552 malF7, putative maltodextrin transport permease
MIISSGDNGAAAKQSSRHAIAAVLCAVVPGFGQFYHRQWAKGLVFLVLIS
SFVGVFFDFLQEGLWGLYTLGEEVPRDNSIFLLAEGIISVLIIGFGVALY
YFSLRDAWVNGKKRDAGIPLNSVRKQYQLLLSEGFPYLMITPGFILLVFA
VIFPILFGFSIAFTNYNLYHTPPAKLVDWVGFKNFVNIFTLSIWRSTFFD
VLQWTVVWTLLATTLQCTVGVLLAILVNQKDLRFKPLIRTIFILPWAVPG
FVTILVFAGMFNDSFGVINNSILAFFGIAPKAWMTDPFWTKTALIMMQTW
LGFPFVFAMTTGVLQAIPDDLYEAATMDGASTSTKLRTITLPLVLYSIAP
IIITQYTFNFNNFNIIYLFNNGGPAVAGSNAGGTDILVSWIYKLTMSSSQ
YAIAATITILLSIFVVGLALWQFRATKSFKNDDMA
>YP0613 malG1, sugar transport system, permease protein
MKSKSWNSIGRWIIYGLLLIVFVGPYWGIIATAFSGAPVKPGELLAWPNQ
FSWDNFIFAWMDIGVWQYLLNSIIVVFFGTVLQVSVSALAAYALARKKFV
GVSLTSLIILSTMMLPEEVIAIPLYMIINWQLPVIDASLYNSYLGMILPI
VGWAFSIFVLTEFMAAIPKELEEAARIDGASEWQIFFHVILPLVKPALGT
VVTFGFIMIWDQYLLPLIVVNQDSLNTIPVILGTLRTDESITPNIFIAIT
LLAMLPSIIVYLGLQKHFNRGIMSGAVKG
>YP1498 malG2, putative binding-protein-dependent transport system, inner membrane component
MSDSLKFICQRTGFYLLLVVILVFFLLPIYWLVTMSFKTYIDAFAMPPKL
WFTPILDNYRQVLGNGDFIRAFGNSLLISLVSTFLCLILGALFAYGLVFF
IERKGRAKQFIMSLRYAPVIMLVIPVYYLITKLGMTDNYLVLILVYTVAN
VPFTILMVTTFFEDIPPEIREAARVDGASEWRVFLSVMLPLARTGLAASG
VLTLFFIWNEFQIVLTLSGDSTQTLPVAITSFLTFQGTEWGPLTAAGTLV
MLPMLVLGLLVQKHLVRGLTMGGVK
>YP1746 malG3, putative sugar ABC transporter (permease)
MTDVQQTSNQKKSDLAQDIADAEISRTLRKAKVSAAFRYIVLIIVGLLML
YPLLWMFSAAFKPNNEIFTTLGLWPEHPTSDGFINGWKTGTEYNFGHYML
NTFKYVIPKVILTIISSTIVAYGFARFEIPWKKFWFTTLITTMLLPSTVL
LIPQYIMFREMGMLNSYLPLYLPLAFATQGFFVFMLIQFLRGVPRDMEEA
AQIDGCNSFQVLWYVVVPILKPAIISVALFQFMWSMNDFIGPLIYVYSVD
KYPIALALKMSIDVTEGAPWNEILAMASISILPSIIVFFLAQRYFVQGVT
SSGIKG
>YP2294 malG4, sugar ABC transporter, permease protein
MKKNINSLIIHLVMFSLALSWLYPYIWMVLSSFKQSADIYTTGLFGSAYS
LDNYRFLFENSGRVEKPFLKTLFNSLFISTVVTVAVTLSSMFIGFALAKM
QFKGQSLFRNLLFLQMVFPASMFIIPQFVLVRELGLLNTYSAMIVPFLMS
SWGIFMISQSFQGTPNDYIHAAKIDNASLWQIMIYLMMPLNKAIIAIVAL
FTFVGTWDNFLWPLIVIQDESKMPLSVLLATFSKSYGVYVGPVIAGAVIQ
TIPIVVLFILFRKYFMQGMSLSLK
>YP2932 malG5, putative permease
MRISKKNLLIYSLLIIISLIVLYPFFFMIMNSFKTGSEIINAPNALPKNF
SFNGYIQAFYSLNLGRIFLNTLFISVTVTLVNTLLSAMVAYAIVKMNLPG
REFWIKLILTSMMVPAVLFTIPTYMMLYSWGWVNTFQALIVPGTISAYNI
FLLVQFLKQVDNAYLEAARIDGAGEFTIFFKVVLPMIRPALATVAILTFM
GSWNDFMGPLLYVRDDSLMTLQLALFKFVNDIPTDNLEQLWAMTTMIAVP
VVLVFFFLQRNFIKAFTGIGVK
>YP3078 malG6, maltose transport system permease protein MalG
MTKEEMQMAMVQPKSQRLRLLGTHFLMLCFIALIMFPLLMVIAISLRPGN
FATGSLIPDQISWEHWKLALGMSVTHADGSVTPPPFPVMLWLWNSIKIAL
ITAMGIVALSTTCAYAFARMRFRGKSALLKGMLIFQMFPAVLSLVALYAL
FDRIGQYMPFIGLNTHGGVIFAYMGGIALHVWTIKGYFETIDNSLEEAAA
LDGATPWQAFRLVLLPLSVPILAVVFILSFIAAITEVPVASLLLRDVNSY
TLAVGMQQYLNPQNYLWGDFAAAAVLSAIPITTVFLLAQRWLVGGLTAGG
VKG
>YP3551 malG7, putative maltodextrin permease protein
MAKSQSIKQEKWIRLSLSWLVIILVSVIIIYPLIWTVGASLNAGNSLLST
SIIPENLSFQHYADLFNGEVNYMTWYWNSMKISFLTMVLTLISVSFTAYA
FSRFRFKGRQNGLMLFLLLQMIPQFSALIAIFVLSQLLGLINSHMALVLI
YVAGMIPMNTYLMKGYLDAIPKDLDESARMDGASNFRIFIEIIMPLSKPI
VAVVALFSFTGPLGDFILSSTILRTPDKYTLPIGLYNLVAQKMGASYTTY
AAGAVLIAVPVAILYLALQKYFVSGLTSGSTKG
>YP1497 malK1, putative binding-protein-dependent transport system, ATP-binding component
MSGIRLSNVFKRFHDTQVINQVDLEIKNGEFCVFIGPSGCGKSTLLRMIA
GLETISSGEISIGDKVVNKLAPADRGVAMVFQSYALYPHMTIYDNMAFNL
KLAKTEPAEIERRVLNAAKILQLELLLQRLPKALSGGQRQRVAIGRAIVR
NPDVFLFDEPLSNLDASLRVATRVEIAKLHHQLGNTMVYVTHDQVEAMTL
ADKIVLLNSGAAMLNEGSIAQTGHPLELYHHPVNEFVAGFIGSPKMNFLS
GELVAGNAQCASIRLGGVREIEVQVSTLKWGSARSICGSATKQRHT
>YP3074 malK2, maltose/maltodextrin transport ATP-binding protein
MANVTLSSVYKAFGEAVISRDINLEIDDGEFVVFVGPSGCGKSTLLRMIA
GLEDITSGELLIGGKRMNEVPPSERGIGMVFQSYALYPHLSVAENMSFGL
KLAGVKKAEIYQRVNQVAEVLQLAHLLDRRPKALSGGQRQRVAIGRTLVS
EPDVFLLDEPLSNLDAALRVQMRIEISRLHKRLERTMIYVTHDQVEAMTL
ADKIVVLDAGNIAQVGKPLELYHYPANRFVAGFIGSPKMNFLPVKVTAAE
PRQVQIELPNHQRVWLPVEGDQVQVGANMSLGIRPEHLLPSSASEVTLEG
EIQVVEQLGNETQIHIQIPAIRQNLVYRQNDVVLVEEGATFSIGLPPHRC
HLFREDGTACKRLYQELGV
>YP0127 malQ, 4-alpha-glucanotransferase
MDRKSLDQAATLAGIAASYINAHGKPQATLAETKEQLLAAMGRSLGAHDT
QTANTPLPVVKVFTFGSPMQLPMAGSGDYHWQLQTENGELHQGRISAKKT
LTLPASLPLGYHRLILEQDLQQWQCSIIVAPKRCYEPDALLQGKKLWGAC
VQLYTLRSEHNWGIGDFGDLKQMLEQVGERGGSFIGLNPIHALYPANPHS
ASPYSPSSRRWLNVIYIDINRVEEFQQSEAAQRWWHQAETQQALAKSRES
EWVDYPLVMQLKLTALRLSFPLFTARKAKDAQVQAFRHFVEQGGSSLHQQ
AVFDALHAHLSEHDPMMWGWPVWPEKYRDGHSSAVADFCREHADEVTFYL
WLQWLAASQFDDCFQSSQQRKMPIGLYRDLAVGVAEGGAETWCDRELYCL
KASVGAPPDILGPLGQNWGLPPMDPHVMVARAYQPFIDLLRANMTSCGAL
RIDHVMALLRLWWIPYGHTADQGAYVKYPVDDLLAVLALESQRHHCMVIG
EDLGTVPVEIVGKLRDSGVYSYKVLYFEHDSENIFRAPQSYPVQAMATIT
THDLPTLRGYWQADDLTLGNKLGLYPDQQILKQLYLDRERAKQGLLEGLH
RYDCVPKKVGHKAALLSMSPVLNRGLQRYVADSASALLGLQPEDWLDMAA
PVNIPGTTDEYPNWRRKLSASLEEIFADSQINRLLKDLDKRRKNVSVG
>YP3989 malS, alpha-amylase protein
MKRLTLPLLLVLSPAAMANWSLQHFPAFTEQDSGIFLSSSSLTKGEYPLK
FYQDKQCWQPTGPVKLNQMLSLQPCQENIAIPWRLFRDGQYQARIDTRSG
TPTLTLSVTAPVAEAVQVVTHVCQRWDGNPVTVDVSKTFAEGEIVRDFYS
GQTATVSLGKITLRPAPESGGLLLLESAQTQQAAPFSWQNATVYFALTDR
FNNGNPANDHSYGRHGDGMQEIGTFHGGDLAGLTEKLDYLQQLGVNALWI
SSPLEQIHGWVGGGTKGDFPHYAYHGYYGLDWTRLDANMGTEQDLRTLVE
QAHKRGIRILFDVVMNHVGYATLADMQNDQFGALYLQGDQQEKTLGKRWS
DWTPGSGQTWHSFNDYINFSDKTAWDNWWGKKWIRTDIGDYDTPGYDDLT
MSLAFLPDIKTESTQPSGLPVFYRNKPDTAAQEIAGATPRDYMTHWLSQW
VRDYGIDGFRVDTAKHVEKPAWQQLKQQSIAALAEWKAAHPEQALDNLPF
WMTGEAWGHGVMKSDYYQNGFDAMINFDFQDQANQALACFSSIESTYNQM
AEKLQNFNVLSYLSSHDTRLFFKDDAQQSLAKQQRAGSLLLLAPGAVQIF
YGDENGRKFGPTGSDPLQGTRSDMNWSELSGEKGALLAHWQKVSQFRARH
PAIGAGVQQSQQTANYYAFSRQHQGDKVLVVWVGDKN
>YP0732 malZ, putative maltodextrin glucosidase
MLSGWHLPVSPFVRLADDALHITLWLQGDSLPAQVFLRCEPDNEEWLLTM
EGHESHDRWRYSVSLPLYEGQPTRRYCFKLLWDDRQQWFGPLGFSVIPPA
QLAQFAVDVPDSGPDWVADQVFYQIFPDRFASSQADHGVQEGSYIHHAAG
CPVSRREWQQPLDDVHAASTFYGGDLAGISQKIPYFQQLGVTALYLNPIF
TAPSVHKYDTEDYYQVDPYLGGERDFLQLRAATREVGIKLVLDGVFNHTG
DSHRWFDRYQQGENGACHHEDSPYRGWFTFLPDGRALDWKGNASLPKLNF
ANEEVAERIYRSDDSVVRYWLRPPYSIDGWRLDVVHMLGEDGGAKGNLHH
LHGIYQAAKEENPQAYILGEHFGDARNWLHAGVEDAAMNYMGFALPVRSF
LAELDVACHPIKLDAADCAYWMDEYRAGLPHSQQLRLFNQLDSHDTARFL
TLLKGDKTRMQMALIWLFSWIGVPCLFYGDEIGLDGGNDPFCRKPFPWDE
AQWDHDLLSLCQRMAALRHKSIALRRGGCQVIHASGDSLVFIRSYQTERV
MVAIQRSDDADIFLPASPLLNVAEWQRLEGGGDLAVSETGVNMGLEGKSV
TLWCGVGEC
>YP2060 manA, mannose-6-phosphate isomerase
MLKMNNAVQNYAWGSTDALTQLYGIPNPQGMPMAELWMGAHPKSSSQVLD
ANGQWHSLRDVIDQDPDNTLGSDIFKRFGELPFLFKVLCAAQPLSIQVHP
SKAAAEVGFAKENQAGIPLDAAERNYKDANHKPELVYALTPFQAMNGFRT
LEDIQALLQPLAAAHPDIAAFLRQPDTEHLASLFASLLSMSGETKTRALG
ILKAALNSQLGEPWDTIRSISCFYPDDSGLFSPLLLNAVTLQPGEAMFLY
AETPHAYLNGVALEVMANSDNVLRAGLTPKFIDIPELMSNLQFIPKPANA
LLTTPKQQGNELIFPIPVEDFAFSLHTLVVEPHVLAQHSAAIIFCVEGCA
VLKKQEQEITLHPGESCFISAKESPVTVQGVGSIARVYNAV
>YP0829 manB1, phosphomannomutase
MPKLTCFKAYDIRGRLGDELNEDIAYRIGRAYGEFAKPKKVVVGGDVRLT
SESLKLALSQGLQDAGTDVLDIGLSGTEEIYFSTFHLGVDGGIEVTASHN
PIDYNGMKLVREGSRPISGDTGLRDIQYLAEQNEFPPVDSEKRGGYKKIS
IINDYVEHLINYINPSLFKPLKLVVNTGNGAAGHVIDALEKRFSELKIPI
TLIKIHHEPDGTFPNGIPNPLLPECRQDTTDAVLMHDADMGIAFDGDFDR
CFFFNNKGEFIEGYYIVGLLAEAFLQKNAGAKIIHDPRLSWNTIDIVNSS
GGTPIMSKTGHAFIKERMREEDAVYGGEMSAHHYFRDFAYCDSGMIPWLL
IAELLCVKEKSLEQLVEERMRIYPASGEINSKLTDPTSAIARVRAEYEVK
AIAIDETDGISMEFDGWRFNLRSSNTEPVVRLNVESHYNKTLMHHKTAEI
LSLLRKE
>YP2298 manB2, phosphomannomutase
MNLSSVIQHNQIGKEMEKLTCFKAYDIRGKLGSELNEEIAYRIGRAYCQW
LKPAKVVVGGDARATSVELKNALAKGLMDGGADVIDIGMVGTEEVYFATR
FYGVDGGIQVTASHNPIDYNGMKLVKKDAQPISGDNGLYEIQRLAQDNHF
APPGVRGQLETQLVREHYVEHLLSYIDLNALLPMKIVVNAGNGAAGPTLD
ALEAALAKRKVPISFIKINHQPDSSFPNGIPNPMLPENQWSTRQAVCEHQ
ADLGIAWDGDFDRCFFFDHLGNFIEGYYIVGLLAEKFLLTNNMGKATHNT
DKIIHDPRLTWNTIDIVQTLNGTAIESKTGHAFIKDAMRHHDAVYGGEMS
AHHYFREFGYCDSGMIPWLLVIELLSKKTTSLFSLIESRKAKFPVSGELN
FTVSDPKTKIQQIKQFYADSAIHVTGIDGLSMEFEHWRFNLRSSNTEPLV
RLNIETRGDVTLLEQKTAQLTQLLYPK
>YP1634 manX1, PTS system, mannose-specific IIAB component
MILGEQSNVAYIDFVPGENAETLIEKYNDRLTGLDTSKGVLFLVDTWGGS
PFNAASRIAIDKENYEVVTGVNIPMLAETFMARDDEPSFAELVAVAVETG
REGVKALKAPDVKSDKPETQPAAPVPTAKAPAVALGPNDHMKIGLARIDD
RLIHGQVATRWTKETNVNRIIVVSDEVAADKMRKTLLTQVAPPGVTAHVV
DVEKAIRVYNNPKYANDRVMLLFTNPTDVVRLVEGGVDIKSVNIGGMAFR
QGKTQVNNAVSIDEKDIEAFNKLNARGIELEVRKVSSDSRLKMMDLISKL
NK
>YP3530 manX2, putative PTS transport protein
MTRPNIVWTRIDERLLHGQIRITWGKHTEANLILVANDDAADGPNSAFMQ
AGMKASAGGEYAVRFFSIQKTIDVIHKASPQQKVFILCNSPTDVARLVEG
GVPITQCNVGNMHYHDGKRQIAKTVSVDEKDLDAFQRMAALGVACTVQNT
PDQTPINVIELAARA
>YP3533 manX3, Phosphotransferase system, mannose/fructose-specific component IIA
MIGIVVSGHINFASGMASAVRAITGEQSQMLFIDFVESMSTDMLESELRR
AAHEVDSGEGVLFLTDIPGGSPCNRALNILMSGSNVELLAGVNLPMIANA
AFEREGASLSELVEILMDIGASSVQNLRAELDTALVTDSGENEDGL
>YP1635 manY, PTS system, mannose-specific IIC component
MVILLSFIGHRRSTMEITTLQIVLIFIVACIAGMGSILDEFQFHRPLVAC
TLVGMVLGDMKTGIIIGGTLEMIALGWMNIGAAVAPDAALASIISTILVI
AGGQDIGAGIALAIPLAAAGQVLTIIVRTITVAFQHAADGAAERGSLRAI
TWLHISALFLQAMRIAIPALIVALSVGTSEVQMMLSSIPEVVTSGLNIAG
GMIVVVGYAMVINMMRAGYLMPFFYLGFVTAAFTNFNLVALGVIGVVMAV
LYIQVSPKYNKSQVVQSGPANNDLDNELD
>YP1636 manZ, PTS system, mannose-specific IID component
MREMVDTTTVDTTTVTKTTTGEKKLTASDIRGVFLRSNLFQGSWNFERMQ
ALGFCFSMVPAIRRLYPENSEERKQAIKRHLEFFNTQPFVAAPILGVTLA
MEEQRANGAEIDDAAINGIKVGLMGPLAGVGDPIFWGTVRPVFAALGAGI
AMSGSLLGPLLFFVLFNVVRLLTRYYGVAYGYKKGVNIVNDMGGGFLQKL
TEGASILGLFVMGALVNKWTHVNIPVVVSRITNPAGETTVTTVQTILDQL
MPGLVPLLLTFGCMWLLRRKVNALWIIMGFFAIGIFGYWIGFLAP
>YP3960 mdfA, multidrug translocase
MQTSFSPATRLGRRALLFPLCLVLFEFAAYIANDMIQPGMLAVVAEFNAS
VEWVPTSMTAYLAGGMFLQWLLGPLSDRRGRRPVMLAGVAFFVVTCLAIL
LVNSIEQFIAMRFLQGIGLCFIGAVGYATIQESFEEAVCIKITALMANVA
LIAPLLGPLAGAALIHVAPWQTMFVLFAVLGAISFAGLWRAMPETASLKG
EKLSVANMWRDYKQVLANRRFLCGSLALGFASLPLLAWIAQSPVILISGE
QLSTFEYGILQVPIFGALIIGNLTLARLSGKTSIPQLIRYGAGPMIVGLM
IAAGSTLYSSHAYLWMTAGLSLYAFGIGLANAGLVRLTLFASDISKGTVS
AAMGMISMMIFTLGIELAKVAYLWGDSRGFNLFNLMSGLLWLGLVMVFIR
RQPEAVATE
>YP0913 melB1, putative transport protein
MAVNMSKQISTRHTLAYGSANLLGSGALAISGAWLMYFYTTFCGLSVVEA
ATIFSIASIIDAISNPVMGYITDNFYNTRLGRIFGRRRFFILLGIPLVLV
YPMLWMSGFGFWYYLLTYALFELIYTSIMVPYETLATEMTTDFAKRSKLT
GSKAIFGKVANFLAAFIPGQFIAIYGKDSATPFLYTGIAYGLIMCCAMIW
LYSSSWERPASEVVRETTSSLGQALKKLCVDMASTFHLRIFRKHLGMYLF
GFGAEWLFASAFTYFIIFGLGQDAALVSQLNSFSSIMQLISTAIFIGICV
KMGFARPFRIALQVVIVSVVAYAALYFTGWSETTTVIVLFCITAVFGLST
GGIYYIPWTVYTFLADVDEVLTGRRREGIYAGAMTFAGKMVRSIIVFAMG
WTLSRFGFVSGQSSQPEIAVQAIVGVFAIGVISLALVAIYYTTQMKLDRK
NHSILLEEIERIKNGGAMADIPAHARAVAEELTGWKYEQCWGNNPLGVKE
SPTVIPKPVTES
>YP3445 melB2, Sodium:galactoside symporter family protein
MTGMSLDSQHLCSLKDEGDKRLKINMNNSGMKIPMKELASYFGYGMGQCF
SFGLVGTFILFFYTDIMGISPVAASMIFLIARVWDAIHDPLIAGVMDTIN
MRRGKFRPYLLFTPFLIFLVTVAAFYNIEASLMTKTIYAGVTYILWGTLY
ALSDIPFWSMSTVMTDEPQERAKTATCAMLGVNAGIGATMILFPYISGLF
AENSADRGYFAGVVILMVLGVILMLNGFFNTKERVNVTVTEKVTLKQTFI
VVWQNKPLFFILSAFFMNVFSNIVNTFYIFFFTYNMGDAELVSVIGLITF
TCALACLGTPFLTRHFKKRDLFITLCVLEIIARVGFWFTGYNNVVSVMVW
LTVITAIFMMTNPLISAMIADTVEYSYYHTGKRCAAITFSGQTFVGKLSV
AVAGGVSGLILSILGYMPNVAQSTWTLNGLFFCISLLPAVGAVVRILIMR
KYKFTEDEHAILREELKQGRFHSSVGK
>YP0357 mglA1, putative sugar ABC transporter, ATP-binding protein
MTHISDVDRDVPLITLKALSKSFGGHQALKNITLTLNKGEVHCLAGANGC
GKSTLIKTISGVYAPDDGSEIIIDEKSYHRLTPDRARALGVQVIYQDLSL
FPNLTVAENIAFEYNLKGYFGWFNKQKIKQKACQILHELAFSLDPDALVQ
HLPIAQRQQVAICRALVADARLVIMDEPTASLTRTEVNQLLRTVNYLRDK
HITVVFVSHRLDEVKEISDRITVIRDGEKVGTWPATELSTGRITELMTGL
TLTHEQKLPNAELGKVVLQLENLSRKGQFDDISFSLHRGEVLGLCGLLGS
GRTELALSLFGITHPDSGKITIDGNPVCIKDNTRAIELGIGYVSEDRLTL
GAVLQQSIADNMVLSILQRIRTPLYLVDDAKQNALVQEWVKDLDIKITDA
DNALSTLSGGNQQKVVLAKWILTKPKVLILDSPTVGVDIGAKDSIYKLIH
RLSGVGISVLLLSDEIPEAYYNCDRILHMQQGRIVNELIPNQMTEQQLAE
VING
>YP3913 mglA10, ABC transporter ATP binding protein
MTQATAFITLENISKRFPGVLALDGVNLTLNKGEVHCLAGQNGCGKSTII
KVISGVYQPEKGASILIDGKLLHQLTPQLSFYYGVQVIYQDLSLFPNLTV
AENIAVHRYLPGGDFWVKRKSMRERALAAMQRVGVTLDLDKKVEQLSIAD
RQLVAICRAIAADARLVIMDEPTASLTSQEVKGLLNVVRDLKSQGICVVF
VSHRLDEVMEVADRISVMRDGKWVGTWQASELDSHELAFLMTGQRFTYRP
LPPLAAKAAPLLEIRKLSRGEQFRNIDLTLHQGEIVSITGLLGAGRTELC
LSLFGMTQPESGEIFVAGEPVRFRHNRDAIRHGIGYVSEDRLTQGLIMEQ
SIYDNTIVSVFDQLHTRSGLLDHSKAAALVNKLVQDLNIKVSDTALPVKT
LSGGNAQRIAIAKWVATQPRILILDSPTVGVDIANKEGIYHIAKALAEQG
MAVLMICDEIPEAYYNSHRVLVMRKGELIAEFYPHQCTEQQIAEVVNG
>YP0370 mglA2, putative sugar ABC transporter, ATP-binding protein
MNHRPDIVMRAEDISMRFPGTLALDSVNYTVYRGKVNVIIGENGAGKSTL
MKILAGVQQQTSGQIYLNGQKVSIANTREAAALGIGMVHQELNLSENLNV
AENIFLGREIQHGLKPINQAAQERVTEQLMVRLDQVISPQEKVSNLKVGQ
QQLIEIAKALAEQADILILDEPTSALSKTEVDVLFRVIRELTRQGVSIVY
ISHRLEELMAIGDYITILRDGRFQAEAAVKDIDVPWIVREMLGSDPVSSF
LRPGRTFGEPMMEVEDVTLINESGNTVVNHVSLHVRAGEIVGIYGLMGAG
RTELFECLLGTQQNYLGTVRLNGTVMNAKTSTAERIRFGMSLVPEDRKKA
GIFPASSVACNLTISSLWRRLKHRFAIWQESEVQVVAATIGELSIKVSSP
DVEIQALSGGNQQKVVIGRSLLTRPNILLLDEPTRGIDVGAKADVFEMMV
KLSEQGIGILFSTSDLKEIMAVSDRILVMSNGKLTANLSRQSASESALVT
ASAQGFE
>YP1297 mglA3, putative ABC transport ATP-binding subunit
MLNMALHITWFTPINGFTPIMILHTVRDGKAADDPILRIENISKNYGPVQ
ALCGVTTAIRRGAIHGLLGENGAGKSTLVGIISGQVTPTSGRIFMDGRLL
EHVDVKAMEEAGVFLVTQEPMIIDKMTTAENLMLGIWPTKNGVIDWKTLR
SDAARILDGSGINASTLAGHLDAVARRKLNILRAMFSGGKVIILDEPTAA
LTVADRRQLFDFMRRLQAAGVTFIFISHYHDEILAICDAVTVLRDGRLAG
GSDDIGSMTSVALSEWVIGRGLELFQRIRRDHTGKPPAVSLRGIQGKALS
LDRLDIGAGEIVGFTGLPGAGAKESARAIFGLYPARGSISINGEAAQALP
KRPRMAFNIGIAYLSDDRRREGGVGQMSIGANIALSSLPSRVKWGVIDRR
AEALVIAHYFAAMGVKALSPDDAVNTLSGGNQQKVCLGRVFATQPRLLMV
DEPTRGIDVGVKQDVLRIIDELSDAGVAVIIVSTDMDELARSVDRVCIFE
HGAIKEILTGDDITAERLRASVQA
>YP1398 mglA4, galactoside transport ATP-binding protein
MADINTAQPRDWLLEMSNIDKSFPGVKALDNVNLKVRPYSIHALMGENGA
GKSTLLKCLFGIYKKDSGSIIFQGQEIEFKSSKEALEQGVSMVHQELNLV
LQRTVMDNMWLGRYPTKGFFVDQDKMYKETKAIFDELDIDIDPRDKVATL
SVSQMQMIEIAKAFSYNAKIVIMDEPTSSLTEKEVNHLFTIIRKLKARGC
GIVYISHKMEEIFQLCDEITILRDGQWITTQPLDGLTMDQIISMMVGRSL
SQRFPDRLNKPGEVILEVKNLTSLRQPSIRDVSFDLHKGEILGIAGLVGA
KRTDIVETLFGIREKVTGTIKLHGKNINNHSANEAINHGFALVTEERRST
GIYAYLDISFNSLISNIRNYKNKFGLLDNTRMKSDTQWVIDAMRVKTPGH
RTNIGSLSGGNQQKVIIGRWLLTQPEILMLDEPTRGIDVGAKFEIYQLMT
ELAKKDKGIIIISSEMPELLGITDRILVMSNGQVAGIVDTKQTTQNEILR
LASLHL
>YP1579 mglA5, ATP binding protein of ABC transporter for ribose
MSGTNHKRCRLSGTGRVDGGSPMDVSIDQRAMAAQESQEGAFLVIHNVHK
RYNGVHALRGINVEIHQGEIYHLLGENGCGKSTLIKVISGAIGADEGELV
INGTVHQQLTPIEALSLGIETVYQDLSLIPNLSVVENIGLTEQLVAQAGR
LNRILDRQRLLSTAKAALAVVGLPSNERFLFTTVEVLPMAQRQLVAIARA
IATKARLVIMDEPTTSLTKKEIDNLIGVIRQLGQQHVAVLFVSHKLDECF
AIGGQVLVLKDGQKIAQGAITHFTQSQLGYLMTGRQMDERRYRRVQQGGE
PLLTVTALGQQAAFDEISFVLHRGEILGVTGSLDSGRNELGLALAGILPA
NRGSIALEGQPIRLRQPRDAINNHIAYVPEDRLDAGLFLSKSILENLIAL
ELDHLLGYWGQVDKGQCQVLATQTVLDLDISAPNINLPVQALSGGNQQRV
LIGRALTIKPWVLILHGPTVGVDIGAKDTIYQLIQTLAQQGMGVILISDD
LPELCQNCDPILVMKKGRICQQVSAVDANENRLYQAQIADEGLTEDL
>YP3141 mglA6, putative sugar transport system ATP-binding protein
MEILLEVRGLSVEFPGVKALDSVDFSLQRGEVVALLGENGAGKSTLIKAL
TGVYKRSAGEVLLDGKAVCPIDTADAQLMGIGTVYQEVNLLPNISVAANL
FIGREPLRWGLIDHNKMNQQAAKLLTGYGLTLDVQQPLANFSIAIQQIVA
IARAVDLSAKVLILDEPTASLDAKEVSMLLDILCQLRDQGIGMVFVTHFL
DQVYRISDRITVLRNGKLVGTKTVAELPRIELVQMMLGHSFDEQLLKRGE
HSITNKNPLVEFKNYGRRGVVENFDLSVSPGEIVGLAGLLGSGRTETAQL
IFGITTPDTGEAKIQGKPVKIRTPRKASKFGFGYCPEDRKTEGIVGAATV
RENIILALQAQRGWLRPLSMREQTQIADDFIQQLGIRTPSPEQQIQYLSG
GNQQKVLLARWLATKPRFLILDEPTRGIDVGAHAEIIRLIEKLCDEGLAL
LIISSELEELAGYADRIIVLRDRRHVAQLDHDEISVPAIMQAIAVQ
>YP3398 mglA7, sugar transport ATP-binding protein
MPYLLEMKDITKQFGVVKAVDNISLTLEAGQVLSLCGENGSGKSTLMKVL
CGIYPVGSYQGEIIFSGETLQAKNIRETEQKGIAIIHQELALVKQMSVLE
NMFLGSEWGRFGIMDYDAMYLRCQRMLAQVKLVVDPHTPVSELGLGQQQL
VEIAKALNKQVRLLVLDEPTASLTESETAILLDIIRDLRNHGIACIYISH
KLNEVKEISDHICVIRDGRHIGTRPASTMSEDDIIAMMVGRELKELYPHE
AHHIGEEILRVENLCAWHPVNRHIRRVDDVSFSLKRGEILGIAGLVGSGR
TETVQCLFGVYPGRWQGDIFIKGQAATIRTCQQAMKLGIAMVPEDRKKDG
IVPVMGVGANITLAALDDFTGAFSLLDDAKEQSIIVQSLARLKVKTSSSE
LAIARLSGGNQQKAILAKCLLLNPQILILDEPTRGIDIGAKYEIYKLINQ
LVQQGIAVIVISSELPEVLGLSDRVLVMHQGRIKADLINHNLTQEKVMEA
ALRSETHVTS
>YP3483 mglA8, galactoside transport ATP-binding protein
MDQYAIEVIQVTKSFGGIHALKSINLQIRTGSIHAIIGENGAGKSTLMKI
LSGIYTKDSGRIMIHGEEKNFTSPIHSKESRIGIIYQELALSPDLTVAEN
IFLDDLGFGTGMINWKRLNEKASLILNELGFQIDPRARVGDLSVAYQQMV
EIAKSLAKDVNILILDEPSAVLSGKEVAILFTQLRKLKARGVTIIYISHR
LEELMVIADVITVIKDGETVKTLDPQSCSEDEIITSMVGRKLESLYPEKN
VPGNEVVLEVKALSTRALLHGINLTLHKGEIVGLAGLVGAGRSEVARCLF
GIDKIAGGTVSKAGTPIQINHPSQAMSHGIGLVPESRKEQGAILVRPIRE
NMTLSNLKAVSGWMGFIRRRQERETSQKLQQKLAIKLGSVEDPIASLSGG
NQQKVVIAKWLNTDCHILILDEPTRGVDVGAKAEIYNIIHQLAERGYSIL
VISSEMVEVINLCHRIYVMSEGRITKELQHDEISEENIMRYAIPKRETI
>YP3769 mglA9, putative ABC transporter ATP-binding protein
MNTFKLKIFLFTKTFQLSHQELLMPHTVATPPPLLQVRGISKQFSGVVVL
KSIDFTLQPGQVHALLGGNGAGKSTLMKIIAGILPPDTGVIEMNGQPCFN
LTPAKAHQLGIYLVPQEPMLFANLSVQENILFRLPKHQADKKKMAQLLKN
LGCHLDLSVSAGSLEVADQQLVEIMRGLIRDSHILILDEPTASLTPAETH
RLFSQIRMLLQQGVGVVFISHKLPEIRQLADWVSVMRDGGIALSGATADF
STEDMIQAMTPEAQKGALTDSQKLWLELPGNRRAQSHAQSQQPVIHVHDL
SGEGFAHISFHVQAGEILGLAGVVGAGRTELAETLYGLRPASTGNVILEE
VNITAMKTANRLAAGLVYLPEDRQASGLYLDAPLSWNVCALAHDRQGLWT
QPAQEAAVLERYRRALNIKFSHLEQPVRTLSGGNQQKLLIAKCLEANPLL
LIIDEPTRGVDVSARSDIYQLIRSIAEQQVAIIFISSDLEEVVQMADRVL
VMHQGEINGALSGAAMNVDTIMHMAFGEHRSASEPQGGTASSAENKGASC
>YP1397 mglB, galactose-binding protein
MKSWTIDIQLPVALDDAFFVKARCYHLVLPYINPEIQMNKKVFTLAALVT
SMMVGAYAQAETRIGVTIYKYDDNFMSVVRKAIEKDAKASPEITLLMNDS
QNDQSKQNDQIDVLLAKGVKALAINLVDPAAAPVVIDKARSNDIPIVFYN
KEPSRKALDSYDKAYYVGTDSKESGVIQGELIAKHWQANPEWDLNKDGKI
QFVLLKGEPGHPDAEARTTYVIKTLNEKGLPTQQLQLDTAMWDTAQAKDK
MDAWLSGPNANKIEVVIANNDAMAMGAVEALKAHNKTSVPVFGVDALPEA
LALVKSGQMAGTVLNDANNQAKATFDLAKNLAAGKPAAEGTTWKIENKIV
RIPYVGVDKDNLAEFTK
>YP1399 mglC, galactoside permease
MNVLNKKDMLTYFKESGIYVVLFVLLAIIIIKDPTFLSLMNLSNILTQSS
VRIIIALGVAGLIVTQGTDLSAGRQVGLAAVVAATMLQSMDNVNKVFPDL
QTVPIPVVILVVCLIGAVIGLINGIIIAYLNVTPFITTLGTMIIVYGVNS
LYYDFVGASPIAGFDPAFSTFAQGFLRFGDFKLSYITFYALIAIMFVWVL
WNKTRFGKNIFAIGGNPEAAKVSGVNVPLNLIMIYALSGVFYAFGGMLEA
GRIGSATNNLGFMYELDAIAACVVGGVSFSGGVGTVIGVVTGVIIFTVIN
YGLTYIGVNPYWQYIIKGGIIIFAVALDSLKYAKKK
>YP1332 mgsA, methylglyoxal synthase
MELTTRTIAARKHIALVSHDHCKKSLLAWVMENRDLLAQHELYATGTTGN
LVQKATGIDVHCLLSGPMGGDQEVGALISEKKIDILIFFWDPLNAVPHDP
DVKALLRLATVWNIPVATNRSTADFLIGSTLFSSEVTIAIPDYDRYMQQR
LDLK
>YP2031 mipB, putative transaldolase
MKPMLFSNKNILIRITLSILYSSMIAAYGFSSIRSLNYPDPEAFMELYLD
TADVAAVKRLARVLPLQGVTTNPSILAKAGKSLWEVLPALRDALGGTGKL
FAQVLASDSERMVSEAVQLSEQIPGLVIKIPVTAEGLAAIKKLKTMSIPT
LGTAVYGAGQGLLSVLAGAEYVAPYVNRLDAQGSDGIAMVRELQQLLTLH
APKAKVLAASFRTPRQVLDCLLAGCQSVTIPVDVAEQFISTPAVKAAIEQ
FEQDWQGAFGTTMLS
>YP2064 mlc, putative ROK family transcriptional regulatory protein
MIMDGQPGHIDQIKQTNVGAVYRLIDLLGPISRIELSKRAQLAPASITKI
VRELVEVHLVKETEYQDVGSRGRPAIGLVLDTEAWHYVSGRISRGTITLA
LRDLSSKLVVEEQIPLPDRHPEPLLSRILNEVDQFFIRHQKKLERLTAIA
ITMPGIIDAPAGIVHKMPFYDVNEMSLGPALEQRTGLPVYLQHDICAWTM
AESLYGASRGCQNIIQVVIDHNVGAGVITSGRVLHAGSRSVVNIGHTQVD
PYGKRCYCGNHGCLETVASIDNMLAIAQQRLNSSMSSLLHHTPLSVESLC
DAALAGDQLAKDIILGVGHSVGRIIAIMVNLFNPEKILVGSPLNKASSIL
HPAIASCIRQQALPAYSENILVESTEFFNQGTMPGAALVKEALYNGSLLV
KLLQG
>YP0583 mrsA, probable phosphoglucomutase/phosphomannomutase
MSNRKYFGTDGIRGKVGESPITPDFVLKLGWAAGKVLARHGSRKIIIGKD
TRISGYMLESALEAGLAAAGLSALFTGPMPTPAVAYLTRTFRAEAGIVIS
ASHNPFYDNGIKFFSIDGTKLPDDVEEAIEAEMEKPLTCVESAELGKANR
IVDAAGRYIEFCKGTFPSELSLNELKIVVDCANGATYHIAPSVLRELGAT
VITIGCEPDGMNINEECGATDVRLLQERVLAEGAHVGLAFDGDGDRLMMV
DHLGNKVDGDQILYIIAREGLRQGQLKGGAVGTLMSNMGLQLALKDLGIP
FVRAKVGDRYVLEAMQEKGWRIGAENSGHVILLDKTTTGDGIVAGLQVLT
AMVRNHMSLHDLCSGMKLLPQILVNVRFSGEHNPLKSDEVEEVTRQVEKE
LGGRGRVLLRKSGTEPLIRVMVEGDAEESLIAEMANRIADAVKAAG
>YP3979 mtlA, PTS system, mannitol-specific IIABC component
MFSPDAKVRVQNFGRFLSNMVMPNIGAFIAWGIITALFIPTGWLPNETLA
KLVGPMITYLLPLLIGFTGGRLVGGDRGGVVGAITTMGVIVGADMPMFLG
AMIVGPLGGWAIKHFDRWVEGKIKSGFEMLVNNFSSGIIGMLLALLAFMA
IGPLVEVLSKGLAYGVDVMVQNNLLPLASIFVEPAKILFLNNAINHGIFS
PLGVQQAAETGKSIFFLIEANPGPGLGVLMAYMFFGKGNAKQSAGGAAII
HFFGGIHEIYFPYVLMNPRLLLAVILGGMTGVFTLTLLNGGLVSAASPGS
ILAILAMTPKGAYFANIAAVATAFAVSFVVSAILLKSSKAKDDEEGLEGA
TRRMQDMKAQSKGVQAANAAAAAGDLSTVRKIIVACDAGMGSSAMGAGVL
RKKVQDAGLKHIAVTNCAINNLPEDVDLVITHRDLTERAMRHAPQAQHIS
LTNFLDSQLYNSLTAELLQASQLVDNTKVQKVIEKLDDSFEAFEDNLFKL
GAENIFLNQHATAKEQAIRFAGEQLVKGGYVEPEYVEAMLDREKLSSTYL
GESIAVPHGTIEAKDRVLKTGVVFCQYPEGVRFGDEEDDVARLVIGIAAR
NNEHIQVITSLTNALDDDSVIARLSKTTSVQEVLDLLGGKTSA
>YP1309 mtlD1, putative D-mannonate oxidoreductase
MNTIANSALPSTVQQPNYDRAALRSRIVHIGFGAFHRAHQALLTDRVLNT
QGGDWGICEVSLFGADTLIQELRKQDHLFSVLEKGAQGNQAIVVGSVCES
VHARLDGIMQVLAKLVEPQVAIVSLTITEKGYCIEPGTGQLDLQNEFIRA
DLAVPNAPTSAPGVLVEALRLRRLRGLPPFTVLSCDNIPENGDVVRNAVL
GLATVRDPALANWIQQHVTFPNTMVDRIVPAATAETLQEIADTLGVADSC
GIACEPFIQWVVEDKFVAGRPDWQVAGVQLVDDVLPFEEMKLRMLNGSHS
YLSYLGYLAGYQHINDCMADENYRLTARRLMMNEQAPTLRVTGIDLNAYA
DQLIERYCNPALKHRTWQIAMDGSQKLPQRMLDSVRWHLKQGNAYPCLAL
GIAGWMRYVGGIDDNGQVIDIRDPMVDSFKQCVAASEDGAARVQSLLTLK
ALFGETLPQQPTFVQAVTEAYLSLQQFGAKETVRRLAEQA
>YP3978 mtlD2, mannitol-1-phosphate 5-dehydrogenase
MAALPTCNANYLAYKQVITARAVGRKWPFYSKVTNMKALHFGAGNIGRGF
IGKLLADAGAQLTFADVNQPLLDELNKRKRYQVNVVGEQARVEEVKNVSA
VNSGSPEVVALIAEADIVTTAVGPQILARIAATVAQGLITRHQQGNTRPL
NIIACENMVRGTSQLKQHVFAALSEDEQIWVEQHVGFVDSAVDRIVPPSE
AGSTDILAVTVETFSEWIVDGTQFKGQPPEIVGMELTDNLMAFVERKLFT
LNTGHAITAYLGQLAGHQTIRDAILDPAVRQTVKGAMEESGAVLIKRYAF
DPQKHAAYINKILSRFENPYLHDDVERVGRQPLRKLSAGDRLIKPLLGTL
EYQLPHDSLVTGIAAAMSYRSEQDPQAQELVTLLAQLGPKAALAQISGLP
ADSEVVEQAVSVYNAMQQKLAH
>YP2299 mtlK, putative mannitol transport ATP-binding protein
MNARVNSSILLELIMASVSLANVVKYYGKIKTIDNVNLEIASREFIVLVG
PSGCGKSTLLRMIAGLEDVNSGEIKIEDKDVTQTNAGARGVSMVFQSYAL
YPHMTVRENLAFGLKNIKIPKQEIADRIANASNILQLDNYLERLPQHLSG
GQRQRVAIGRSIVSRSKVFLFDEPLSNLDAALRIQMRQEIGKLHERLGKT
TIYVTHDQTEAMTLADRIVILNQGRIEQIGTPEEVYNHPANLFVAGFIGA
PKINLFNAVYEQDGYVNINGLRFFIPRLVNLDLAMGAVLTLAIRPEHFSL
TNSTELSLAVKTDITEMHGDSTVVLFSSTEHGTLQMKVPYQLKLSVGEDV
TIGASCEHILVFDEHGQAIHGES
>YP1087 nagA1, putative N-acetylglucosamine-6-phosphate deacetylase
MYALTHGRIYTSHEVLDNHAVVVADGLIERICPVDELPAGIEICDLGGAI
LAPGFIDVQLNGCGGVQFNDSLEAISAETLDIMQRANEKSGCTSFLPTLI
TCSDEFMKHGVDVMRSYLQKNQHQALGLHLEGPYISPLKKGTHNPAFIRK
PSAEMIDYLCANADVITKLTLAPEMVDPKYIQQLTEAGILVSAGHSNATY
QQARQGFTAGIRFATHLYNAMPYISGREPGLIGAIFDTPEVYTGVIADGL
HVDWANIRNAKRLKGEKLVLVTDATAPAGAKIEQFIFAGKTIYYRDGLCV
DENGTLSGSALTMIEAVQNSVEHVGIALDEALRMATLYAARAIGVDKQLG
SIEVGKVANLTAFTRDYKITKTIVNGNEVLS
>YP3534 nagA2, 2-deoxy-D-gluconate 3-dehydrogenase
MRTAYLADRTFTPQGIETGVAVIVEQGEIVAVTRELPADAEIVHLTGKTL
IPGLIDIHIHGRQGADVMDASAEALRTIARALPQTGVVAWVGTTVSAPIQ
DIFAALAQVRDFIADPDNARDTRTATLLGSFLEGPYFTAPFRGSHPEKYL
TTPTPQELEQLRHSAGNTLLRAAIAPESPEALAAIRWLVNHGIKTSVAHT
AANFEQVTAAYQQGADCGVHLYNGMSGLHHREPGCCGAVLYHDMLAELIA
DGIHVHPVMMNLAYRMKGYRRIALITDCMRAGGLGEGRYLLGAQHITVRQ
GEARTDDGSLAGSTCSLDQALRNMIQHAQVPEWEAVQMASAVPAAYLGLA
STLGSIQMGAQASMVVMESDFTVAATLIKGEWAYRHSA
>YP1086 nagB, putative glucosamine-6-phosphate isomerase
MRLIPLRNTAEVGKWAARHIVNRINAFKPTAERPFILGLPTGGTPMEAYK
YLIAMHKAGEVSFKHVVTFNMDEYVGLPKEHPESYYTFMHTNFFDHVDIP
AENINLLNGNAADIDAECRRYEEKIKSYGKIHLFMGGVGVDGHIAFNEPA
SSLASRTRIKTLTQETRIANSRFFGGDANLVPKYALTVGVGTLLDAEEVM
ILVTGHGKAQALQAAVEGSINHMWTISCLQLHANAIMVCDEPSTMELKVK
TVKYFRELEAENVKDL
>YP0724 nagC1, Transcriptional regulators
MRIGIDLGGTKIEVIALANDGQVLFRKRVGTPRHDYQKTIQAIADLIADA
EHATGEQGSIGVGIPGTLSPFTGKVKNSNSVWLNGRELDKDLSVFLNRPV
RLANDANCLAVSEATDGAGAGKKWVFAAVIGTGCGSGIAIDGGSHAGGNG
IAGEWGHNPLPWQDEEEREYAQEVTCYCGKKGCIETFVSGTGFATDYFRL
SGKPLKGHEIIELVEQGDVIAEQAMNNYERRFAKSLAHVINLFDPDVVVL
GGGMSNVDRLYDTLPALISPWVFGGECETPILKALHGDSSGVRGAAWLWN
TLRP
>YP1088 nagC2, putative N-acetylglucosamine regulatory protein
MATRFYHKRVTLLMSTGGQAQIGNVDLVKQLNGAAVYRLIDQQGPISRIQ
IADLSQLAPASVTKITRQLLERGLIKEVDQQASTGGRRAISIVTENRQFH
TVAVRLGRNDATITLFDMSGKSLGEEHYALPERTQETLEHALFNIISQFI
DAYQRKLRELIAIAVILPGLVEQSKGIVRYMPHISVSNWPLVDNLQARFN
VTSFVGHDIRSLALAEHYFGATRDCEDSILVRLHRGTGAGIIVNSQIFLG
SNGNVGEIGHIQIDPLGDRCYCGNFGCLETVASNAAIENRVKHLLTQGYP
SKLSLDDCHIGAICKAANRGDLLACEVIEHVGRYLGKAIAITINLFNPQK
VVIAGEIIEAEKILLPAIQGCINTQVLKNFRQNLPIVTSQLNHQSAIGAF
ALAKRAMLNGVLLQRLLETHP
>YP1503 nagC3, Transcriptional regulators
MAMAMAHSTKPAGAVTQAIADIRMVLDIEEVVVNESVGLTDGMLDRVRKS
LQAFPARFNLPVTPMLGGGTYRMTECCQRSSASVRRVHDRPGVMSR
>YP1758 nagC4, Transcriptional regulators
MKKGRLMYYGFDMGGTKIELGVFDENLQRIWHKRVPTPREDYPQLLQILR
DLTEEADTYCGVQGSVGIGIPGLPNADDGTVFTANVPSAMGQPLQADLSR
LIQREVRIDNDANCFALSEAWDPEFRTYPTVLGLILGTGVGGGLIVNGSI
VSGRNHITGEFGHFRLPVDALDILGADIPRVPCGCGHRGCIENYISGRGF
EWMYSHFYQHTLPATDIIAHYAAGEPKAVAHVERFMDVLAVCLGNLLTML
GSPFGRGGWGVV
>YP1759 nagC5, Transcriptional regulators
MVGGGLSNFEKIYQELPKRLPAHLLRVARLPRIEKARYGDSGGVRGAAFL
HLAEK
>YP1879 nagC6, putative transcriptional regulatory protein
MKKRVCAGINIKDTMNIRPERLELRGSQRLLLELIRRHAPVTRAELARLS
NLTAGAITQQCRELIFAGLVVEGERNTGQRGQPSLPLRLNPGGGCAIGLS
FSPGFIDMTVVDLSGRQLLSVAEPHQENQPLTATLCQIKTLVEQTLKKRQ
LQHARIIGIGYAVPGFLKADGHKRHCVPWLHTWREADLQQVFADNLPWPT
RVENNANASAIGELYSGEWNNYSDLTFIDLGYGIGAGVISGHKLLRGGFF
NAGEVGMAFPSGTPRPSYKDLLATLEREGFSETQLPVLSAGRHPVLEKWF
ERCCDQVQQTVFGCVQWVDPQLIVLGGAMPKPIISRLVQEISQRLNTCLD
PERPKVTLAASSMGAESASRGAAMIPLYQVINED
>YP2644 nagC7, putative sugar kinase
MGKGLALDIGGTKIAAAVVTESGMLIGRQQIATPRGGAGQLAAALETLIA
PYRHQVDFIAVASTGIISGGRLTALNPANLGGLADFPLYDCIRSISDLPC
VLLNDGQAAAWAEYQALGDKNDNMMFVTVSTGVGGGIILNKKLLVGQRGL
AGHIGHTLSDPHGVLCGCGRRGCVESVASGTAIGAETLGWKQPVSAATVF
DMAQQGDAQAGKVINRSAAAIAQMLADMKMALDLEVVILGGSVGLAVGYL
ERVVAAQKTLPGIYRVPVQEAHHRQDSGLLGAALWARTSL
>YP1085 nagE, pts system, N-acetylglucosamine-specific IIABC component
MSILGYLQKVGRALMVPVATLPAAAILMGVGYWIDPVGWGADNALAALFI
KSGAAIIENMSVLFAIGVAYGMSKDKDGAAALTGFVGFLVLTTLCSPAAV
SMIKQIPLDQVPAAFGKIENQFVGILVGIISAELYNRFSGVELPKALSFF
SGRRLVPILTSFLMIAVAFMLMYIWPLIYNALVTFGEYIKDLGSVGAGIY
AFFNRLLIPVGLHHALNSVFWFDVAGINDIPNFLGGQESINKGTGIVGIT
GRYQAGFFPIMMFGLPGAALAIYHCARPENKAKVAGIMMAGAFAAFFTGI
TEPLEFSFMFVAPVLYFLHAVLTGISVFIAASMHWIAGFGFSAGLVDMVL
SSRNPLATQWYMLIPQGLIFFVIYYLVFRFTIQKFNLLTPGRELAVEGSE
EDGYDVNVDKTPAVNESEINSLARRYIGAIGGSDNLTAIDACITRLRLNV
KDSALVNDSVAKRLGASGVIRLNKQSVQIIVGTRAELIAAAMRTVLAGGP
IPAASSNAAPTGARPQAVINTAKTASLVLVSPITGDVVPLAQVPDEAFAS
KAVGEGVAIRPTDKIVVSPASGTIVKIFNTDHAFCLETETGAEIVVHIGI
DTVKLNGQGFTRLVEEGTTVVAGQPVLELDLAYLNANAHSMISPVVVSNI
DDYAGISLLASGSVVAGQSQLFEIRGK
>YP2646 nanE, Putative N-acetylmannosamine-6-phosphate epimerase
MSNLSNLRHKLQNGLIASCQPVPGSAMDTPEIVAAMACAALAGGAVGLRI
EGISNIQAVRRATDAPIIGIIKRDLPDSEVRITPWLEDIDALSAAGADII
AFDVTCRERPVSVADLYQRARATGCLTMADASNIDDGLLAHHLGIDFIGT
TLSGYTQATVPTEPDLALVTQLAQAGCRVIAEGRYHSPALAAAAISAGAY
AVTVGSAITRIEHICGWFCDAIKQCETEKLTEY
>YP2640 nanT, putative sugar transporter
MSISVGPSREDKPLSGGAKPPRWYKQLTPAQWKAFVAAWIGYALDGFDFV
LITLVLTDIKQEFGLTLIQATSLISAAFISRWFGGLVLGAMGDRYGRKLA
MITSIVLFSFGTLACGLAPGYTTLFIARLIIGIGMAGEYGSSSTYVMESW
PKNMRNKASGFLISGFSIGAVLAAQAYSYVVPAFGWRMLFYIGLLPIIFA
LWLRKNLPEAEDWEKAQSKQKKGKQVTDRNMVDILYRSHLSYLNIGLTIF
AAVSLYLCFTGMVSTLLVVVLGILCAAIFIYFMVQTSGDRWPTGVMLMVV
VFCAFLYSWPIQALLPTYLKMDLGYDPHTVGNILFFSGFGAAVGCCVGGF
LGDWLGTRKAYVTSLLISQLLIIPLFAIQGSSILFLGGLLFLQQMLGQGI
AGLLPKLLGGYFDTEQRAAGLGFTYNVGALGGALAPILGASIAQHLSLGT
ALGSLSFSLTFVVILLIGFDMPSRVQRWVRPSGLRMVDAIDGKPFSGAIT
AQHARVVTQK
>YP0080 pfkA, 6-phosphofructokinase
MVKKIGVLTSGGDAPGMNAAIRGVVRAALSAGLDVFGIEDGYLGLYENRM
KKLDRYSVSDMINRGGTFLGSARFPEFRDPEVRKVALKNMHERGIDGLVV
IGGDGSYAGADLLTKEGGIHCVGLPGTIDNDVAGTDYTIGFFTALETVVE
AIDRLRDTSSSHQRISIVEVMGRYCGDLTLAAAIAGGCEFIAIPEVEFKR
DDLVAEIKAGIAKGKKHAIVAITEKLDDIDSLAKYIEKETGRETRGTVLG
HIQRGGAPVAYDRILASRMGAYAVDLLLQDHDYKKGGFCVGVQNEKMVHE
LISVCIAPENKKSKFKEDWYDTAKKLF
>YP3080 pgi, glucose-6-phosphate isomerase
MKNINPSQTAAWKALQQHFEQMKDVTISSLFAKDDQRFNRFSATFDDQML
VDFSKNRITSETLEKLQDLAKETDLAGAIKSMFSGEKINRTEDRAVLHIA
LRNRSNTPIVVDGKDVMPEVNAVLAKMKQFCDRVISGDWKGYTGKAITDV
VNIGIGGSDLGPYMVTEALRPYKNHLNMHFVSNVDGTHIAEALKPLNPET
TLFLVASKTFTTQETMTNAHSARDWFLSAAGDPAHVAKHFAALSTNAKAV
GEFGIDTNNMFEFWDWVGGRYSLWSAIGLSIALSVGFEHFEQLLSGSHAM
DKHFAETPAEKNLPVLLALIGIWYNNFFGAETEAILPYDQYMHRFPAYFQ
QGNMESNGKYVDRNGHPVDYQTGPIIWGEPGTNGQHAFYQLIHQGTKLIP
CDFIAPAISHNPLSDHHAKLLSNFFAQTEALAFGKSLEDVEAEFAAAGKT
PEQVAHVAPFKVFEGNRPTNSILLREITPFSLGALIALYEHKIFTQGVIL
NIYTFDQWGVELGKQLANRILPELADDQEVTSHDSSTNALINRFKNWR
>YP3519 pgk, phosphoglycerate kinase
MSVIKMTDLDLAGKRVLIRADLNVPVKEGKVTSDARIRASLPTIEAALKQ
GAKVMVTSHLGRPTEGEYNEEFSLLPVVNYLKEKLSSPVRLAKDYLDGVE
IAAGELVVLENVRFNKGEKKDDEALSKKYAALCDVYVMDAFGTAHRAQAS
THGVGKFAPIACAGPLLSAELEALGKALGNPARPMVAIVGGSKVSTKLTV
LGALSKIADKLIVGGGIANTFVAAQGHNVGKSLYEADLIPEAKRLLETCD
IPVPTDVRVATEFSETAAATLKPANEIKDDEQILDLGDESAERLAEILKN
AKTILWNGPVGVFEFPNFRKGTEIVARAIAESEAFSIAGGGDTLAAIDLF
GIADQISYISTGGGAFLEFVEGKKLPAVVMLEERAKQ
>YP2488 pgm, phosphoglucomutase
MATPLLRTCIGVVTVANHPRAGQPAQQSDLINVAQLTSQYYVLQPDAEDP
AHAVKFGTSGHRGSSVRHSFNEAHILAIAQAIAEVRHQHGISGPCYVGKD
THALSEPAFISVLEVLTANGVDVVVQQDNGFTPTPAISHVILCHNAQGKA
LADGIVITPSHNPPEDGGIKYNPPNGGPADTNLTSVIEKRANQLLSQNLK
GVKRQTLDKAWQSNHLREQDLLQPYVEGLVDVVDIPAIQQAGLKLGVDPL
GGSGIAYWQRIAEYYKLDLTLVNNAIDQTFRFMHLDHDGVIRMDCSSESA
MAGLLALRDKFDLAFANDPDYDRHGIVTPAGLMNPNHYLAVSINYLFQHR
PQWGAGVAVGKTLVSSAMIDRVVADLGRKLVEVPVGFKWFVDGLHDGSFG
FGGEESAGASFLRFNGTPWSTDKDGIIMCLLAAEITAVTGKDPQRHYDDL
AQRFGAPSYNRIQAPATQAQKNALSRLSPEMVKANTLAGDPITARLTNAP
GNGASIGGLKVMTENGWFAARPSGTEEAYKIYCESFLGAEHREKIEQEAV
KIVSEVLAEAK
>YP2196 ppsA, phosphoenolpyruvate synthase
MLWYNQLGMHDVDRVGGKNASLGEMITHLSELGVSVPNGFATTAQAFNDF
LEQSGVNQRIYQLLDNTNIDDIAELSKAGAQIRQWVIETPFHPEFEQSIY
DAYKQLADGEPEASFAVRSSATAEDMPDASFAGQQETFLNVQGIDAIMVA
IKHVFASLFNDRAISYRVHQGYDHRGVALSAGVQRMVRSDLASSGVMFTI
DTESGFDQVVFITAAHGLGEMVVQGAVNPDEFYVHKPTLRNGKPAIVRRN
MGSKKIRMIYAENQEHGKQVCIEDVPEIQRNRFALSDDEVEALAHQALLI
EEHYGRPMDIEWAKDGHTGQLFIVQARPETVRSNEQVMERYQLNNQSNVL
VEGRAIGHRIGAGPVKVIHDISEMDRIQAGDVLVTDMTDPDWEPIMKKAS
AIVTNRGGRTCHAAIIARELGIPAVVGCGNATELLKEGQNVTVSCAEGDT
GYVYHELLDFSVQSSQVTELPDLPLKIMMNVGNPDRAFDFARLPNEGVGL
ARLEFIINRMIGVHPKALLEFDQQEPALQAEIKALMHGYDDPVEFYIGRL
TEGIATLGAAFWPKPVIVRLSDFKSNEYANLVGGAGYEPHEENPMLGFRG
AGRYVSDHFRDCFALECEAMKRVRNVMGLTNVEVMVPFVRTVAQAEAVVA
ELARQGLKRGENGLKIIMMCEIPSNALLAEQFLEHFDGFSIGSNDMTQLT
LGLDRDSGVVSALFDERNEAVKALLSMAIQAAKRHGKYVGICGQGPSDHE
DFALWLMEQGIDSLSLNPDTVVKTWLSLAQHTKH
>YP0010 proP1, putative membrane transport protein
MIKSARSMAGLPWIAAMAFFMQALDATILNTALPSIAESLNRSPLTMQSA
IISYTLTVAMLIPVSGWLADRFGTRRIFILAVSLFTFGSLLCALSGSLAF
LVASRVIQGIGGAMMMPVARLALIRAYPRSELLPVLNFVTIPGLVGPVMG
PLLGGLLVTYTTWHWIFILNIPIGLLGIFYARKYMPNFTMPKRTFDFVGF
LLFGISLVMISTSLEIMGRPEIADYLPAATLLGGLLMLIFYIFHAKGHPN
PLIGLPLFKTRTFSVGIAGNVASRLGTGCVPFLMPLMLQVGFGYSALIAG
CMMAPTAIGSIMAKSAVTQVLRSLGYRKVLVGITLIIGVLIASFALQSPG
MSAWMMILPLFILGIAMSTQFTAMNTITLADLTDNNASSGNSVLAVTQQL
SISFGIAISATVLRFYDGLSLGGNVDHFHYTFITMGIVTLLSSLVFLLLK
PRDGDNLIQGRNVKKVAPQVKNNV
>YP0917 proP10, putative membrane protein
MSTKIHQQAVQPGISQQVSTRLAFFIAGLGMAAWAPLVPFAKARIGLNDA
SLGLLLLCIGIGSMLAMPLTGVLTAKWGCRAVILLAGAVLCLDLPLLVLM
NTPATMAIALLVFGAAMGIIDVAMNIQAVIVEKASGRAMMSGFHGLFSVG
GIVGAGGVSALLWLGLNPLTAIMATVVLMIILLLAANKNLLRGSGEPHDG
PLFVFPRGWVMFIGFLCFVMFLAEGSMLDWSAVFLTTLRGMSPSQAGMGY
AVFAIAMTLGRLNGDRIVNGLGRYKVLLGGSLCSAIGIIIAISIDSSMAA
IIGFMLVGFGASNVVPILFTAAGNQTVMPANLAVASITTIGYAGILAGPA
AIGFIAQLSSLSVAFGCVALLLLTVAASARAVTR
>YP1213 proP12, putative membrane protein
MSAYSRPVLLLLCGLLLFTISIAVLNTLVPLWLSHQQLPTWQVGMVSSSY
FTGNLVGTLIAGRFIQQLGFNRSYHCSCILFALATCGLMLTVDFWSWLGW
RFLAGIACALIWVIVESALLRSGTLTNRGQLLAAYMMVYYLGTVIGQLLL
GIVSTQLLSVIPWVGALVITAMLPLLFAQFSHQSRHESPPIAVWPMLKRR
SARLGINGCIISGVLLGSLYGLLPLYLSHKGMSDASVGGWMALLVSSGII
GQWPMGRMADRYGRLLVLRIQVFVVILGSVAILGNYAMAPALFILGCAGF
TLYPVAMAWACEKASADELVAMNQALLMSYTLGSLAGPTMTSLLMQRYSD
NLLFIMIAGVAFVYLMMLLRKPDHQQTPYAAV
>YP1394 proP13, putative exported protein
MALRVALSGFLALVVAMGIGRFAFTPQVPLMIAEHQFTLTSAGLVAAFNY
LGYLFGAFDAMRASRHVERRLWLGLWGAALLTLLSAVVVGPWWHGLVRFA
IGWASGWSMVLIAAWTNERLAHFGRPALSAAVFAGPGAGIFISGMLAVAI
HSYDLSAAEAWWVYGVLALVIIASISINLPRGGELHRPQVVAVPLTLTPA
LKRLVWSYSLAGFGYILPATFLSQMASARFPDSLFAQFVWPVFGGAAVIG
IALGILTRHCLTSQTRLALTLWVQALGVLCAEWVPGVSGLALGALLTGGG
FLSVVQLSLQHGRELAPEHTRYMAGLLTTGYAIGQLVGPILSAISTTLTH
RLEPALYVAVVALIIAGGLVIKTPARTQEALAT
>YP1451 proP14, putative transmembrane transporter
MTQISFFNALISLTFSPSRRHPLVMSLTRRSNMSNFNHYPDPTLNSAIKK
AWYRLMPLMFIMYFVAFIDRINVGFAKDAMSADIGLSQSAFALGAGIFFA
AYALFGIPANLMMNKLGAKVWLSSTTVVWGLLSAGTGLVSNEYQFVILRF
LLGVAEAGFYPGILLLASIYFPNKIRASVIGIFVLGVPAALTLGSPISGA
LLDMQGFLGQPGWFWMFLLEGLPAVGLGIFAFFYLDDSPATARYLNPEEK
QALLTQLSIEQSDTESSSVKAVLLSPKVWHLALIYGTIQVGVYGLIFFLP
SQVATLLGSTLGFKESLVAAIPWAFSALGVYYIPRYADRKTHRRNPIATL
NLVVAAIGLIISAYASPVLAIAALCLCAIGFLAVQPIFWTFPAQILSGKA
LAAGIGFCTTMGAFFSFLAPIIRVEAESQFNSPPAGLITLALFSLLSATL
IFSLKFWPAKATAEVI
>YP1460 proP15, putative sugar transporter
MILRHPIERVITTMNIYKKISADGWQPQQLTIKDVKFATWLAFFAWVFAV
YDFILFGTLLPEIGDHFGWDEIEQAKLATWVAAGGAVVALTVGPIVDRLG
RRLGIVFTVTGAAISSLLTAIGGAWGKGVLVGIRSIAGLGFAEQTVNATY
LTEMYAAINDPILNRHKGFIYSLVQGGWPVGALVASGLSALLMPIIGWQG
SFIFAAVPSFIIALLALKLKETPQFQIHQHIRRLTEAGQPEKARQVAKDY
HFEYADHQRTGLSAIFRGTSLRTTLVLGGALMINWFAIQIFGVLGTTVIT
KVHDVSFESSLWVLVLSNLVGYCGYLAHGWLGDRFGRRNIIALGWMLGGL
SLATMLYGPADFSLIVILYSAGLFFLIGPYSAALFFFSESFPTAIRATAG
AFIIAMGPIGAIIASMGATSILSSGGNWQTAALLFGAIPCFISGVIMLFA
HHVAPQSVK
>YP1674 proP16, putative sugar transporter
MRCSQELKSQSVKEIFMRWFSDLNQTERKTFIAAFGGWALDALDFMVFTF
VIATLMALWQIDAGQAGMLSTVTLLFSAIGGWGAGILADRYGRVRILQIT
ILWFSLCTVLIGFAQNFEHVFILRALQGLGFGGEWAVGSVLMGEIVRAEH
RGKAVGTVQSGWAIGWGAAALLYTLMFSVLSEEWAWRALFWIGVLPALLV
LYIRKNVPEPALFLKSRHEQQAKDRRVSSFAIFSPALLKTTVLASLLCTG
VQGGYYAITTWLPTFLKLERNLSVIGTGGYLMVIIFGSFVGYICGAYLTD
KLGRRANLIIFSLLSCITIFAYTQLTLTNTQMLVLGFPLGFSASGIFSGM
GAFLTELFPSAVRATGQGFTYSFGRAVGALFPGLVGYLSQSSSLAFAIGV
FAGSAYCIVLVMSLLLPETKNKQLE
>YP1683 proP17, putative membrane protein
MANQSVSRTGTEVKESWVPMITIALAQILMSFNVASLPVALGGMVKSFNV
PPTTIATAIVMYSLSVAGFVMLGAKLNQRFGPLIVFRCTVLLFGLAQTMM
TFSPNVTVMIGAQALSGLAGAALVPALVALIAENYRGPQQATALGALGSA
RAGAGVAAFLIGGILGTHIGWRPAFGILIVLSVIVFVLSFRLKADKGRPE
VGIDVIGVVLAASAIILLSFGFNNLNRWGFGLVRDGAPFDLLGFSPAPFM
IVLGIVLGQAFVVWTRRRQEQGKTPLLALDVITSPSERAAVFAMFAVVAL
EAMLNFSVPLYIQIVQGSSPMATAIAMMPFNLSVFFSAMLIVRFYKKLTP
RKIGRYGFITCTLALLWLAFVVRNNWSEWSVLIGLVVFGIGQGSLVTLLF
NVLVSASPKELAGDVGSLRGTTNNLASAIGTAVAGALLVGLLSANVMRGV
AETPILTDEIQAQVNMDSINFVSNDRLNSVLAQTSATPEQVAEAVRVNEE
ARLRALKFGLLVMALLSLLAIFPAGRLPDYLPGELPADNLDKKASK
>YP1737 proP18, putative transport protein
MNPSTSDGLPVPQRYAAILVIALGIMMAVLDGTIANVALPTIARDLNTSP
ATSIWVVNAYQLAITISLLSMASLGDIIGYRRVYQAGLLIFSVTSLFCAL
SDSLWTLTFARVLQGFGAAALMSVNTALIRIIYPRAQLGRGIGINTLIVA
VSSAAGPSIAAAVLSVASWQWLFALNVPIGLLAWCLGIKFLPANNTKSNG
NRFDITSCVLNALTFGLLITAISGFSQGQSPAVIAAQVVALLLIGFFFVR
RQLTQSFPLLPVDLLRIPIFALSIGTSIFSFAAQMLAMVSLPFFLQTVLG
RDEVATGLLLTPWPLATMVIAPIAGRLVERYHAGLLGGIGLAVFASGLFL
LAVLPANPSDVDIIWRMILCGAGFGLFQTPNNHTIISAAPQHRSGGASGM
LGTARLLGQTSGAALVALMFNMFSTNGTHASLILAGCFASIAALVSLLRV
TQKSH
>YP1798 proP19, putative membrane protein
MNKWTKLCFLILGGGTIFKLSSMKDVFYIPMQQDWGLTNTQIGFGFTVYA
IIQTVGLFSSLYIADRFSKKILLPVGLIGVGLCGAYLATLPPFTGYLIAF
GAMAFFGEVVYWPVLLKAVRLLGTKEEQGRMFGFLEAGRGVIDVLIASGA
LFVFVQFGEGKAGMQAGLIYYTIATILVGVITWFIVDSDDKIKVDNADKV
NKHVLAGIKDVIKSPNLWLASFCIFFVYSAYCGLTYFIPFLKDIYGLPVA
LIGAYGIINQYGLKMVGGPVGGFLADKVAKSPTVYLKWTFLISAIAMILF
IQLPHDSMNVYLGMMATLGFGAIIFSQRAIFFAPMDEIGTSREHAGSAMA
FGCIIGYMPSMFAYALYGSLLDNFEGIQGYNYIFSLMVAFSLLGFICATI
LTKRMRAVAVA
>YP0165 proP2, conserved integral membrane protein
MNNSNRIRLTWISYLSYALTGALVIVTGIVMGNIAEYFNLPIASMSNTFT
FLNAGILISIFLNAWLMEIIPLKRQLVFGFILMLIAIAGLMVGHNLMIFS
ISMFIFGVVSGITMSIGTFLVTHMYEGRQRGSRLLFTDSFFSMAGMIFPI
AAAMLLARHIEWYWVYACIGLLYVGIFVLTLCSEFPVLGHKATDQSKPVV
KEKWGVGVLFLAIAALCYILGQLGFIQWVPEYATKTFNMNISQAGQLVSN
FWISYMIGMWIFSFILRFFDLQRIVTVLAAMATLAMYLFVSTDNPAYLSY
YILALGFVSSAIYTTLITLGSLQTKVSSPKLVNFILTCGTVGTMLTFVVT
GPIVANNGVHAALETANGLYLAVFILCLALGFFTKHRSHGHVTH
>YP1883 proP20, putative membrane protein
MALVSQARSLGKYFLLFDNLLVVLGFFVVFPLISIRFVDQLGWAALVVGL
ALGLRQLVQQGLGIFGGAIADRFGAKPMIVTGMLMRAAGFALMAMADEPW
ILWLACALSGLGGTLFDPPRTALVIKLTRPHERGRFYSLLMMQDSAGAVI
GALIGSWLLQYDFHFVCWTGAAIFVLAAGWNAWLLPAYRISTVRAPMKEG
LMRVLRDRRFVTYVLTLTGYYMLAVQVMLMLPIVVNELAGSPAAVKWMYA
IEAALSLTLLYPLARWSEKRFSLEQRLMAGLLIMTLSLFPIGMITHLQTL
FMFICFFYMGSILAEPARETLGASLADSRARGSYMGFSRLGLALGGALGY
TGGGWMYDTGKTLDMPELPWFLLGIIGLITLAGLYWQFNRRRIESAMLSS
S
>YP1940 proP21, conserved hypothetical phage protein
MRKTSSLFLLFGTLFSAGGYGATFLISAWFHSQGGNDIDAGATLGMALFG
TLIGVPLVGWFAGKLDASRLAALAALIQSCGYFLLGSLSGGSGYLPHVAA
LLIGLGWGMFYIGGPMALSERLTDTERGPGFTRFSAFQMTGICGSPILLT
IAVVQGGIPIQAAFLLVGVMGVFASILLMIFGTREPLIRHENSLRPWVKK
ITVLAKSGVIRPIVMVCLGGAVFSGMMSFQDSLTDGSLASASTFFAVHAT
TAVVSRLLLAHKLSSWPRTPLVAVLLCCLMIGLVCLLGIPTHVSFQIAAA
MLTGAGYGLLYPVIQTWAVNESAPENRHAALTWFVVAYFVGIFGFPPFGG
WVLVTVGKVWFIWVLATLATLELVTAIVKWPQTTHRPLSS
>YP1949 proP22, putative multidrug resistance protein
MQKFLFLLLSLILLGPLGIDLYLPTIPAIAKGLNSSESLIQSTIALFILV
LGIGQLIAGPLVDKYGRKPIAIIGIVLYMLGAAMAALAVDPVMFVSSRLL
QGVSVCCTAVVAFSGVRDRLSGNEAARAFGFLNGTLNIVPALAPLLGGLL
AEAFGWRAPFWFLALYGLLVLVLIIMFLPETRPANTQPINGLPIKNYLRI
LRDSRFLVFALVNAGAMGMALTYVSLAPNVLMVDAGLSPLQFSLAFGANG
FWIMAVSFFANRIIQKVGRPTCLMIGSLLMALGCFGLLFGLTQLSVDVQH
HWLVYMLPVASACAGLAFMMGPATSYALEPYANEAGVASALVGFVQMAGG
AALGLLAMALPIEPKLSLAIVMLAVYWRGKRAEPVNMSAASWKKYTNNGK
>YP2035 proP23, putative integral membrane protein
MSESSTESLSQPTQLQEENNAYRKTVWHLLPLLMLCYVLNYLDRVNVGFA
KLQMADDLQFSDTVYGLGAGMFFIGYFFLEIPSNLILHRVGARLWIARIM
ITWGIISACMAFVTTPMSFYVMRFLLGVAEAGFFPGIILYISYWFPSHRR
GRVYGLFVISVPLSGIIGAPLSGWIMQYFNGFQGYAGWQWMFILEGIPSV
LVGILIIYKLKDRITHATWLTDKEKDILQTNIENEAAHYAHSRLRDAFLQ
PRVWLLTLIYFCLISGFYTIGFWLPTLIRDSGVKDILSIGFLTAIPSAAA
AVTMIVVSRSADRLRERRWHLALTAVLGAVGIILSTYFSDNIVVAMVCLT
IGAMGALSTIPLFWSLPTAFLGGSAAAAGIAFINSWGNLGGFVAPYMMGY
LKDLTQSTTTGMLIISTTLFIGAALVFLIPAKAVNH
>YP2175 proP24, putative drug resistance protein
MKTSSSFMFYLAGLSMLGYLATDMYLPAFGAMQRELQTTAGAISASLSIF
LAGFAIAQLIWGPLSDKLGRKPVLLAGLGLFAIGCLGMLWVENATQLLVL
RFIQAVGVCSAAVSWQALVVDRYRDGKANRVFATIMPLVALSPALAPLLG
AWLLNHFSWRSIFVVLLAITLLLLIPTMVLQERKKARADNSDQPKNTVSF
WQLLQSPTFSGNVMIFAACSAGFFAWLTGSPFILENMGYSPNVIGLSYVP
QTLAFLLGGFGCRSALAHIKGNTLLPWLLVGYAGSMIALYLIATLTTPSL
LTLLIPFCLMALVNGACYPIIVANALMPFPDNTGKAAALQNTLQLGLCFV
ASMLVSAYISQPLLATVTVMLLTVVLAALGYGIHCYALRKDKTRLMTRTP
>YP2278 proP25, putative transporter protein
MQTLPSEKIRMDDVPLNRFHIRIAGLTFGAHFIDGYILGLIGFALIQLKP
IMALTPLWEGLLGSAALIGLFLGSLILGWISDYIGRQKIFSFSFVIITLA
SALQFFASTPEQLFILRVIVGIGIGGDYSVGHTLLAEFSPRKHRGVLLGA
FSVIWTFGYVSASFVGHYLSMVSPEAWRWLLSSAALPALLILLVRIGTPE
SPRWLMGKGREDDAMAIVHKYFGPNVTLIDEEPATSTRRFLSLFGRKYWR
RTAFNSLFFVCLVIPYFAIYTFLPSILNVMALSQNFATDLLLNGLLVVGA
LVGIVLTAFCSRRSFLISSFIFLATCLLLLSILPSNQTFWLIALFAAFTL
VMSAVSNLVGVFPAESFPTEVRSMGVGFATSMSRLGSAIGTSLLPLAIVN
YGMPVTTTLLAFVLIIGAIVSIAWAPETKGLTLVDASQSATTPRPPSSII
PN
>YP2346 proP26, putative sugar transporter
MKYDGYIIMRRIYMDSKIPNARWFRVIVPIMIACIISFMDRVNISFALPG
GMESDLAITSQMAGLAGGIFFIGYLFLQVPGGRIAVHGSGRKFIAYSLAV
WAIVSILTGFVTHHYQLLFLRFVLGVSEGGMLPVVLTMVSNWFPEREIGR
ANAFVMMFAPIGGMFTAPLSGFIINTLDWRWLFFLEGGLSALVLVMWWFV
ISDRPEEAKWLSARERDYLVTELSRERAERMFNKPVTNAPLKAVFLNKGL
MKLVALNFFYQTGDYGYTLWLPTILKNLTGGNMASVGILAVLPFVATTAG
IYVISALADKTGKRRLLIMISLFCFAAALVASVIFRHNVLVSYLALVVCG
FFLKAATSPFWSIPGRIAVPEVAGGARGGINGLGNLGGFCGPYLVGVMIF
FYGQSAAVCMLAGSLIIAGLITLTLPKECDVEVKSTGKAIADNGLTKAKR
A
>YP2865 proP28, putative membrane protein
MSQDVLADKPLLSRSMVAVLCAQFFSAFGDNALLFATLALIKQQLYPDWS
QPILQMAFVATYIVLAPFVGQIADGFAKGRVMMVANGLKLAGALVICFGL
NPFLGYSLVGVGAAAYSPAKYGILGEITSGEQLVKANGMMEASTIAAILL
GSVAGGILADWHLMAALGVCALVYAIAVIANLFIPRLAAARSGASWRPRA
MTGSFFTACRLLWQDSETRFSLAGTSLFWGAGVTLRFLLVLWVPVALGIA
DNATPTLLNAMVAIGIVVGAGAAARFVTLKTVKRCLPAGVLIGVMVTIFS
LQNSMPMAYLLLIIIGILGGFFVVPLNALLQERGKHSVGAGNAIAVQNLG
ENTAMLFMLGLYSLVVKLGAPVVAVGVGFGVVFALAIALLWGWQWRQQRQ
KTRQPE
>YP3429 proP29, putative membrane protein
MPRSNQARNARSITMKYNANITSLFGLSSLFGLFSLFGLYCAQGVPLGLA
IFALPGILRSLGADMRLIGLVGLSMLPWAFKMLWASFIENHKPWFFRGLP
TGLAWIQFCKVCSLIAMTLLWFFAPETHVLALLLLVTLINFFYASQDVAV
GALVVRVFAGSRHVRVNVSQIAGFSLGMLLGGVVSLYVFSVWGWSVTVWW
FLLLQGLCHLPFMFHLGRFAAENKLPVIPGSASLWKIFRRKGWVPIVVMA
VVFKFASTMGAALVSPLLVDMGVSLEQIALLAGGVLIISYIVGAILSGVL
HRWFSSPQLTIFGLLGSMLCWLGMTLSLSFSAHNSLPVFVFFILEGFFFN
LCCVSIFAWFMCWSEGDEDQGIVQPGTDFTLLQCCEVLGGSIAMVLSGTL
AYYLGFTYAFGVATVCAFLVVLLTLYCFRRSQSAYAGFQKDRHTVEIG
>YP3451 proP30, putative membrane protein
MRISSESDARSSGLTSSTHWPLAFCVGLLGIGQNGLLVVLPVLVSRTHLS
LSVWAGLLTLGSMLFLVGSAWWGRQSEIRGCKFVVIMALAGYLLSFVLLA
LAVWGLSAGWLSEMAGLGWLIVARIIYGLTVSGMVPASQTWALQRAGYEQ
RMAALATISSGLSCGRLLGPLCAALALSIHPIAPLWLMAIAPLIALLVVY
RQYNDPPLPPVVHQQNRLRLNMLPYLLCALLLAATVSLMQLGLAPHLSRL
FSHSATTVSHHVAILLSIAAGCTLLAQFLVVRPQRFTPPQLLLVAALLMV
LGLGLMCVQPLVLFYLGCALASFGAAMATPGYQLMLNDRLSTGKGSGVIA
TSHTLGYGMSALMVPVVAKFYGESQLVAAAFMMAILLGGISGWLWCQHRT
TAHSVGE
>YP3715 proP31, putative transport protein
MSQDHNSSQVGSSQIDSSQHHVDQQHNHNRRLNKQDYKTLTLAALGGALE
FYDFIIFVFFAAVIGDLFFPADMPEWLRQVQTFGIFAAGYLARPLGGIIM
AHFGDLVGRKKMFTLSILLMALPTLAIGMLPTYATIGITAPLLLLLMRVL
QGAAIGGEVPGAWVFVAEHVPRKRIGIACGTLTAGLTAGILLGSLVATVM
NTTLGHQAILEGGWRIPFFLGGIFGLFAMYLRRWLQETPIFKEMQARKTL
AEELPLKSVVVNHKKEVVVSMLLTWLLSAGIVVVILMTPTYLQKQFNVPP
ELALQANSLAIIALVIGCVVAGLAIDRFGASKTFIVGSLMLAMSTWSFYH
TNLTNPSQLFPHYMLAGFCVGIVGAVPYVMVRAFPAEVRFTGISFSYNVA
YAIFGGLTPILVTLWMKSSAMAPAYYMLVLSLVGLLLGIYLRNDINSEVK
VQMPKRVMNGVN
>YP3897 proP34, putative metabolite transport protein
METLSADSAITAAENDPLRDVKRKNAIKGAFFSEFIDMFDIYLPVIVLPP
VLFYFQPPNLSSSTANILASLVFITTLLGRPIGALLFGIMADRIGRRMAS
IYSVSGFGVVTFLIALIPGYETLGIASYLLLVLLRFIDGIFLGGGYTGAI
PLALEYSKKEQRGFVGGLILSGFPAAYVAINLVAMLMFALIPLDGLYSPY
AQWGWRIPFVIGGLLAGFLALYYVFNVTESEVWQQGSSKKRAREKQPLST
LVSGQSGRNLWQVLLMMSGFWLTQNLITLFLPTGLLINTLNMRGLQVTSI
LLVTYCVLFFSYIGMGMLGQKIGRRRFFMIAGPLIATMGSALLYVLSHGD
GLSFSTVMLLVCLLAVVVTSPWGVIITYINEHFATGVRATGFGVGFSLSV
IIPSFYAFYMDWLSVVVPFELTAVVLLALGGMIGTVGAIMGPETKEVDFT
SSAG
>YP0192 proP4, Permeases of the major facilitator superfamily
MWLSLISDPVSKKPAFIAGFLLCTRSLIFCVIANDLVITAASGADIKINQ
PRFGGNQWLLKPINGY
>YP0377 proP5, putative membrane protein
MKKIFNTFFPLYSATVLMLLGSGLLTTYISLRLTAINVSALLIGAIIAAN
YIGLVIGGKVGHFLIARVGHIRAYVACAGIITAAVLSHGLTEYIPAWVVL
RLIIGLCMMCQFMVLESWLNDQAASNQRGTVFGFYMAATYAGLALGQVVL
MFQPALGLITLMVIALFFALCLVPVALTTRSNAQQMSPAPMELKFFVSSI
PKILASTLVIGMIVGSFYGLAPVYSSLQSLSTQETGLFMALSIFAGLVAQ
FPLSWLSDRYNRTQLIRINALLLALTALPLALIPHISFRFLLSLGFVVSL
LQFTLYPLVVALANDLIEPERRVSLAACLLMSFGVGASIGPLVVGALMAP
LGGNILYAFFSLCGLGLIALSRTVKQDQDEFVNDAPVPHIAIPDCLVSSP
LSSALNPSFDEQMIQNVMPPPEQPATINTPADSLSDPDTTPSPHSQ
>YP0461 proP6, putative membrane protein
MMWGDHLYTEGGIFFPVVEIDMPQEFAGSARAIGYLIGYLPSLFGYRLYG
YFLDTYLGIQGVNYVFYIMAAFSAGRFICAAVWAK
>YP0669 proP7, probable sugar transporter
MQKTDTPGLSPALIVLMSVATGLAVASNYYAQPLLETIATNFNLSVNQAG
FIVTAAQLGYAVGLMFLVPLGDMFERRGLIVGMTLLAAGGMLITAMSQNL
TMMIIGTALTGLFSVVAQLLVPLAATLAAPEKRGKVVGIIMSGLLLGILL
ARTVAGALATLGGWRTIYWVASALMFIMALVLWRCLPRYKQHTGLNYGQL
LGSIFALFIHTPVLRTRALLGALSFANFSVLWTSMAFLLAAPPFGYSEAT
IGLFGLVGAAGALMATKAGQLADKGKARVTTSAGLVLLLLSLLPIAFGQH
SIIALIIGIIVLDLAVQAVHVTNQSVMYRMMPEARNRLTAGYMTSYFIGG
ALGSLISAAAYQHAGWYGVSTAGLVLCLLNIVTWLVGKRSDQPANQTVE
>YP0707 proP8, putative membrane protein
MQLKIPEPDSVVIWVVIGIFATWGGVVRLLLQDTKSKNLREKISAISTQV
IVSGFTGMLGGLISFEYGSSPYISFAMAGIFGSLGDTGLMYIQSYFIKKR
R
>YP0762 proP9, putative transporter
MAMNDNKMTPLELRATWGLGTVFSLRMLGMFMVLPVLTTYGMALSGASEA
LIGIAIGIYGLSQAIFQIPFGLLSDRIGRKPMIIGGLLVFALGSIIAALS
DSIWGIILGRALQGSGAIAAAVMALLSDLTREQNRTKAMAFIGVSFGVTF
AMAMVLGPIVTHAFGLQALFWGIAILALLGIVITLTVVPSANSHVLNRES
SMVKGSVSKVLHNSRLLKLNFGIMCLHILLMSSFVALPQMMANAGLAPAQ
HWVVYLVTMLVSFAAVVPFIIYAEMKRRMKQVFMGCVAVLFIAEVVLWFA
GQDLWIIIAGVQLFFIAFNVMEAILPSLISKESPAGYKGTAMGIYSTSQF
IGVAIGGSLGGWIFGLEGADMVFAAGAIIALVWFAVSVTMQEPPYVSSLR
ITLSESAVKNTTLEERLKAQPGVTEAVVVTAERSAYVKVDIKQTNRNQLE
QLINAA
>YP0818 prt, paratose synthase
MLEHEVVGTVRAGSVCNRITDIGNVNLINVTDSGWIDKVLSFSPDVVINT
AALYGRKGELLSELVDANIQFPLRILEMLVSTGKGLFFQCGTSLPADVSQ
YALTKNQFTELAREYCNKFSGKFIELKLEHFFGPFDDSTKFTTYVINSCR
SHSDLKLTAGLQRRDFIYINDLINAFKIMISKSESLISGESISIGSGHAV
TIKEFVETVAKMTSYQGNLQFGAIPTRENELMYSCASLARIQELGWLCQY
SLNSAIKDTLNRMRV
>YP3776 ptsA, putative phosphoenolpyruvate-protein phosphotransferase
MITFVQYLTFLSHSREGIAAFILVASQRGEESPMTKQVTFICGLLNGVHA
RPASHIERVCNRFQSRFHWYNPRSGIVGDGKSVLSLIAANILLGDECQVT
IEGEDEQVAFERLSIFIEHELPHADPILPKREESAEWEPLPASLAHLHPT
LLRARSVSPGTACGKLLSLIRADLNALGDLPVAQGIEREQQMLADGVAQL
GKAWESLLVANSSTAANSSTTENNSTTENNSTTRAIREVHRSLLRDGTFR
QRLLSHIVAGESCATAIVATAAYFSQQLALAANTYLRERELDIRDVSFQL
LQQIYGEQRFPSQQALSEDSLCIADELTPSQFLALDKRYLKGLLLGRGGS
TSHTVILARSFNIPTLVGVDAAALQPYINQSLQIDGELGLVVCLLDEPVR
RYYRQEQWLHDQLREQQSRYQNMPGRTLDGVRMVVAANITHAVEVEGAFN
QGAESIGLFRTEILYMDRAAAPSEEELYTLYAQALGAAKGKPIIIRTIDI
GGDKPVSYLNIPAESNPFLGYRAVRIYHEFLSLFHTQLRAILRASMHGPL
KIMIPMISSMEEILWVKDQLAEVKQSLRISHLQFDETVPLGMMLEVPSVM
FIIDQCCEEMDFLSIGSNDLTQYLLAVDRDNAKVSEHYHCLPPALLRALD
YAVCEVHRHGKWIGLCGELAAKDSVLPLLVAMGLDEISMSASFIGATKAR
LAKLDRGECRLLLNRVMACRTSREVEYLLVQYDGEQRDEPLIIPECITLG
ADWRSKEEVIKGMVDNLLLAGRCRYPRKLAADVWAREALFSTGLGFGFAI
PHAQSEHIEQSTISVAKLAKPVNWGEEDALFVMMLTLNKQASGDQHMRIF
SKLARRIMHEGFRDALVSAGTAQQVEMLLKHELEL
>YP2246 ptsG, PTS system, glucose-specific IIBC component
MFKNAFANLQKVGKSLMLPVSVLPIAGILLGVGSANFSWLPSVVSHVMAE
AGGSVFANMPLIFAIGVALGFTNNDGVSALAAVVAYGIMVKTMAVVAPLV
LHLPAEEIATKHLADTGVLGGIIAGSVAAYMFNRFYRIQLPEYLGFFAGK
RFVPIISGFTAIFLGILLSFIWPPIGKAIQIFSEWAAYQNSVVAFGIYGV
VERSLVPFGLHHIWNVPFQMQIGEYTNAAGQVFNGDIPRYMVGDPTAGKL
SGGFLFKMYGLPAAAIAIWHSAKPENRAKVGGIMISAALTSFLTGITEPI
EFSFMFVAPILYFIHAILAGLAFPICILLGMRDGTSFSHGLIDFVVLSGN
SSRIWLFPLVGICYGLVYYTIFRVLITKLNLKTPGREDSSTEQSVQGGTE
MSAALVEAFGGKDNITNLDACITRLRVSVADVSKVDQAGLKKLGAAGVVV
AGSGVQAIFGTKSDNLKTDMDEYIRNH
>YP2618 ptsH, PTS system, phosphocarrier protein
MFQQEVTITAPNGLHTRPAAQFVKEAKGFTSEITVTSNGKSASAKSLFKL
QTLGLTQGTVVSISAEGEDEKKAVEHLVKLMAELE
>YP2619 ptsI, PTS sytem, enzyme I component
MISGILVSPGIAFGKALLLKEDEIVINRKKISADQVEQEVERFKAGRAKA
AEQLEAIKTKAGVSLGEEKAAIFEGHIMLLEDEELEQEIIALIKDEHASA
DAAAYSVIEGQAKALEELDDEYLKERAADVRDIGKRLLKNILGLNIVDLS
AIQDEVILVATDLTPSETAQLNLDKVLGFITDIGGRTSHTSIMARSLELP
AIVGTSNVTKQVKNDDYLILDAVNNKVYLNPTADVIEQLKAVKNQYITEK
NELAKLKDLPAITLDGHQVEVVANIGTVRDIAGAERNGAEGVGLYRTEFL
FMDRDSLPTEEEQFQAYKAVAEAMGSQAVIVRTMDIGGDKDLPYMNLPKE
ENPFLGWRAIRIAMDRKEILHAQLRAILRASAFGKLRIMFPMIISVEEVR
ELKAELELLKSQLREENKAFDETIEVGVMVETPAAAVIARHLAKEVDFFS
IGTNDLTQYTLAVDRGNELISHLYNPMSPSVLGLIKQVIDASHAEGKWTG
MCGELAGDERATLLLLGMGLDEFSMSAISIPRIKKIIRNTNFEDVKVLAE
QALAQPTAKELMDLVTTFIEEKTLC
>YP2380 ptsN1, phosphotransferase enzyme II, A component
MLKTLLTSDVIQVVSQAKDWRDAIAISCQPLIDNGAVEARYVEAIYRSHE
AIGPYYVVGPGIAMPHARPEDGVNRLSLALTVITEGVTFNAEGNDPVKLL
IVLAATDSNSHIEAISQLAQLFDTASDVQALLNAKTPQDILSVIARY
>YP3839 ptsN2, nitrogen regulatory IIA protein
MKDEMTNDPALQLSSVLNIESTKSSVHCSSKKRALEIISELAAKQLNLPS
QVVFDAVLTRERMGSTGIGSGIAIPHGKLEEDTLRAVGVFIRLEQPIAFD
AIDNQPVDLLFALLVPADQCKTHLHTLSLVAKRLADKTVCRRLRSAQSDD
ELYQIITELPPEIA
>YP3841 ptsO, putative phosphocarrier protein
MTVKQTVEIKNKLGMHARPAMKLFELVQSFDAEVMLRNDSGTEAEASSVI
ALLMLDSAKGRQIEVEATGVDEIQALAAVIELFNSGFDED
>YP1907 pykA, pyruvate kinase II
MSRRLRRTKIVTTLGPATDRDNNLEKIIAAGANVVRLNFSHGSAEDHELR
ANKVREIAARLGRHVAILGDLQGPKIRVSTFKEGKVFLNINDKFLLDANM
AKGEGDKNKVGIDYKGLPADVVPGDILLLDDGRVQLKVVEVQGMKVFTEV
TVGGPLSNNKGINKLGGGLSAEALTEKDKADIVTAAKIGVDFLAVSFPRT
GEDLHYARRLARDAGCNAQIVAKVERAEAVATDEAMDDIILASDVVMVAR
GDLGVEIGDPELVGIQKKLIRRARQLNRAVITATQMMESMITNPMPTRAE
VMDVANAVLDGTDAVMLSAETAAGQYPAETVAAMARVCLGAEKIPSINVS
KHRLDVQFDNVEEAIAMSTMYAANHLKGITAIIAMTESGRTALMMSRISS
GLPIFAMSRHDHTLNLTAIYRGVTPVYCDPHTDGVLAATEAVKRLQDKGF
LVSGDLVIVTQGDVMGTIGTTNTSRIIRVE
>YP2180 pykF, pyruvate kinase I
MKKTKIVCTIGPKTESEEMLTNLLNAGMNVMRLNFSHGDYAEHGQRIKNL
RAVMAKTGKKAAILLDTKGPEIRTMKLEGGKDAALVAGQTFTFTTDQSVV
GNDKIVAVTYPGFAADLKIGNTVLVDDGLIGMEVIEVTEHTVVCKVLNSG
DLGENKGVNLPGVSIQLPALAEKDKGDLIFGCEQGVDFVAASFIRKRSDV
LEIREHLKAHGGEHIQIISKIENQEGLNNFDEILEASDGIMVARGDLGVE
IPVEEVIFAQKMMIEKCNRARKVVITATQMLDSMIKNPRPTRAEAGDVAN
AILDGTDAVMLSGESAKGKYPLESVTIMATICERTDRVMPSRIESLNDNR
KMRITEAVCRGAVETAEKLEAKVIVVATGGGKSAKSVRKYFPTATILALT
TNEMTAHQLILTKGVITQLVDEIASTDDFYRLGKEAALASGLAQKGDVVI
MVSGALVPSGTTNTSSVHVL
>YP1133 rbsA1, ATP-binding component of D-ribose high-affinity transport system
MSQPLLKITDMAKSFSGVWALSNVQLTLEQGEIHALLGENGAGKSTLLKA
LSGAQPQTHGEIWFNGEMLALDDSPVERQNKGIITIYQEVNLLPNMTVAE
NMFLGREPRRRQVFVDEKAVNQEAQAILDYLQLNVSPTTAVARLSIAQQQ
MVEIARALTLNAKLIVMDEPSAALSDSEVESLHRVVRELKGRGVSIIYVT
HRLHEVFQLCDRFTVFQDGRYTGSDEVAGTNVEKIIRLMVGRDVVFNRRP
ASETHHQDQPIRLSVQGLCREKPPLDPHGVALKDISFHVHAGEVLGIAGL
VGAGRTEVARCLFGAGAFTSGNFEIDGVPYQPRDPMFALEQGIALVPEDR
KKEGAVQGLSIRDNLTLSSLAGLLQWRFFVNTRKEDQLIETYRLALQIKM
VNSEQAVRKLSGGNQQKVILARCMALNPRILIVDEPTRGIDVGTKSEVHQ
VLFDMAKQGVAVIVISSDLPEVLAVSDRIITLSEGRVTGEIHGDDASEER
LMTMMTINHNALNAA
>YP2315 rbsA2, putative sugar transport system, ATP-binding protein
MTPLLELKQIKKSFPGVKALDGIDLTIQRGEVHALLGENGAGKSTLVKIM
CGIYQPDSGGIFLEGQRCRFANYRDAIDAGIGIIFQEFSLIPYMNTIDNI
FLNREIKNRWGLLDRREMRRKARAIFKRLTVDIDLDCPVEQLSVAQQQFV
EIAKALSLDARILVLDEPTATLTPGEAEHLFSIMHDLKLLGVGMVFISHH
LDEIFTICDQITVLRDGAYIQTLPAAETNVEELVKLMVGRKIENTFPVKS
HPVDTSVRVLEATVQHTKHVMENSFHLYKGEILGFAGLVGSGRTELMSAL
IGARSCYQKSVSLNGQPTVLRNPAQALDHGIGLLPESRKTEGLVLPFSVA
QNITLNRHEKRGKIFVNAGKEHDIVQRLIRAVGVKTPDADTAVSTLSGGN
QQKVVIARWLNNDCDILIFDEPTRGIDVGAKSEIYQLMQQLTQKGISIIM
ISSELPEIIGVCDRVLVFRGGHIVAELAGDEIESNNIMLHATGSAL
>YP3327 rbsA3, sugar transport ATP-binding protein
MNKVPLLEMRNITKSFGKFQALKGVDLTVFSGEIHALMGENGAGKSTLMK
ILAGAYTTTSGEILIEGRPWSIKGPKDALNAGISLIYQEMQLAPNLTVAE
NIFLGSELSRGGLVQRKEMVMQTQAVIDRLGAQFKASDLVMGLTIAEQQQ
VEIARALHRNSRILVMDEPTAALSTRETHRLFELILRLRDEGMAIIYISH
RMAEVYELSDRVSVLRDGQYVGSLMRANLNANELVRMMVGRPLSDLFNKE
RDIPLGHLRLKVHHLTDGAKVQAVSLQVRSGEIVGLAGLVGAGRSELAQL
IFGVRKATGGTIEIDGVPLVIHSPREAIRHGIGFLTENRKEQGLFLELAA
QDNITMATLERDACYGLLDRKKARAISDDAINRLNIRVPHAQVRAGGLSG
GNQQKLLISRWVAISPRILILDEPTRGVDVGAKSEIYRIMSQMAREGVAI
LMISSELPEVVGMSDRVYVMHEGRIAGELHHPDITQENIMTLATGVTEDH
KKEVYHD
>YP3555 rbsA4, sugar transport ATP-binding protein
MFERCNVIVAGVWTFFIPHSSVHLFLVRSYEAFMIRNEILAKKPDYLLEA
TGLKKSFGDVIALNNAEFCLKRGSIHALCGGNGAGKSTFLGLLMGFIQPD
DGAFFINGQYCEFDSPGQALAAGITIVQQELSGVQDLSVAENIYLGSEPR
RFGIVDFRALNRQADVLLHELGFAISPKAKMRSLSVAEQQRVEIAKALSH
THADIIIMDEPTSALGEEDAQKLFQTIKKLASLGKGVIYVSHRLSEIFQI
ADSYTVFRDGCYICEGETSHITREQLIEHIIGGEIDGEFSKYNTPTNVPL
FKASGICWKSKVNDVSLTLHCGEILGIYGLVGSGRSEFLNLLFGLERADH
GSIHIGDEILLKHTPEKAINAGIAYVTEDRQETGLVLNHSVSENINISSL
NVISRMSIINENDIQRRADHTIRIFNIKTPSRQQRVANLSGGNQQKVVLG
RWALLDPKVLLLDEPTRGIDIGAKKEIYRFMSDFALKGKGIVMVSSELSE
IIGMSDRILVFKKGKIVGEITGTEATQAKLMSMAV
>YP0358 rbsB1, putative sugar ABC transporter, periplasmic protein
MHQKIAIQQKQANLLYINIIKPALPIALSEDVMMRKLILPCLITTLLASH
AAWSADSNTPQKANKPFTLGVVVKVGGIPWFNVMEQGIKAEGQALGVNAW
QVGPTTADPAEQVRAIEDLIAKKVDVIGVVPNDAKVLEPVLKRAQEAGIK
VITHESPGQINADWDFELLDTQSMGANHMKDMAQCMGEEGKYAMFVGSLT
VPLVNEWADAAIAYQKANYPKMVLVEDRFGVAESVDDSMRTANDLLSKHK
DLKGIMSFGSQGPIGAGRAIDKRKKNDTTCVFGTFTPGQGIKLLEKGAID
GGYISNPMVAGKVFVQVATAMMNGEPIKDGVKLGDMGEIKTQGNTILSDN
PEKLDIENTKRLVKLGL
>YP3482 rbsB10, putative sugar ABC transporter periplasmicbinding protein
MKKRLIGLLLAGVTISMSVSAAEPLKIGFANRTLNGAFFNGLTEYMKIHA
KEKGYTLITTDARGDLNKQIADVEDMLSQGINYLILNPQDPQAGLRITEI
AKRAGVPTVILDSDIALEAPVITRVQANNAKNNNLIGEYAVGQFGDKPMN
CIFLSGNQGNLVGQARRDNFLLGVAEAQLRKYNRTNVNFLSQGWGNWDQQ
GGLKAMEDIIVAQGDKINCVYSEMDDMALGAIRALKAANKLDNVKVYAHD
GYKKGLEAVKKGELQATASNNPDLLTSTVLEVIGQYQAGQTSFPDYVYIP
SILITKDNVDKYYKEDSIF
>YP3557 rbsB11, sugar-binding periplasmic protein
MNAPGAFMKKTMLQTLLAATLILSFAASVQAAPVKIAILMYGMKAEFVQL
MEKSAKEHPAVTQGLTTLTLFDGRYDPLVQNNQAETAIRTRYDAIIIVPI
DFEANVDVVTMANKANIPVIVANARLNTDKATSGIFSDDVQGGYLEAKAV
LDKMQCQGNVVVIEGPIGQSAQIQRGQGNDKAIAECGPGKINVLERKTAN
WSRAEAMPLMENWLQKHRGKINGVIGQNDEMALGAIEAIKSAGLNVQDFA
IAGIDGVSDAIRAVKQGEMMSILQDGQAQIQGAIDIAMRSVQGERYQPMS
TIWQQYQGKMDWQQGTAKMYEVPWTEVTPQNADELLKMRQ
>YP3772 rbsB12, putative periplasmic solute-binding protein
MRTQRLKKLALVCALGFACITTAQAAERIAFIPKLVGVGFFTSGGKGAVD
AGKALGVDVTYDGPTEPSVSGQVQLINNFVNQGYNAIVVSAVSPDGLCPA
LKRAMQRGVKILTWDSDTKPECRSVYINQGTPNQLGSMLVDMAANQVKKE
QAKVAFFYSSPTVTDQNQWVNEAKKKIQQEHPGWEIVTTQFGYNDATKSL
QTAEGILKAYADLDAIIAPDANALPAAAQAAENLKRANVAIVGFSTPNVM
RPYVERGTVKEFGLWDVVNQGKISVYVANEMLKKGDLNVGDKIDIPNIGV
VEVSPNRVQGYDYEAKGNGIVLLPQRVIFTKENISKYDF
>YP3914 rbsB13, putative periplasmic binding protein
MQHNKISYLATVPLPERKQEGIAMKFNLALLNVCIVSACMLFTTQTLAAE
KKHEIAVVAKVTGIPWFTRMEVGVNEAAKKLNVNAYQVGPATPDPAQQVK
VIEDLIAKNVDAIIVVPNDAKVLEPVLKKAQEKGIVVLTHESPDQRIGQW
DVETIDSEKYAQANMDELAKAMGNKGGYAIYVGSLTVPLHNAWADYAIKY
QKEKYPEMFEVTPRLPVAENIDKSYSTTLDLMKTYPQMKGIIGFGSLGPI
GAGQAVAKKRAKDQIAVVGIAMPAQAAPYLMRGDIKKALLWDPKDAGFAV
VEIANQLLNGQKVTEDLTIDGLGKADVDSKNGVIRFNKILEVTKDNAKTL
GF
>YP0368 rbsB2, putative sugar ABC transporter, periplasmic protein
MRRKIMKNTLLKSCLTAALISMAGVAGAASNGLIAIITPSHDNPFFKAEA
EGAKAKATELGYTTLVASHDDDVNKQNQLIETAIARKAKAIILDNAGSDA
TIGPLKKAKAAGIPAFLIDREINETGIAVSQIVSNNYQGAQLGAEKFVTL
MGGKGKYIELLGRESDTNAHVRSQGYHDVIDEHSDMKMVAQQTANWSQTE
AFNRMESILQANPDITGVISGNDTMALGAEAALKAAGRNDVVVVGFDGSD
YVRDSIINNGNIKATVLQPGWAQAQMAVVQADQYLKTGKTGLEEKQLMDC
VLIDENNAKNLNVFALKD
>YP1134 rbsB3, putative sugar-binding periplasmic protein
MKKLILAALIVFTSGVAFAENEQIVFSTPNLAMPFEVHMQRTAVKTAKAL
GVKLQVLDGQGSSPKQVADLENAITRGAQGFIVSPNDINAISSAVEEIQQ
AKLPVVTLDRSVESEKKVPHFGANNYKGGEAIANYVKSMFPNGAEIVLLT
GQPGSSSNIERTKGIRDSLKTGGDKYRIVVDQTGNWMRSEGMRIIESVLP
SLPKPPQVILSANDDMALGAIEALQSHGMKPGEIMVTGFDAVPEALARVR
EGWMAVTADQRPGYAVTTAMNQLVANIRDQKAITGADFLPTMITKENLDQ
AERVSEAGK
>YP1298 rbsB4, putative periplasmic carbohydrate-binding transport protein
MTKATQAGVSRRGLLVGGAVLGLGMVIGRGALAQNRLSIPYSNKSLDYYF
FVIQEASVKRAVLARSGEFQATNANFDNTRQLEQWQSLLLSRPSAIISDP
IDSQAIVSAIRRYNREKIPVGIIDTPADGGDVAITVSFDNFQGGVMAAEE
IVNRLITRYGRPKGTVLNCYGALASVAWRLRKEGMDSVFAKYPGITYLAR
PTDGQLEKMLSVTLSTLSEYPDLDAVHAPSDSPSRGIVTALQQKGRWKKI
GEAGHVIFVNIDGEPIALKWIQDGYMDACISQDPVAYGEIAVDMIVKHAL
KGEAVPLGTYQDKKYFWESGEIVQGKTGPTLIIPAFVINRDNVQDPRHWA
AVAEKTWGIPYT
>YP1407 rbsB5, putative sugar ABC transporter
MMEFLMKKIAYPILALSLLTALPVFAADPVTLAPVPDAIANHQGQIKIAV
IRNLGSDDNTTQFLSGVLKEGKKLGFKVDTFLSNGDDARFQDFVNQAISQ
KYDGIILSQGRDPYSTELVKRITDNGIAVSVFDTAIQGEIPGLTVTQQDD
ASLTNESFGQLIKDFDGNANIIKLWVAGFPPMERRQAAYQALLKQNPGII
ELESIGAVSSDVQGDTANKVGAVLAKYPKGKIDAIWGTWDAFTQGAYKAL
QENGRTEIKLYSIDISNQDLQLMREANSPWKVSVAVDPKLIGAINLRLIA
KKIAGETTPASYEFRAASIPQALLASQPGPVNVAGLSKIIPGWGQSDDFN
SPWFATLAAQNGQ
>YP1580 rbsB6, putative sugar-binding periplasmic protein
MMIKKLCLIAALVFSLGIMGAYAQRSQSIVTVVKVIGEPWYTRMGEGAKE
FGDENPSISTRTVGPARADSALQLRIVEDLIAKKVDALAVAPMDPSTLEG
ALKKAMSRGIIVVTNEAYDMVNMHADIEAVDNATFGAKMNEGLVNCMGES
GKWTTFVGSLGTNNHVLWAKSAAVNAQKYPNMTLVDPLNESFNDANRAYD
KAKEIMRKYPDIKGFQGHSAIDVIGIGRAVEEAGLQGKICVFGIGLPQDS
GKYLDSGAINGISFWDPKDASLAMDTVAKLLLDKKPLTDGMNLGVPGYEN
VAIRKGKGDGVLVIGDAAKFVDKTNWQQYPF
>YP2316 rbsB7, sugar binding protein precursor
MFSFFKKALSFSIAGVMLFASQSVMAKQIVIGVSFQELNNDYFVSMKEAL
EQAANDIGAKVYIADAGHDVSKQINDVEDMLQKKIDILLINPTDSVGVQS
AVMAANKAGAVVVAVDAQAEGPLDSFVGSKNYDAGFLAGEYLAKSLGGKG
KVAILDGIPVVPILERVRGFEDAIKKYPDIKIVTKQNGKQKRDTALTVTE
NMLQSVPDLAGIFSVNDVGALGALAAIESNGAKVKLVSVDGQPEAIKEIL
KPNSPFIATSAQFPRDQIRIALGIALARYWGANVPATIPVEVKLIDSSNA
QGFSW
>YP3140 rbsB8, putative periplasmic protein precursor
MYRRLLLAAAVTAAMCSAVQAAPLVVGFSQIGSESGWRSAETKVAKQEAE
KRGITLKIADAQQKQENQIKAVRSFIAQGVDAIFIAPVVATGWTPVLQEA
KEAKIPVFLLDRMIEVNDPSLYTAAVASDSVYEGKVAGEWLLQDVAGKPC
NVVELQGTVGSSVAINRKKGFADGIASAPGVKIIRSQSGDFTRSKGKEVM
ESFIKAEQNGKNICAVYAHNDDMAIGAIQAIKEAGLKPGSDIKIVSIDGV
PDIFKAMSSGEANATVELTPNMAGPALDALIVLKKDGTQPPKFIQTESRL
LQPDTAKQEYELKKSLGY
>YP3325 rbsB9, sugar-binding transport protein
MRLKPIMTALIAGAMIASSPALQAKELNSIGVTVGDLANPFFVQITKGVE
LEARKLAGDKVKVTLVSSGYDLGQQVAQIDNFIAAKVDMIILNAADSKGI
GPAVKRAKDAGIVVVAVDVAAEGADATITSDNTQAGAMACKYISDRLKEK
GNVVIINGPPVSAIQNRVEGCESEFKKYPDIKVLSSNQNAKGSREGGLEV
MTSLLAVNPKIDGVFAINDPTAIGADLAAKQAQRNEFFIVGVDGSPDAEE
ALKRGGNTLFVATPAQDPQVMASKAVEVGYGILQGNPAPKDPILIPVTLI
DKNNISTYKGWTMK
>YP2314 rbsC1, putative sugar transport system, permease protein
MIRTEHSSSTQESGSTLHRHKRWEKLLHHPAMLPFIGFVVLFVLMSGLND
SFLTVNNLTNVARQVSINAIIAVGMTCAILTGGIDLSVGPVMALSGSIAA
GLMLAGIPIPLAMMAALLVGALFGLANGSCIAYLRMPPIIVTLASMGIAR
GLALLYTGGYPISGLPDMFSFFGRGTVLGIQVPILIMAGVYLFAWIMLNH
LSFGRYIYAIGGNEEAARLSGIRVSRYKMLVYVVSGLTAALAGLVLTSRL
MSGQPNAGEGFELDAIAAVVLGGAAISGGKGAIIGTLVGAMMLGVLNNGL
NLMSVSPYIQNVVKGGIILAAIYLSSVRRK
>YP3556 rbsC3, sugar transport system permease
MVMSLTRTSKFRKAIHQYGIILAFVGLCAVIALAGEFAVNSGTWSENYFL
SRDNTLIILRQVSINGILAIGMTFVIITAGVDLSVGAVLGLAGIVAARFA
TNNSAIALGGTDWPLLVPIVIAIGIGLVCGAINGFILGKYRLQPFIVTMG
MLSVARGLTLLTTGGNPVSQLTDEFRWLGNGYILGIPVPVLIFIILFAIA
WFVLNKMTFGRYVYAVGGNEKSARTSGINVLRIKVAVYTLCGILAAIAGL
ILTARTGSAQTGAGVSYELDAIAAVVIGGTSMAGGIGTLRGTLFGVLIIG
VMNNGLDLLGVQSYYQQIIKGVLIVFAVMLDPSRKQ
>YP0007 rbsD1, ribose permease
MKKGVLLNADISAVISRLGHTDQIVIGDAGLPIPATTTRIDLALTRGVPG
FLQVVDVVTQEMQVENAYLAEEIVKNNPQLHEALLVLLTQLEQRQENQIA
LRYISHEAFKEQTKQSRAVIRSGECSPFANIILGSGVTF
>YP3927 rbsD2, putative carbohydrate transport protein
MRPDRILHPELAAALATLGHTDIILVTDAGFPIPPQAKRIDLGFWPGTVD
VLHILRVLRKEIFVEEVRFASEVRDCHPQLYRDVQTLYTGSGAEFQAASH
ETLCHDLAHQAKVVIRSGSFNPWANFALVASTDPFAWFTDESGVKPLPAY
VARRQRILDNVVPELNA
>YP0008 rbsK1, ribokinase
METGKLVVLGSINADHILNIEQFPRPGETVIGQQYNVAFGGKGANQAVAA
GRSGADIAFIACVGDDDIGERVRQQLTADKIDTQPIEAIKGATTGVALIF
VNSDGENVIGINAGANSAVTPEYLRRYQQQVIDADALLMQLESPLDTVIA
AAKLAKQHQTQVILNPAPARKLPDELLTLVDMITPNETEAERLTGIHIEQ
DDDAAKAAQILHDKGIATVIITLGSRGVWLSEQGKGKLVAGFKVNAVDTI
AAGDTFNGALLTALLEGQSMDVAVRFAHAAAAIAVTRPGAQPSIPWRAEI
DSFLQERV
>YP1577 rbsK3, putative sugar kinase
MSKIVSLGIHVLDVLGRHVNRFPPGGELDIINEIRLTVAGTAAGMSVDLA
KLGGDVYAMGAVGLDESGNFIIDTLRRYGVNTDHIVRKSEVQTSCSMLPI
RPNGERPVLHVLGANATYRLEDIHWDVIASADILHFGGTYLLPGLDGPPT
ATILKFAKEHGVTTTLDLLVNAQPDLLAKLEPALPYIDYFMPGLDEARAI
CGLEKRADVIAFFLNRGVGHTVFKMGAEGSSIASLEMAEILIPAYKAQVV
DSTGCGDSYCAAFIMGLTKGWDLATSGRFASAAASLVVSGLGSDAGIIDF
EHTLKVMNTAETLPIAQET
>YP3322 rbsK4, PfkB family carbohydrate kinase
MIERNGIIAAGNMLVDHVHQIEQWPQRGWLAEIVHSERSTGGAPLNVLLT
LAKMYTGLPLQAVGLIGDDHDGDYIMAMLDQYQVNRQHVRRTTLAPTSMS
QVMTDPSGQRTFFHSPGTNRLLDLPAFDGLDTSFKIFHLGYLLLLDSLDV
EDTEYGTRSARLLALMSQLGYETSLDLVSREGDPRYHLLVTPTLCWLDYL
TINELEAGELSGLEMRLADGTPDVHHIAQAAKQLLEAGVRQRVVIHCPEG
AWGVEHGQEGAWVPSWKLAQEEIVGSVGAGDAFCAGILYGYHERWPLNDC
IQLAHACARANLLCANAIDGAKPLAELDVFIRENS
>YP3926 rbsK5, probable carbohydrate kinase
MMSVFILGSYAKALVMTTDRIPLAGETLIGYDFRQTWGGKGSDMAVQAVR
LGAEVAYAGVVGDDTFGHEFVGLMQEEGVNIDALTISGELPTGAGLIVKD
KEARNVIVVDMGANKLFTPALVDSALSQLKQSNVVLTQLEIPLETARYGL
QRAKEFGKITILNPAPARDLRGLDLSAIDYLTPNETEARVALGLPPDDPR
SNREIANLLLETGCQYVVMTLGESGSAVFGRNDTQEIPPCIIDVVDSNGA
GDSFNAALAVALDEGLPISEAVLFANATAALCCMDWETVPSYRYREDVDA
FMRSITVKEE
>YP0059 rfaD, ADP-L-glycero-D-manno-heptose-6-epimerase
MNTMIIVTGGAGFIGSNIVKALNNIGYKDILVVDNLKDGTKFVNLVDLDI
ADYMDKEDFVASIVAGDDMGDIDAIFHEGACSSTTEWDGKYMMDNNYQYS
KDILHFCLDRSIPFLYASSAATYGGRTDNFIEDRQYEQPLNVYGYSKFLF
DQYVREILPQADSQICGFRYFNVYGPREGHKGSMASVAFHLNNQINAGER
PKLFAGSENFKRDFIYVGDVADVNLWFWQNGVSGIFNCGTGRAESFQAVA
DAVVDYHQSGPVEYIEFPEKLKGRYQAYTQADLTKLRAAGYGKPFKTVAE
GVKEYLAWLNRSV
>YP0484 rhaA, L-rhamnose isomerase
MHMTNSIEQAWDLAKQRFAAVGVDVDAALTRLDTLPVSMHCWQGDDVTGF
EDPDGVLTGGIQATGNYPGKARNATELRSDLELALALIPGPKRLNLHAIY
LESDTPVARNKIEPRHFSHWVAWAKKHQLGLDFNPSCFSHPLSADGFTLS
HADPEIRQFWIEHCQASRRVSAYFGEQLGTPSVMNIWIPDGMKDTPIDRL
APRQRLLSALDEVISEKLNPAHHIDAVESKLFGIGAESYTVGSNEFYMGY
AASRQTALCLDAGHFHPTEVISDKISSAMLYVPRLLLHVSRPVRWDSDHV
VLLDDETQAIASEIIRHNLFDRVHIGLDFFDASINRIAAWVIGTRNMKKA
LLRALLEPTDRLRQLELRGDYTARLALLEEQKSLPWQAIWEGYCQRNDVP
VDARWLDAVREYEQQILSQR
>YP0485 rhaB, rhamnulokinase
MVAIDLGASSGRVMLASYYPGQQQLTLREVCRFTNQIKSIDGSDVWDIDA
IEQSIREGLSQLDSEGIALDSIGIDSWGVDFVLLDKQGKRIGQPVSYRDS
RTQGVMARAQQTLGSNAIYRRTGIQFLPFNTLYQLRALSEQQPHLLADVA
HLLLIPDYLHYRLTGQLNWEYTNASTTQLLNIETGDWDSDLLAYAGVPAH
WFAKPGKPGNTIGYWHSANGQQVPVVAVATHDTASAVLAAPLIDADAAYL
SSGTWSLMGFESGTPLTHQQAQCSNITNEGGAEGRYRVLKNIMGLWLLQR
ATDELQIDDLPQLIEQAARQPACRSLINPNDSRFINPPNMCREIQNACRE
HQFPVPNTAAQLARCIFDSLAMLYRQVAQELATLRGRPISHLHIVGGGCQ
NQFLNQLCADACGLNVSMGPVEASTLGNIGSQLISLGEVADVTHYRRIVA
NNFPLHHLSPHDNSDFAAHWLQFQSLSQLPKELCI
>YP0483 rhaD, rhamnulose-1-phosphate aldolase
MQAILSSWFIQGMIKATSDMWHKGWDERNGGNISLRLLAEEVEPYRRDFY
QQPRKVELTQPAPELANSWFLVTGSGKFFRNVELNPAENLVLLQVSNDGM
AYHIHWGLTQGGLPTSELAAHFQSHIVRMQVSGGTNRVIMHCHATNLIAL
SYVQKLENASFTRLLWEGSTECLVVFPDGIGIVPWMVPGTDGIGTQTAEQ
MREHSLVLWPFHGIFGSGPTLDDAFGLIDTAEKSAEIMVKVLSMGGKKQT
ISREQLIALAARFDVTPMAAALDA
>YP0272 rhaT1, putative membrane protein
MNRLPTLYGIIAILLWSMSVALTRGLAEALGPFGAGSAIYSVSGILVWLV
AGKPRVRGQHPAYLYGCGLLFVVYMVAFALAIGMANDRQQTLEIGLINYL
WPSLTLLLAVPLLKLRARWWLWPGAALALFGVIWVVSGGEGLDVKTLAVN
ISSNPLAYSLALIAAFTWAGYSNLVRLYSQGPGALPLFLIACALCLWLMF
FMWTPGKLHFTPRAIFELLLMGANTALAYQCWDRAYQCWDSAMKKGNATL
VAALSYFTPLLSILIASVWLNTLPSAAFWPGVAMVVAGSLLCWSASRNPL
RT
>YP2274 rhaT10, putative membrane protein
MIVKDVHVDRSPSLFTSKKFVFFGATFCCLLWGSAYPAIKNGYQLFNISP
DDIPSKMVFAGYRFLLAGLVLLLFALASGKAIGRLKKGQYQQIAILGLTQ
TALQYVFFYIGLAYTTGVKGSIMNATGTFFSVLLAHYLYKNDRLTLNKII
GCALGFVGVMVVNVGSDLMDFNFSLLGEGSVVLAAFILSAASIYGKRISQ
TMDTTVMTGYQLAIGGLVLTLGGYLFVFGLGQ
>YP2402 rhaT12, putative membrane protein
MNVLFPLFAVIIWSVNAVVSKISATAIDPAAISFYRWLLALLTLSPFLLL
GVVRNWQAIRVYWWKLMLLGMLGMVLYQSLAYYAAHSVSALFMGILSSLI
PLLTVLISIVLLRVAPTVGIALGSLLSLGGLVWLISAGNPVQLLQHGIGK
GELMMLGASASYALYGVLTKRWAIQLPNWQSLYMQIVFGVVLLLPGFLMT
PDVQLTAQNIPLVLFAGIPASILAPYLWIQGVMRLGANTASIFMNLTPVF
TAIIAVVFLHEQLHSYHLIGGGITLAGVVLAQRLRSPLRRNLDLAGHIPN
NKNSR
>YP3259 rhaT13, putative membrane protein
MHFTLSLSQFIVLLLVITTILWAFSFSLIGEYLAGQVDSWFSVLMRVGLA
ALVFLPFLRWRNIPWRVILLYMAVGSIQLGIMYLFSFRAYLYLTVPEFLL
FTVMTPLYVTLIYDLLRRQRLRWGYALSALLAVLGAAIIRYDQLSEHFWW
GLALVQAANICFAIGQVGYKRLMEVHPIPQHVAFSWFYLGAFVVAVVAWF
AFGNPQRLPTTGLQWGILVWLGVGASALGYFMWNYGATQVDAGTLGIMNN
VHVPAGLLVNLAIWQEKPHWPSFIIGAAVIMASLWVHRRWIAPHPLQTAN
DRKRADEQNE
>YP3383 rhaT14, putative membrane protein
MHAYSGISYGVIFCLISAAFDVYVGYITQSISPAVIILYCFISSTIVFLL
FSILKQGIAVFYKAKANLPLLLLANVAVLLNWGGLIVSLRYLEPAIVGIA
SVACGPAITTIISRCIDNRSGKNSGLEFIISWLIMVGVILMLCNSLMGKS
GVTTTTVDERLIGIICVILSALGTVIYTFISRELYQRQWETYEILGFRNM
LMLLIAVIYCFYADIPLSINMNLAAPMVLLVVIGHLLPIYLIQNTIKRLQ
PLHVSLVLLLLPVFTLLLQYFDTRVEISFDSIAAVSIIAILLFILGINKI
IGNPKTKGA
>YP0489 rhaT2, L-rhamnose-proton symport protein
MRPSCSAPTRTITAKDNKMNNAIILGIIWHLVGAASAACFYAPFKQVKKW
SWETMWSIGGLVSWLILPWTVSYLLLPDFWQYYGSFSIATLLPVFLFGAM
WGIGNINYGLTMRYLGMSMGIGIAIGITLIIGTLMTPILQGRFDVLLGTP
GGRMTLLGVFVALIGVAIVSYAGLLKERAMGIQAEEFNLKKGLILAVMCG
IFSAGMSFAMDAAKPMHEAASALGINSLYVALPSYVIIMGGGAIINLSYC
FIRLATLKNLSVKADFSVAKPLLITNILFSALAGLMWYLQFFFYAWGHAK
IPQQYDYMSWMLHMSFYVLCGGIVGLLLKEWKCSTKKPVAVLCIGCLVII
LAANIVGLGMAA
>YP0573 rhaT3, putative membrane protein
MDTKQQAGLGIFLALTTAVFWGALPIAMKQVLEVMEPFTIVWYRFMMAAI
GLGIILASRRQLPSLKLFRQRRWLALLIIATCGLLGNFIFFSSSLQYLSP
TTSQVIGQLSPVGMMVASVLVLKERMRITQVIGAGMLICGLLLFFNTSLH
EIFTRLTDYTLGVALGVCAAVVWVSYGVAQKVLLRRMASQQILLLLYTLC
AIALFPLAKPAVIFQLSGWQFACLLFCGVNTLVGYGALAEAMARWQAAQV
SALITLTPLFTLFFSILLALAWPDMFAAPSLNLVGYAGAFVVVAGAMFSA
IGHRWWPRRTEINLVALQKQPVNDLRRK
>YP0934 rhaT4, putative membrane protein
MLKQNRRNLWLLIGSLFTLYFVWGSTYLVIRIGVESWPPLMMAGLRYLIA
GVLLFSFLAIRGHALPTLRQWAAASAIGILLLAIGNGLVTIAEHQHVPSG
IAAVMVATVPLFTLCFSLLWGMRNTKLEWAGIALGLVGIILLNTGSNLLG
NPVGAMLILLASASWAFGSVWSSRLALPAGAMSGAAQMLVAGVVLLLAST
LSGEELQQPPTMSGILALLYLIVFGSMLAISAYMFLLKNVRPAVATSYAY
VNPVVAVLLGIGFAGESLSPTEWGALAVIVSAVVLVTLGKFLFARR
>YP0989 rhaT5, putative membrane protein
MTTRVLKAHLQMLGFTALLGGSFIASATISNALPPMVITWLRYAIASLFF
VVLLVSQGLLTLPHYRDLGRYTLISLPPLLYFACMIFSLQTTSAINSSAL
YTTVPLMSMVMSVVFLNAKSTWPVVAALLLGILGALLIIFKGDLSQVLRL
SLMPSDYLFLFGCLGMALNPIVVKKLHRGEHALVLTGWSLICATLLLTVI
IAYQLPEIEWRNISVITWSGVLYLATFATALSFFLFQKACIVLSPTKVSG
YVYLIPLSVIVTNMMLGQTINWQEIASGAILVIIAMAILVKAK
>YP1248 rhaT6, Permeases of the drug/metabolite transporter (DMT) superfamily
MAEPDMNQGALLAILASLIFSVMNVLVKTIADEIPTGEIVFFRSSIGCLL
IGLLMYQRGIAFSREDRPLLVLRGTMGALYLICYFYSIAHLTLADASMLA
YLSPFFSIVLSLLVLRERVNATMAFWLVMVIIGAIILIRPWNFSTYTLAS
LVGVMSAVFAAIAYLSVNKLTKRHHNYEIVFYFLFIATLISIPLMWHNFV
WPSGYQFGILIAIALVSLLGQVVLTQAFSSDNLIVVSVVRYIGIVFNITW
GWLFWDEVPLMLSLMGGGLVVVSCIQLGLRSKKKAA
>YP1952 rhaT7, putative membrane protein
MMKWYDGLRHPGVLAALSAAILFGAGTPLAKQLLNTVSPWLLAGLLYLGS
GIGLTLYRLITRPAAVSLPRNELLWFIGAILSGGIIAPVLLMVGLTGMPA
SGASLLLNAEGVFTALLAWFAFKENVDRRIALGMVIIIAGAVVLSWPEEV
LNWWPKEAQFAGLWPTLAILGACFAWGIDNNLTRKVSLNDATWIAAVKGG
VAGVVNLALAFALGATLPPLANLAGALLVGFLAYGVSLALFVIGLRHLGT
ARTGAYFSIAPFLGAVLAVALGDTVTIPLLIAGLLMAIGIGLHLTEQHEH
QHTHDEMIHEHEHIHDEHHQHRHDFPVDAGTAHKHRHQHLPMAHSHSHFP
DSHHQHKHPRHKHNQHKYHQHKH
>YP2203 rhaT8, putative membrane protein
MAPMKGYLWGGASVVLVTVAQLVLKWGMMNIPLLSLADINVQFLTMYFVQ
LASVMCGLMGYALSMLCWFFALRYLPLNRAYPLLSLSYALVYLGAVLLPW
FNEPATLLKTLGAGFILLGIWLINIKPIKAS
>YP2204 rhaT9, putative membrane protein
MNSYLLLLMVSLLTCIGQLCQKQAAQCWEQPQARRLNLTLRWLAIAVVSL
GLGMLLWLRLLQQLPLSVAYPMLSFNFVLVTLAAQLFYGEKATLRHWLGV
AAIMFGILLMSWHL
>YP0833 rosA, putative membrane efflux protein
MTDRSDTGCQQPVNVSVKRTSFSILGAISVSHLLNDMIQSLILAIYPLLQ
AEFSLSFAQIGLITLTYQLTASLLQPLIGLYTDKHPQPYSLPIGMGFTLS
GILLLAVATTFPVVLLAAALVGTGSSVFHPESSRVARMASGGRHGLAQSV
FQVGGNFGSALGPLLAAIIIAPYGKGNVGWFSLAALLAIVVLLQVSKWYK
LQQRASYGKVLKISSAKTLPKNKIISTLAILMVLIFSKYFYLTSISSYYT
FYLIHKFGVSVQSAQIHLFVFLFAVAAGTIIGGPLGDKIGRKYVIWGSIL
GVAPFTLALPYASLYWTGILTVFIGVILASAFSAILVYAQELIPGKVGMV
SGLFFGFAFGMGGIGAAVLGYVADLTSIELVYQICAFLPLLGIFTALLPN
LDDK
>YP0157 rpe, ribulose-phosphate 3-epimerase
MEKRMKKYLIAPSILSADFARLGEDTAKVLAAGADIVHFDVMDNHYVPNL
TIGPMVCKALRDYGITAPIDVHLMVKPVDRIVPDFAKAGATYITFHPEAS
EHVDRTLQLIKESGCKAGLVFNPATPLSYLDYVMDKLDVILLMSVNPGFG
GQSFIPETLNKLRQVRKLIDDSGYDIRLEVDGGVKVENIRQIAAAGADMF
VAGSAIFNQPDYAAVIDAMRNELAMAANG
>YP1299 rpiA1, putative ribose 5-phosphate isomerase
MATPPLCSHDQESRMSNQQNDAKRAAARRVIQDFVFDGMTLGLGSGTTSH
FFVRELGQHVAKGLQLTCTTTSRATSEVARDVGIELSDPNEMNEIDLTID
GPDEIDRRFNMIKGGGACLLWEKIIAHASKRMICICDETKIVNCLGQFPL
PVEIVPFAWKQTERRVERVLAEQGLHHVPIIRRMGGGHPVITDSGNFILD
CHCGAIITAPEPLEIELNRIPGVVENGLFTREATGMVVGYFDGSSYVQLR
>YP3612 rpiA2, ribose 5-phosphate isomerase A
MTQDELKKAVGWAALDYVKPGTIVGVGTGSTAAHFIDALGSIKHQIEGAV
SSSDASTAKLKSYGIPVFDCNDVDVLDIYVDGADEINGQMQMIKGGGAAL
TREKIIAAIARKFICIADESKQVGVLGKFPLPVEVIPMARSYVARELIKL
GGLPEYRQNVLTDNGNVILDVHNLSILDAIALENQINGIAGVVTVGLFAN
RGADVALIGTANGVKVIG
>YP0334 rpiB1, ribose 5-phosphate isomerase B
MLSIAIGCDDAAIEMKNQIVIFLQSKNITVVDYSCDQHQEPTMYPDIAIQ
VALAIKAGKHERGILICGTGIGMSISANKVFGVRAAQCHDTFSAQRARKS
NNAQIICLGARVIGPELAKTLIEAWLDAEFDGGGSTEKVERIRYYEQSLH
D
>YP1838 rpiB2, putative sugar-phosphate isomerase
MKIALMMENSQAGKNAIILKELNAVASEKAYPVFNVGMSDEQDHHLTYIH
LGIMASILLNAKAVDFVVTGCGTGQGAMMSLNIHPGVVCGYCIDPADAFL
FAQINNGNALSLPFAKGFGWGAELNVRYIFEKAFTGVKGEGYPLDRKEPQ
VRNAGILNQVKAAVVKENYLDTLRAIDPELVKTAVSGARFQQCFFENCQD
KEIEAFVKQILA
>YP3653 setA, putative efflux protein
MRSARAFSRRINPVFLAFFVVAFLSGIAGALQAPTLSLFLSTELKVRPLW
VGLFYTVNAIAGITVSFLLAKRSDLGGDRRKLILICYLMAVGNCLLFAFN
RDYLTLITLGVLMASVANTAMPQIFALAREYADNSAREVVMFSSIMRAQL
SLAWVIGPPLSFMLALNYGFTLMFSIAAGIFVISALVVWFILPSVKQPEP
VADAPVVVQGSLFADKNVLLLFIASMLMWTCNTMYIIDMPLYITANLGLP
ERLAGLLMGTAAGLEIPIMLLAGYSVRRFGKRKIMLFAVMAGVLFYTGLV
LFKFKTALMILQIFNAIFIGIVAGIGMLYFQDLMPGRAGAATTLFTNSIS
SGVILAGVLQGVLTETWGHNAVYVAAMVLVILALIICAKVREA
>YP2381 sgaB, Phosphotransferase system component IIB of unknown specificity
MKITVVCGNGLGTSLMMEISIKSILKELAVSAEVDHVDLGSAKGTPSDIF
IGTKDIAEQLVAQAVGGKIVALDNMIDKKAMKERLSAALTELGAL
>YP1800 sgaU, Putative L-xylulose-5-phosphate 3-epimerase
MKIGLETESYHLFFQQGKMDIFDFIDKAWSLGLDGVEINIIPDEGLHPEF
GVLSSDDPTYLARVRHAIEQRNLYCEIDTRFTSVKAISKAVQFASALGAD
VIRTYMFRRGQYEPLEYPRIIHELKSLVPLLQANRIRLAVENHEDETADE
IIQIVKAVDSLWVGAHCDIGNGMMAWEEPVVTVSQLAPFTYSTHFKDHIV
TQHDEQLVVCGVPIGEGSIDIDNCFRILVEKSGITRVNIETCFPYASAFS
RPCNPNEVSTLKGTFEVKTPPFDSSRIKPLEYYYPDKISPELLQELMQAQ
DHCVYTSVQVLKALRDKYCPNTTTGIVE
>YP0353 sgbK, putative L-xylulose kinase
MSHYFLGIDLGGTVTKAGIYTADGSEIAVTEQALPVLSPQAGFCERDMEA
LWIATCQVIRQTLNKACALSEYHIAAENIGGISFSAHGKGLYLVDKQGLP
VRNGIVSSDSRAQKLVNRWQQEGKDHAAYERSLQQLWPSHPAALLRWLKE
NEPENYQRSGYVLMVHDYIRYRLTGEFTIEETNISGSNLYNQYNGSFDPQ
LMAIFAIEEVMEKTAPIIGSADLAGHVSEDAANACGLKAGTPVFGGMFDV
VGAALTSGLHDSRQLSAVAGTWSIATRIFEAITPSEYPYVWGKYCIPGTY
FVHEGSPTSASNLAWFVKQFLPELPNSYQTLNQWAALGYEKSEDILFFPW
LYGSNHSANLSGGLLGLSGHHNIEDIVYAIYQGVVFSHLLHQDKILALDD
TIDCIRFTGGPTHSAIWMQMFCDASNLPLEIVDIQQSGCRAAALCAAVGS
HYYHGFEEAIRACPPPITRLLPNAEKHQRLRARFDKFKQVAEALSTVM
>YP0354 sgbU, putative hexulose-6-phosphate isomerase
MRIHPLGIYEKALPAGTSWVEKLAVAKSCGFDFVEMSVDESDERLARLDW
SREERMAVISAIQQTGVRIPTLCLSAHRRYPFGSRDATTREQAHTVMLQA
IRLAQDLGIRTIQLAGYDVYYEPQDSETIARFEAGIAWAVKQAAAAQVMC
AVEIMDTQFMNSISKWKALDNKIGSPWFTVYPDIGNLTAWGNEVNSELAK
GIDRIAAIHLKDTFAVTADSPGQFRDVPFGEGCVDFVNLFKTLRRLNYRG
TFLIEMWTEKAAEPLLEIIHARHWIEDKMRLAGWDNESGQLTR
>YP2555 suhB, putative inositol monophosphatase familyprotein
MHPMLTIAIRAARKAGNLIAKNYETPDAVEASQKGSNDFVTNVDRDAEHL
IIDVIRKSYPKHTIISEECGELVGEDDDVQWVIDPLDGTTNFIKRLPHFA
VSIAVRIKGRTEVAVVYDPMRNELFTASRGQGAQLNGYRLRGTNAKDLDG
TILATGFPFKVKQHAPAYIRVVGKLFEQCADFRRTGSAALDLAYVAAGRV
DGFFEIGLKPWDFAGGELLVRESGGIVTDFAGGHNHFSSGNIVAGNPRIV
KSIVQAMSNEISDALKR
>YP3718 talB, transaldolase B
MPKVHAQTMRNDNMTDKLTSLRQITTVVADTGDIAAMKLYQPQDATTNPS
IILNAAQIPEYRKLIDEAIAWAREQSSDHAQQIVDATDKLAVNIGLEILK
LIPGRISTEVDARLSYDTVASVAKAKRLIKLYNEAGISNDRILIKLASTW
QGIRAAEQLEKEGINCNLTLLFSFAQARACAEAGVFLISPFVGRILDWYK
ANGDQKEFAPSEDPGVVSVTEIYQYYKKHGYKTVVMGASFRNLGEIIELA
GCDRLTIAPSLLKELAESEGPVERKLAYTGEIQAKPAPLTEAEFYWQHNQ
DPMAVDKLADGIRKFAIDQGKLEKMISDLL
>YP0372 tktA1, putative N-terminal region of transketolase
MNPYSLSIDELVRKARAIRRRIVLLNANSPAGGHTGADLSQVEILTALYF
RILNCAPERLTDPERDIYVQSKGHAVGGYYCCLAEARYFPEEWLATYQRA
DSHLPGHPVKHKTPGIELNTGALGHGLPVAVGIALAAKRANSKRRVFVLT
GDGELAEGSNWEAALVAAHYQLDNLVIINDKNKLQLAGTTKSIMNTDPLA
DKWRAFGLQVTECRGNDMQSVVETLETLPQNGKPNVVIANTEKGAGISFI
QGRVEWHHRVPKGAEIDLALEELNDE
>YP0373 tktA2, C-terminal region of transketolase
MSNAEHLASVMVEQFIKAVDNGVDLVPVVADSTSTAKIGPFITRFPDRVV
NVGIAEQAMVGMAVGLSMGGKIAVTCNAAPFLISRANEQLKIDVCYNNSN
VKLFGLNSGASYGPLASTHHCIDDIAILRGFGNIEIYAPADPQECRQIID
YALAHQGPVYIRLDGKALPPLHDEHYRFAPGQIDVLQEGRDIALVAMGST
VHEAVSAAAILADNNISAAVVNVSSIRPCDTQQLFAILQQSQRVITIEEH
NINGGVGSLVAEVLAEAGSGTPLVRLGIPDGGYAIAADRAEMRAYHGFDA
AGIVARALRFCRGE
>YP3516 tktA3, transketolase 1
MSSRKELANAIRALSMDAVQKAKSGHPGAPMGMADIAEVLWRDYLNHNPT
NPHWADRDRFVLSNGHGSMLIYSLLHLTGYDLPMEELKNFRQLHSKTPGH
PEYGYTAGVETTTGPLGQGIANAVGFAIAERTLGAQFNRPGHDIVDHHTY
AFMGDGCMMEGISHEVCSLAGTMKLGKLTAFYDDNGISIDGHVEGWFTDD
TAARFEAYGWHVVRGVDGHNADSIKAAIEEAHKVTDKPSLLMCKTIIGFG
SPNKAGTHDSHGAPLGEAEVAATREALGWKYPAFEIPQDIYAAWDAKEAG
KAKEAAWNEKFAAYAKAYPELAAEFKRRVSGELPANWAVESKKFIEQLQA
NPANIASRKASQNALEAFGKVLPEFLGGSADLAPSNLTIWSGSKSLSDDL
AGNYIHYGVREFGMSAIMNGIALHGGFIPYGATFLMFVEYARNAVRMAAL
MKIRSVFVYTHDSIGLGEDGPTHQPVEQMASLRVTPNMSTWRPCDQVESA
VAWQYALERKDGPSALIFSRQNLAQQPRTAEQLANIAKGGYVLKDCAGQP
ELILIATGSEVELAVAAADQLTATGRKVRVVSMPSTDAFDKQDAAYRESV
LPSAVSARVAVEAGIADYWYKYVGLNGAVVGMTTFGESAPAELLFKEFGF
TVENVVAKAQALLK
>YP1745 togA, putative sugar ABC transporter
MAEVIFNKLGKVYSNGFRAVHGIDLKINDGEFMVIVGPSGCAKSTTLRML
AGLETISDGEVRIGDRVVNNLAPKSRGIAMVFQNYALYPHMTVKENLAFG
LKLSKLPKDQIEAQVAEAAKILELEDLLDRLPRQLSGGQAQRVAVGRAIV
KKPDVFLFDEPLSNLDAKLRASMRIRISDLHKQLKKSGKAATTVYVTHDQ
TEAMTMGDRICVMKLGHIMQVDTPDNLYHYPTNMFVAGFIGAPEMNIKPS
TLVEKEGQIGLTVGQYTLVLNERQQAKVATHTGEKVFFGVRPEFISMSLQ
PFVGNHSQGELVRVENMGHEFFMYIKVENFELTCRLPSDEARPIIENGLH
RTVYFQFDMDKCHIFDAKTEKNISL
>YP1744 togB, putative sugar-binding protein
MKKAILHTLIASTLALLSHQAFAAQDDVNLRMSWWGGNGRHQVTLKALEE
FHKQHPNINVKAEYTGWDGHLSRLTTQIAGGTEPDVMQTNWNWLPIFSKD
GTGFFDLNNVKEQLDLAQFDPIELQQTTVNGKLNGIPISVTARIFYFNDA
TWAKAGLEYPKTWDELLNAGQVFKEKLGDQYYPVVLEHQDTLALIRSYMT
QKYNIPTVDEANKKFAYTPEQWVEFFTMYKKMVDSHVMPSSKYYASFGKS
NMYEMKPWINGEWAGTYMWNSTITKYSDNLTKPAKLDLGPYPMLPDAKDA
GLFFKPAQMLSIGKSTKHPKESAMLINFLLNSKEGVDALGLERGVPLSAA
AVAQLRANGVIKDEDPSVAGLNMALELPHEMKTSPYFDDPQIVSLFGDAI
QYIDYGQKSVEETAEYFNKQGDRILKRAMR
>YP1747 togM, putative ABC sugar transporter (permease)
MNENRMLGLAYISPYIIGLIIFTAFPFVSSFFLSFTEYDLMSPPVYNGIE
NYRYMLTEDDLFWKSMGVTFAYVFLTIPLKLAFALGIAFVLNFKLRGIGF
FRTAFYIPSILGSSVAIAVLWRALFAIDGLLNSFIGVFGFEAINWLGEPS
LALTSVTLLRVWQFGSAMVIFLAALQNVPQSQYEAAMIDGASKWQMFMKV
TVPLITPVIFFNFIMQTTQAFQEFTAPYVITGGGPTHYTYLFSLYIYDTA
FKYFDMGYGAALAWVLFLVVALFASIAFKSSKYWVFYSADKGGKND
>YP0089 tpiA, triosephosphate isomerase
MRHPLVMGNWKLNGSTHMVNELIAGLRKELSTVDGCGVAIAPPAIYLNQA
KHELAGSRIALGAQNVDVNLSGAFTGETSAEMLKDIGAQYIIIGHSERRT
YHQESDELIAKKFGVLKEIGLIPVLCIGESEAENEAGQTEAVCAKQLDAV
LNTLGVKAFEGAVIAYEPIWAIGTGKSATPAQAQAVHKFIRDHIAKQDAA
VAAQVIIQYGGSVNDKNAAELFTQPDIDGALVGGASLKADAFAVIVKAAA
KAKKA
>YP3847 treB, PTS system, trehalose-specific IIBC component
MRARNLYGKDDKMGKVKQQDIDQLIVLVGGRENIATVSHCITRLRFVLKD
PSIASPKEIENLSMVKGCFTNAGQFQVVIGPEVDDYYKALIAKIGQSEVD
KEQTKLAARQNMTWFERGISHFAEIFFPLLPALISGGLILGFRNVIGDIP
MSEGKTLAQMYPAWQTIYDFLWLLGEAIFFYLPVAICWSTVKKMGGTPVL
GIVLGITLVSPQLMNSYLLGQQLPDVWNFGWFTIEKVGYQAQVIPSILAG
LALGWIETNLKRIIPAYLYLVVVPVVSLLLAVFLAHTLIGPFGRMIGDGV
AWGVKAVMTGSFAPVGAALFGFLYAPLVITGVHQTTLAIDMQMVQSMGGT
PVWPLIALSNIAQASAVLGIIIISRKINEREISVPAAISAYLGVTEPAMY
GINLKYRFPMLCAMIGSALAGLICGLTGVMANGIGVGGLPGILSIQPQFW
GIYAVAMLVAIVVPLALTILVYKRKERRGELPV
>YP3848 treC, putative trehalose-6-phosphate hydrolase
MNNPIPWWQHGVIYQIYPKSFQDSTGNGYGDLAGVAQRLDYLQKLGVDAI
WLTPVYVSPQVDNGYDVADYCAIDPAYGTLDDFKRLVAGAHQRGIRIIMD
MVFNHTSTEHAWFKASQDRNSPYRQFYIWRDGDGGDGSLPNNWRSKFGGH
AWQWHAASGQYYLHLFAPEQADLNWEHQPVRDELKKVCEFWADLGVDGLR
LDVINLVSKQQDFPNDLDGDGRRFYTDGPRIHEFLQELSRDVFQPRRLMT
VGEMSSTRLEHCQRYAALGGDELSMTFNFHHLKVDYLNGEKWSLMPPNRV
ELKHIFNQWQQGMHNRAWNALFWCNHDQPRIVSRFGHEGALRLPAAKMLA
MVLHGMQGTPYIYQGEEIGMTNPNFTDITQYRDVESLNMFAELSVAGREP
DELLAILAAKSRDNSRTPMQWDSSDNAGFSQGTPWIAPCSNYHEINVNAA
LADADSVFYAYQYLIALRKQYDIFTFGDYQDLCPQHPDLWCYLRSWQGKQ
LLVVANLSEEPQRWQPEGLTLDGNWQLLMSSYDQSAFQPQDMILRGYEGI
YWVCE
>YP3254 ugpA, sn-glycerol-3-phosphate transport system, permease protein
MSPSRPGFSCSWLPYLLVLPQLAITAIFFLWPAGEALWYSVQTLDPFGLS
SEFVGLSNFIQLFQDEYYLASFYTTLIFSALVAGIGLIVSLFLAAMVNYV
LRGSRLYQTLLILPYAVAPAVAAVLWIFLFDPGLGLITHALAKLGYSWNH
AQNSGQAMFLVVLASVWKQISYNFLFFLAALQSIPKSLVEAAAIDGAGPV
RRFFNLVLPLISPVSFFLLVVNLVYAFFDTFPVIDAATGGGPVQATTTLI
YKIYREGFAGLDLSSSAAQSVILMLLVIGLTVIQFRFVERKVRYQ
>YP0611 ugpB1, putative sugar binding protein
MKTQMIMSKVKIKSLLLLTYLAMGIPSLHAAETLQVWIRASNDSKNIYKK
EADTFEKKTGIKIEYFNATTDFEQRLARAAAGNALPDLIFNDAVAIGQFV
QLGIVEPIEPKNIIGGENIFDTAWKSTQYIDGKYYGVPTSAQTFALFVRK
DWREKLGLEQPKNWQDISTLAKAFTFNDPDGNGKNDTYGFILPGSTTRGY
ASWFISSYLWQAGGDFIRPAGEGKFIASLEEPAATETLSFMRGMVCDKTV
QPGAINATTADAIPSFRSGQSGMFFSGPYHIALFDKDPGTEAFEVIPPPT
GPKGQATLAEGTTVFMMKSSQKKAAAQKFIEFMISPEGQQIGMGMGTKNM
PVVRLSINKLVDTKAVYDDPRWAIFADLYAEQGRYIPQVPNWTPIRQVTA
EGFNRILANCDSDIAAELKAVNQKVNDELAKQNVLGQ
>YP1500 ugpB2, putative exported solute-binding protein
MSIKKIGIAGIIGTLLMAGNASAQETLRVLLEGHSTSDSIKALLPEFEKQ
TGIKVQAEIVPYSDLTSKALLAFSSHSGRYDVVMDDWVHAVGYASAGYIT
PVDQWMESDTAFYDGADFVKSYADTLRYKDGYYGLPVYGESTFLMYRKDL
FEQYGIAVPKTFDELTAAAKTIKEKTEGKVAGITLRGAQGIQNTFAWASF
LWGYGGQWIDDNGKSAITSPQAVEATKSFVNILKNYGPIGAANFGWQENR
LVFQQGKAAMTIDSTVNGGFNEDPKESTVVGKVGYAPVPVQPGDHPGNSG
ALQVHGLYISSDSKKQDAAWKFISWATDKQTQMKSVELNPNAGVSSLSAI
NSDAFTKRYGAFKDGMLAALQNGNAKYLPTIPQSTQIINITGIALSEALA
GTQTVENALQQANTRNDKALSR
>YP2296 ugpB3, putative solute-binding protein
MNERHDFNVKHKMMRCEILHIIIEITLLFYFNVKIGLPAFSFNNGPGNRI
MLEKMKNTLISLAIASSCVVFTGCDNDTASAKNEKQDITLWIAPNNVQEA
FWSEVVGEWNKQPDKKKVVFSTIPAAGSSEEAIMNAIASDRAPDISENIF
TGFGSQLADLGQVVDLSTLDGYENLISTRQMTDIMDNWRYNGKNYILPIY
MNPVLFWWRGDLLKEQGFSEVPKTYDEVYALSEKYTIPDKRYAIQATSGR
NWWDRWFDFIALYYAQSDGKPYIANQQASYDNQAGRDVLDFMHTLFSKKW
TLYDFGQDDPLVTGKVLGAVRGPWDISRYQQQYPEILKHIKMGPMLVKEQ
QDKPHTFADGKGLVLFSHSKVKPEAWEFIQWVFSQPKFDKRWMELTGMPP
ARADLLTNPFFAEYYQEHPYAAAYAEYVNVAIPPVSSGETVEIQRSMTQM
IEKTAFNTATPDEALQQSIKEVNAILKP
>YP2930 ugpB4, putative sugar binding protein
MPNIRASGLINNMKILYYIAIAIASLPLMAAERLEIMVPSGSYVSFMRNT
VTPEFNKLYPEVNLVVSNDEQLDTRMAAGDNPNVYIGVFGYQPAKLAKLG
KLAYLDKFPGFAELNERIDPHFLRENFGRTYYIPWNATTQMMIYNKELFA
EAGLDPERPPATWDEFLLAAEKISALPPRSDGSKVYGTVFWNDVLSFGSW
YWNLLAPMYYNVNQGQYQLLNRYGTDIVFDRPDANMAQFMRTMQQAQRFA
PLTMEKSFFSRNIGMWLQFGFGWKATLSSAAERPMVVGQDVAIAPIPVQT
KGDIHYSVLDGRAIMIFKDEARKEQLSWALLNLLMRDDINLQANIALGQL
PTLKALQDAPYFQSAEAQPFVQQLQHAILSEPFANAMEVANIILANYSKV
VLKGEISPEQAVATSAQAARQLLNEH
>YP3253 ugpB5, glycerol-3-phosphate-binding periplasmic protein
MFNNSIHKVSICIALTLTFSANAMAVTEIPFWHSMEGELGKEVDSIADRF
NQSQPDYKIVPVYKGNYEQSLAAGIAAFRSGKAPAILQVYEVGTATMMAS
KAIKPVYQVFKDANIDFDESVFVPTVAGYYTDSKTGRLLSQPFNSSTPVL
YYNKEAFKKAGLDPEQPPKTWQELAADTAKLRAAGSSCGYASGWQGWIQI
ENFSAWHGQPIASRNNGFDGTDAVLEFNKPLQVKHIQLLSDMNKKGDFTY
FGRKDESTSKFYNGDCAITTASSGSLASIRHYAKFNFGVGMMPYDADAKN
APQNAIIGGASLWVMDGKDKETYKGVAEFLQYLVKPEIAAEWHQKTGYLP
ITTAAYELTKQQGFYEQNPGADVATRQMLNKPPLPYTKGLRLGNMPQIRT
VVDEELEAVWTAKKTPQAALDNSVKRGDVLLRRFEQANK
>YP3256 ugpC, sn-glycerol-3-phosphate transport, ATP-binding protein
MACLKLQAVTKSYDGVTPVIKQIDLDVADGEFIVMVGPSGCGKSTLLRMV
AGLERTTTGDIYIGDQRVTDLEPKDRGIAMVFQNYVLYPHMNVFDNMAYG
LKIRGFGKEQIRQRVDEAARILELQPLLKRKPRELSGGQRQRVAMGRAIV
REPAVFLFDEPLSNLDAKLRVQMRLELQQLHRRLKTTSLYVTHDQVEAMT
LAQRVIVMNKGVAEQIGTPSEVYKRPASLFVASFIGSPAMNLLDGTVSPD
GRTFILSDGLTLPLEIPQPQWGGRRLTLGIRPEHIQQTTSAQGVPMNLLT
LELLGADNLAHGLWGGQSIIARLSHEEMPVAGSTLHLYLPPAALHFFDTD
SGLRIEP
>YP3255 ugpE, sn-glycerol-3-phosphate transport system, permease protein
MIENRRGLDIFCHIMLIIGVLLILFPLYVAFVAASLDDSQVFQAPMTLIP
GPHLWQNISHIWHAGVGNNSTPFGLMLLNSFVMAFAITVGKITVSILSAY
AIVYFRFPLRNLFFWLIFLTLMLPVEVRIFPTIEVIANLNLLDSYTGLTL
PLMASATATFLFRQFFMTLPDELLEAARIDGAGAMRFFWDIVLPLSKTNL
AALFVITFIYGWNQYLWPILITSDASMGTAVAGIRSMISTSGAPTQWNQV
MAAMILTLIPPVVVVLLMQRWFVRGLVDSEK
>YP3369 uhpC, putative regulatory protein
MHLQNTLRPEMWFFLKSRDNVPLVTDQTQIDSSYKYWRIQLMWTMYIGYA
AFYFTRKSFNFIMPAMLTDLGLSMSDVGILGTLFYITYGCSKFVSGMISD
RSNPRYFMGIGLVMTGIINILFGMSSSLLVLGALWILNAFFQGWGWPPCS
KILTSWYSRSERGGWWAIWNTSHNFGGALIPLLVGVITLHFSWRYGMIIP
GIIGVVIGLLMCWRLRDKPSTMGLPSVGKWRNDAMELIQESEGQGLSNKE
IVKRYVLTNKYIWLLAVSYVLVYIVRTAINDWGNLYLTQEKGYSLLTANS
AISLFEVGGFIGSLVAGWGSDKWFRGNRGPMNLIFAIGIFLSVASLWTLP
SISFVLQAGCFFAIGFFIFGPQMLIGMAAAECSHKDAAGAATGFVGLFAY
LGAALSGYPIARVMEIWHWNGFFVVISVAACLSAFFLLPFLRAQSPQLKQ
ATT
>YP2901 uxaA, altronate hydrolase
MQNIIKIHPLDNVAVALQDLAADERIESGEFSVKLAQPVVRGHKFALTAI
ELGQMIVKYGLPIGHALTLIQPGEHIHSQNAKTNLSDLDEYEYQPEFSSL
PPQMADRDVQIYRRPKGDVGIRNELWIIPTVGCVNGIARQIQQRFLKETQ
DAEGIDGVYLFSHPFGCSQLGQDHENTRTMLQNMVRHPNAGAVLVIGLGC
ENNQVDVFQTTLGKVDEERVRFMVCQQHDDEVEAGLEHLHALYQVMRHDR
REPGQLSELKFGLECGGSDGLSGITANPLLGRFSDYVITNGGTSVLTEVP
EMFGAERILMSRCRDEATFEKTVSMVNDFKQYFIAHDQPIYENPSPGNKA
GGITTLEEKSLGCTQKAGQSQVVDVLKYGERLQRPGLNLLSAPGNDAVAT
SALAGAGCHMVLFSTGRGTPYGGFVPTVKLATNSELAAKKPHWIDFDAGK
LIHGTSMDTLLNEFVDLIVEIANGKPARNEVNDFRELAIFKSGVTL
>YP2900 uxaB, altronate oxidoreductase
MQTLNRRDFPGRSHPDKIIQFGEGNFLRAFVDWQIDLLNEHTDLNAGIVV
IRPIDTDFPPSLSTQDGLYTAVIRGLNEQGEAVRESRLIRSVNREINIYR
QFDDYLALARDANIRFMFSNTTEAGIAWNEADQFSDAPPSSFPAKLTRLL
FERFEHFDGAADKGWVLLPCELIDYNGEALRELVLRYASHWQLPAAFTHW
LTENNTFCSTLVDRIVTGYPRDEVAALQTELGYQDSFLDTAEYFYLFVIQ
GPQGLAQELRLDQLDLNVRIVDDIKPYKERKVAILNGAHTALVPVAYLSG
LDTVGQTMDDAQISRFVEKTITEEIVPVLDLPEDELLSFSQAVLSRFRNP
FIQHQLLSIALNGMTKFRTRILPQLLTYQQQKGQLPPRLTFALAALIAFY
RGEREGQTYPLQDDAHWLERYSTLWNGVKHGDIALAELVNRVLSDANHWG
QDLTSVPQLANQVTEQLQTILSRGMRAAVAAYS
>YP2899 uxaC, uronate isomerase
MYSSEESIMSQFLTEDFLLDTEFARRLYHDYAKDQPIFDYHCHLPPEQIA
ENYRFKNMYDIWLKGDHYKWRAMRTNGVAERLCTGDASDREKFDAWAATV
PHTIGNPLYHWTHLELRRPFGITGKLLSPATSEEIWQRGNELLAQDPFSA
RGIMQQMNVKMVGTTDDPIDDLRHHKAIAADGSFNIKVLPSWRPDKAFNI
EAAGFNDYMQRLEAAADTSISRFADLCVALNKRMDHFAAHGCKVSDHALD
VVVYGEADETTLDAILARRLAGNQPSTEEIAQFKTAVLLFLSGEYHRREW
VQQYHIGALRNNNSRMFNLVGPDIGFDSINDQPLAQPLSRLLDAQGLRNA
LPKTILYCLNPRDNEVIGTMVGNFQGEGEAGKMQFGSGWWFNDQKDGMQR
QMTQLAQLGLLSRFVGMLTDSRSFLSYTRHEYFRRILCQMIGRWVADGEA
PADIALLGAMVKNICFDNAQQYFAIEL
>YP1308 uxuA, mannonate dehydratase
MEQTWRWYGPNDPVSLDDIRQAGATGVVTALHHIPNGVVWPVSEIKQRQA
ELAAKNLVWSVVESVPIHEDIKTHSGNYQQYIENYQQTLRNIAECGIDTV
CYNFMPILDWTRTDLEYELPDGSKALRFDQIAFAAFELHILKRPGASNDY
TAEEQVQAEAYFNAMTEADIAKLTGNIIAGLPGAEEGYTLDQFRARLAEY
DGIDKAQLRENMAYFLRAIIPVAEQVGLRMAVHPDDPPRPILGLPRIVST
IEDMQWLKETVDSIHNGFTMCTGSYGVRADNDLVKMIETFGDRIHFTHLR
STCREGNPKTFHEGGHLQGDVDMYSVVKAILTEEQRRQSLGDMRPIPMRP
DHGHQMLDDLHKKTNPGYSAIGRLKGLAEVRGVELALKRTFFPELKQ
>YP0816 wcaG1, putative CDP-D-glucose-4,6-dehydratase
MTRSICMNYGKKAGHLGRYGNNKMINNSFWQGKRVFVTGHTGFKGGWLSL
WLQTMGATVKGYSLPPPTVPSLFETARVADGMQSEIGDIRDQNKLLESIR
EFQPEIVFHMAAQPLVRLSYSEPVETYSTNVMGTVYLLEAIRHVGGVKAV
VNITSDKCYDNKEWIWGYRENEAMGGYDPYSNSKGCAELVTSSYRNSFFN
PANYGQHGTAVATVRAGNVIGGGDWALDRIVPDILRAFEQSQPVIIRNPH
AIRPWQHVLEPLSGYLLLAQKLYTDGAEYAEGWNFGPNDADATPVKNIVE
QMVKYWGEGASWQLDGNAHPHEAHYLKLDCSKAKMQLGWHPRWNLNTTLE
YIVGWHKNWLSGTDMHEYSITEINNYMNTK
>YP0826 wcaG2, putative nucleotide di-P-sugar epimerase or dehydratase
MDKKRVFIAGHRGMVGSAIVRQLENRNDIELIIRDRTELDLMSQSAVQKF
FATEKIDEIYLAAAKVGGIQANNNYPAEFIYQNLMIECNIIHAAHLAGIQ
KLLFLGSSCIYPKLAAQPMTEEALLTGVLEPTNEPYAIAKIAGIKLCESY
NRQYGRDYRSVMPTNLYGENDNFHPENSHVIPALLRRFHEAKIRNDKEMV
VWGTGKPMREFLHVDDMAAASVHVMELSDQIYQTNTQPMLSHINVGTGVD
CTIRELAETMAKVVGCTGNLVFDSTKPDGTPRKLMDVSRLAKLGWCYQIS
LEVGLTMTYQWFLAHQNNFRK
>YP1241 wcaG3, Nucleoside-diphosphate-sugar epimerases
MKVLVTGATSGLGRNAVEYLRRQEISVIATGRNQAMGALLTKLGAKFIHA
DLTDLVSSQAKAMLADVDTLWHCSSFTSPWGTEQAFALANVRATRRLGEW
AAAYGVENFIHISSPAIYFDYHHHRNIQEDFRPVRFANEFARSKAAGEEV
IKLLALSNPQTHFTILRPQGLFGPHDKVMLPRLLHMIKHYGTLLLPRGGD
ALVDMTYLENAVHAMWLATQSQKTLSGRAYNITNQQPRPLRTIVQQLLDA
LDMKCRIRSVPYPMMDIMARAMEKMSNKAEKEPVLTHYAVAKLNFDLTLD
TLRAEQELGYRPIISLDEGILRTARWLKEHGKFRG
>YP1440 wcaG4, putative exported protein
MKKVAIIGLGWLGMPLAQSLSRRGIDVVGSKTTPDGVDAARMSGINCYPL
VLTPELICEPDDLAQLMAVDALVITLPASRTTAGGDHYFQAVQQVVDSAL
AFGVPRIIFTSSTSVYGETRGRIKESSPLQPVTVAGKTLMALEQWLHQLP
HTSVDILRLAGLVGTDRHPGRFLAGKTGVKGGSQGVNLVHQEDVIAAIEL
LLNRPKGGHLYNLCAPIHPRKRDFYPACARALQLTPPEFAVEEQEGANRE
IDGSKICSELGFEYLYPDPSRMPLN
>YP1447 wcaG5, Nucleoside-diphosphate-sugar epimerases
MTKNKTGSETLKKLLLTGATGFLGGAVLEKLLLASSDFNYLLLVRANTPE
QGLMRIRENLEKFYLPNELINKININHVLLGDLAEPDSFINDVRIDDVTH
VINCAAIASFGNNPLIWKVNVEGTLAFGKRMAQVAGLQRFVHVGTAMACT
PEADTVVDERVLSTENDAHLVEYTKSKSAIECLLAEHCPTLPLVFARPSI
VVGHTRLGCQPSSSIFWVFRMALMLRKFMCSLDDHIDVIPVDYCADALLY
ILEYPNLPDDIYHISAGEKGSVSFSEIDQAMSVAAKQKPVGVNYSQVEYT
ALVQMRNQLKGIFGPCNERLMLKAMRLYGSFAMLNVRFSNERLLSLGMPR
TPRFTDYIARCVESSHGMTIQQQMAVDFK
>YP1828 wcaG6, putative dehydrogenase
MKVLVTGATSGLGRNAAQWLLEAGHEVYAIGRDQLAGEELRKLGATFIPL
DLTMTTMEVCQQWLKTCDVVWHCAAKSAPWGNPQDFHQTNVVVTHKLAQA
AGREGVKRFIHISSPAVYFDFRHHHDLPETYRASRFSSHYASSKYAAEQV
LHECIAHYPDTTYVILRPRGLFGPHDRVIVPRLLQQLSRDRNVLRLPGGG
QAQLDLTFVLNVVHAMMLATDNDGLRSGAIYNITNQEPQRLVTMLDSLLN
QQLHINYTLQPVPYSLLSVVAAGMELVASMTQKEPLLTRYSVGAVYFDMT
LNSERAINELGYRPRYSMAEGIVLAGEWLSAQRSGQHG
>YP1831 wcaG7, Nucleoside-diphosphate-sugar epimerases
MTNILITGASGFIGGAFMRRFACHDGIRLCGIGRRSVEGFPTSVRYQALD
LARLATLDFTPDVVIHAAGRAGPWGTRREYYRDNVVTTEQVIKFCQSRGN
PRLIYLSTAAVYYRYCHQLALTEQSEIGPEFANDYALTKHQGEALIEAYQ
GEKTILRPCAVFGPGDQLLFPPLLDAASRHGLPLLISEVPARGELMHIDV
LCGCLYSLVQGTEIMIYLAAIWLGILLFKLIFTLRMMKRGTQAGCGVPQA
TATILQPVLSGDPQLATVLEANVVALKQARFFWLIDDDDTVAREIAISIQ
SRYPDREIKASYFPPAPEGVNPKVFKLEQAWREVASDILLVLDDDAFLSA
ESFGTLLNQIEEGALVTALPYYCADSNGYSRLLAQFVNDNSGFTYLPLLP
FSPPLTINGMCYAISVNTLAQVGGFAAILHDLADDLALATLLRQHHIRLI
QSTAPVRVQTSLSSGKKYIQQMHRWFLFATLLLREKTVLIKLIIFLLQGL
HPLLMWAMLLTVGWEWVTAAHGITGINLGIIAACLLIRHAALRHVQQAIA
PDIRSNPIFSLLSELMQPLHLLHALCNRTIYWRTRRYRVLSNKKFNSL
>YP2036 wcaG8, Nucleoside-diphosphate-sugar epimerases
MMNIMITGAAGFLGRRLIDGLLQQDYLTDQQGEPRNINKIIAYDVLPLME
VEDPRVQVVCGDIADQNGLSAVWDRQIDTIFHLAAVVSSQAEDDFDLGMR
INVDATRSLLELARQSGQCPKVIITSSVAVFGGALPKVVPDNQVWSPQSS
YGTQKALNDLLLSDYSRRGFIDGRSLRMPTIVVRPGKPNRAASSFASGII
REPLQGHDAICPVSMQTPLWLLSPKMAIDNLIHGHELDASQLRLGRVINL
PGLSVSVQQMIDALRRLAGDEVVERIQVQRDPSIERIVNSWPGDFEASYG
KVLGFRRDPDFDSIIQDFIIENLPELAAEKHFI
>YP3400 xylA, xylose isomerase
MQSYFNELEQVRYEGSQSTNPLAFHHYNPDEMILGKRMADHLRFAACYWH
TFCWGGADMFGANAFDRPWQQPGDALALAKRKAEVAFEFFHKLNVPYYCF
HDVDVSPEGASLQEYLNNFAVMTDVLAEKQAASGVKLLWGTANCFTHPRY
GAGAATNPDPEVFSWAATQVFTAMNATRQLGGENYVLWGGREGYETLLNT
DLRQEREQIGRFMQMVVEHKHKTGFQGTLLIEPKPQEPTKHQYDYDVATV
YGFLKQFGLEKEIKVNIEANHATLAGHSFHHEIASAIALGIFGSVDANRG
DPQLGWDTDQFPNSVEENTLVMFEILKAGGFTTGGLNFDAKVRRQSTDKY
DLFYGHIGAMDTMALALKFAAKMIEDGQLDQIVAKRYAGWNSELGQQILQ
GKMSLEELSRYASQHNLNPQHQSGHQELLENKVNRYLFG
>YP1300 xylB1, putative carbohydrate kinase
MQALLGIDIGTSGCKALLIGIDGAVIAADTASYPLSQPQLGWAEQDPELW
VEGARRAVAGALAKAPTLELLCVGLSGQMHGLVSLDAGHQVLRPAILWND
QRNSAECEQITEAAGGLKGLLAATNNRMLVGYTGGKIVWMQQHEPDLFAR
MTTVLNPKDYLRLRLTGEVATEVSDASGTGLFDVRARQWASDLIENVGID
RALLPPVFESQVISGQVSAVGAELFGIPKGTPVAGGGGDAVIQTFGSGVI
APGELQTTIGTAGILAAALDTPQANPDGRLQVFCHVVADKWHCMGVSLNA
GGAMSWFRDTFYVGVNAAVPSFDQFTPSDQITPSDQITPSFEQIVAEAAA
SPAGARGLLFLPYLNGERCPHPDPAARGAFIGLTACHNRGDVARAVMEGV
VHALVDMHTLMKPLGINGRVVKTSGGGARSPLWRQMQADIFGCDVLTTKG
AAEGAAFGAALVAGLAIGVWPDATSATANCRIITREPPNPATAAVVAEAQ
RIYRTLYPALRETFAELGDPTFM
>YP3401 xylB2, xylulose kinase
MYVGIDLGTSGVKAILLAENGRVIASQNAALVVSRPHPLWSEQNPADWWQ
ATDQVMQALAAEHDMQQVKALGLTGQMHGATLLDKQHQVLRPAILWNDGR
SFSQCQTLEQAVPASRQITGNLMMPGFTAPKLQWLAEHEPDMFQCIDKVL
LPKDYLRFLMSGDFATDMSDAAGTMWLNIAQRDWSDEMLAACGLGRQHMP
TLFEGNQITGHVSADIAKRWGINRIPIVAGGGDNAAGAVGVGLYQAGQAM
LSLGTSGVYFAVSEGFLSNPASAVHSFCHALPNTWHLMSVMLSAASCLDW
ACQLTGAESVPALIAEVEKTPMAATPVWFLPYLSGERTPHNNPKAKGAFW
GFTHEHRRPDLARAVLEGVGFALADGMDALHASGLQPKSVTLIGGGARSA
YWRQMLADISGQTLEYRTGGDVGPALGAARLAQIAMNPDVSLADLLPALA
LEQTHLPDPQKHHYYTDRRVTFKKLYQQLLPLCE
>YP3766 xylB3, putative carbohydrate kinase
MTPNKQGIQEERAMSQLDTTTPSGDYLMALDAGTGSVRAVIFDLNGNQIA
AGQAEWLHLPVPDVPGSMEFDLTTNWQLTCQCIRQALHLAKLPASAIRAV
AACSMREGIVLYDRSGTPIWACANVDARASREVSELKELHNNGFELEVYQ
CSGQTLALSAMPRLLWLAHYRPDIYRQAGTLTMISDWLANMLSGELAVDP
SNAGTTGMLDLVTRNWQPNLLEMAGLRADILSPVKETGTLLGHVTAKAAQ
ECGLLAGTPVVMGGGDVQLGCLGLGVVHAGQTAVLGGTFWQQVVNLPQPI
IDPNMNTRINPHVIPGMVQAESISFFTGLTMRWFRDAFCAEEKLLAQRLG
IDTYSLLEDMAARVPAGAYGVMPIFSDVMRFKSWYHAAPSFINLSLDPEK
CNKATLFRALEENAAIVSACNLAQIAEFSGVKASSVVFAGGGAKGKLWSQ
ILADVTGVPVKVPVVKEATALGCAIAAGVGVGLYEALDKTGERLVRWERE
YIPNTEHKALYQAAKTNWQAVYTDQLGLVDCGLTTSLWKAPGL
>YP3399 xylF, sugar-binding periplasmic protein
MKFKNILLSACAALVMFSQPGFSKEIKIGMAIDDLRLERWQKDRDIFVNK
AESLGAKVFVQSANGNEETQMAQIENMINRGVDVLVIIPYNGQVLSNVIA
EAKREGIKVLAYDRMINNADIDFYISFDNEKVGELQAKNLVERVPQGNYF
LMGGSPVDNNAKLFRQGQMTVLNPLIKDGKIKIVGDQWVDAWLPENALKI
MENALTANNNNIDAVVASNDATAGGAIQALAAQGLAGKVAISGQDADLAA
IKRIVAGTQTMTVYKPISKLANDAAEIAVTLGNGEQPKANSTLNNGMKDV
PAYLLTPIQVDKNNIDSTIIADGFHKKADIY
>YP1658 ybtX, putative signal transducer
MSRVLMRNCSHIMDVIRRCGRRKWPRACGATTGFPRLESGCMSDVQSNVK
PLTLTTGRVIFAIAGVYVTQSLVSALSMQSLPALVRAAGGSLALAGATTL
FMLPWALKFIWAPWIERWRLPPGSQERRSRMLILRGQVALAAILTIAAAI
GWFGREGGFPDTQIVALFVLFMVAGTVASTIDIASDGFCVDQLTRTGYGW
GNSVQVGGSYLGMMCGGGVFLMLSAASGWPVAMLMMAVLIMALSLPLWRI
TEPTRTATIPHVPALGYALRRKQARLGLLLVLMLNSGMRFVLPLLAPLLL
DHGLSMSALGALFSGGNIAAGIAGTLAGGLLMKYTSPGRALLTAYGVQGI
ALLAVVMTLMMAPGHLLLPILQCLVIVQSISLACALVCLYATLMSLSSPL
QAGVDFTLFQCTDAAIAILAGVIGGVVAQHFGYAACFLFAGAFTLLAAWV
AYIRLHSARELMTSAID
>YP1405 ydeF, putative multidrug resistance protein
MQRFSSRVTNLLIASLVLTIGRAVTLPFITIYLVEHFQLAPDTVGLLLGA
SLALGIFTSLYGGYLVDKFNKKRLILLTIILFSATFFALPWIEHPAWVIL
TLALLHSAYSVYTIAVKACFADWLPVNERIKAFSANYTLVNVGWAIGPVM
GVLVVGFGPQLPFIISGALALLVAIVLKFRINDADMLATERVSSESVPDL
RQTFNILRHDKRLIYFTLGSLLGAMVFAQFSGYLSQYLITVFDAKFAYQV
IGAVMTVNATIVIALQYLLSRRMNQQNLMRWLMIGTLFFIIGLLGFMVAQ
DSIPLWMLAMAIFSLGEIIVIPAEYLFIDFIAPANLKGSYYGVQNLGQLG
GAINPVLCGFLLAYTVPEMMFYMLIIAATLGLVLFYRGYHLAK
>YP2717 yegB, putative membrane protein
MVTQATSVRWQLWIVAFGFFMQTLDTTIVNTALPSIAASLGENPLRMQSV
IVSYVLTVAVMLPASGWLADRIGVKWVFFSAIILFTFGSLMCAQSATLNE
LILSRVLQGVGGAMMVPVGRLTVMKIVPREQYMAAMAFVTLPGQIGPLVG
PALGGFLVEFASWHWIFLINLPVGVIGALATLLLMPNHKMSTRRFDISGF
IMLAIGMATLTLALDGHTGLGLSPLAIAGLILCGVIALGSYWWHALGNRF
ALFSLHLFKNKIYTLGLVGSMSARIGSGMLPFMTPIFLQIGLGFSPFHAG
LMMIPMIIGSMGMKRIIVQVVNRFGYRRVLVNATLLLAVVSLSLPLVAIM
GWTLLMPVVLFFQGMLNALRFSTMNTLTLKTLPDRLASSGNSLLSMAMQL
SMSIGVSTAGILLGTFAHHQVATNTPATHSAFLYSYLCMAIIIALPALIF
NRVPPDTGANRHLAR
>YP1909 zwf, glucose-6-phosphate 1-dehydrogenase
MTFFDAFLSGFTGYSQREYISNVRKLQISCNEENSMAVMNTVQVAQACDL
VIFGAKGDLARRKLLPSLYQLEKAGHIHPDTRIIGVGRAEWDKDAYTAVV
KEALDTFMKEPLDDELWQKLSSRLDFCNLDVNDSKHFTKLGKMLDQKHRT
TINYFAMPPSTFGAICKGLGEAGLNKEPSRVVMEKPLGTDLAPSRVINDQ
VAEYFNECQVYRIDHYLGKETVLNLLALRFANSLFASNWDNRTIDHVQIT
VAEEVGIEGRWGYFDQAGQMRDMIQNHLLQILTMIAMSPPADLSTDRIRD
EKVKVLRSLRRIDHTNVRETTVRGQYTAGFVQGNKVPGYLEEEGANKNSN
TETFVSIRVDIDDWRWAGVPFYLRTGKRLPSKCSEVVVYFKNPALNLFRE
SYQQLPQNKLTIRLQPDEGIEIEVLNKVPGLEHKHRLQTTKLDLSFSKTF
NEQHIADAYERLLLETMRGIQALFVRRDEVEEAWKWVDSIMNAWAADNEA
PKPYQSGTWGPVASVAMITRDGRSWNEFE